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This thesis deals with synthesis, reactivity and catalytic studies of group 10 (mainly 
palladium) organometallic compounds bearing benzannulated or remote N-heterocyclic 
carbene ligands. The findings of the research are presented in three chapters. 
Chapter 2 describes the synthesis and properties of complexes with the 
1,3-diisopropylbenzimidazolin-2-ylidene ligand (iPr2-bimy). Reaction of the sterically 
bulky 1,3-diisopropylbenzimidazolium bromide (A) with Pd(OAc)2 in the presence of 
NaBr yielded the monocarbene dimeric complex [PdBr2(iPr2-bimy)]2 (1) in high yield. 
Complex 1 can be readily cleaved by CH3CN, salt A, PPh3, pyridyl or bipyridyl ligands, 
isocyanides and different NHCs to afford monocarbene complexes with the respective 
co-ligands. A preliminary catalytic study showed that complex 1 is a highly active 
precatalyst in aqueous Suzuki-Miyaura coupling reactions. Three Pd(II) bis(carbene) 
complexes (12-14) with the iPr2-bimy ligand bearing different anionic co-ligands have 
also been synthesized, and their catalytic activities studied in the Mizoroki-Heck coupling 
reactions. In addition, the two Pt(II) complexes [PtBr2(iPr2-bimy)(DMSO)] (15) and 
[PtBr2(iPr2-bimy)2] (16) were obtained when salt A was reacted with PtBr2 in the 
presence of NaOAc in DMSO. The reactivity of complex 15 with PPh3 and pyridine was 
studied. 1H NMR and X-ray diffraction analyses revealed interesting intramolecular 
C-HM anagostic interactions in all complexes with the iPr2-bimy ligand synthesized in 
this work. 
Chapter 3 deals with a series of Pd(II) complexes with the 
1,3-dibenzhydrylbenzimidazolin-2-ylidene ligand (Bh2-bimy). Reaction of sterically even 
more demanding 1,3-dibenzhydrylbenzimidazolium bromide (C) with Pd(OAc)2 in 
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DMSO yielded a monocarbene Pd(II) complex (19) with a N-bound benzimidazole 
derivative, which resulted from an unusual NHC rearrangement reaction. Reaction of C 
with Ag2O, on the other hand, cleanly gave the Ag(I) carbene complex [AgBr(Bh2-bimy)] 
(20), which was used as a carbene-transfer agent to prepare the acetonitrile complex 
trans-[PdBr2(CH3CN)(Bh2-bimy)] (21). Dissociation of acetonitrile from complex 21 and 
subsequent dimerization afforded the dinuclear Pd(II) complex [PdBr2(Bh2-bimy)]2 (22) 
in quantitative yield. Furthermore, the catalytic activity of complex 22 in aqueous 
Suzuki-Miyaura cross-coupling reactions was studied and compared with that of its less 
bulky analogue [PdBr2(iPr2-bimy)]2 (1). 
The synthesis and properties of Pd(II) complexes with pyrazolin-4-ylidene ligands are 
described in Chapter 4. A few neutral and cationic mononuclear pyrazolin-4-ylidene- 
phosphine complexes (26a/b and 29a/b) were prepared via oxidative addition of 
4-iodopyrazolium salts to [Pd2(dba)3]/PPh3 and their catalytic activities are compared in 
aqueous Suzuki-Miyaura coupling reactions. The substituent effect of pyrazolin-4- 
ylidenes on complexation was studied in a series of Pd(II) complexes with PPh3 (33a-c) 
or pyridine (34a-c) as co-ligands where the 3,5-substituents of pyrazolin-4-ylidenes were 
varied from Me, Ph to iPr. In addition, two iodo-bridged dinuclear complexes (35a/b) 
were also synthesized via oxidative addition of 4-iodopyrazolium salts to [Pd2(dba)3]. 
The possibility of preparing di(pyrazolin-4-ylidene)-bridged complex was also explored 
and two such complexes (38-39) were successfully obtained. 
Most of the new compounds synthesized in this work have been characterized by X-ray 
diffraction analyses and are depicted in Chart 1.
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32a (R = Me); 32b (R = Ph); 
32c (R = iPr)
34a (R = Me); 34b (R = Ph); 
















































37a (n = 1); 37b (n = 2); 37c (n = 3)
n 2 BF4
26a (R = Ph) ; 26b (R = Me) 27a (R = Ph) ; 27b (R = Me)
28a (R = Ph) ; 28b (R = Me) 29a (R = Ph) ; 29b (R = Me)
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Chapter 1. Introduction 
 
1.1 Definition of carbenes 
 
Carbenes are neutral compounds featuring a divalent carbon atom with only six 
valence electrons. The geometry at the carbene carbon atom can be either linear or bent, 
depending on the degree of hybridization. The linear geometry is based on an 
sp-hybridized carbene center with two nonbonding energetically degenerate p orbitals (px 
and py). On the other hand, the bent geometry is adopted when the carbene carbon atom is 
sp2-hybridized. Upon transition from the sp- to sp2-hybridization, the energy of one p 
orbital, usually called p, remains almost unchanged while the newly formed sp2-hybrid 
orbital, normally called , is energetically stabilized as it acquires partial s character 
(Figure 1.1). The linear geometry is rarely observed. Most carbenes contain an 










linear bent  
Figure 1.1. Relationship between the carbene bond angle and the nature of the frontier 
orbitals. 
 
As shown in Figure 1.2, four electronic configurations can be conceived at the 
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sp2-hybridized carbene carbon atom. The two nonbonding electrons can occupy the two 
different orbitals with parallel spins (1p1), which leads to a triplet ground state (3B1 
state). Alternatively, the two nonbonding electrons can be paired with antiparallel spins in 
the same  or p orbital leading to two different singlet ground states (1A1 state). Under 
this category, the 2p0 configuration is generally more stable than the 0p2. Last, an 
excited singlet state with an antiparallel occupation of the  and p orbitals (1p1) is also 










 p11  p02  p20  p11
3B1 1B11A1 1A1  
Figure 1.2. Electronic configurations of sp2-hybridized carbenes. 
 
The ground-state spin multiplicity is a fundamental characteristic of carbenes that 
determines their properties and reactivities.2 Singlet carbenes possess a filled and an 
empty orbital and hence exhibit an ambiphilic character. On the other hand, triplet 
carbenes can be regarded as diradicals since they have two unpaired electrons. The 
multiplicity of the ground state is related to the relative energy of the  and p orbitals. A 
large energy gap of at least 2 eV between the  orbital and the p orbital is required to 
stabilize a singlet ground state, whereas an energy difference of less than 1.5 eV leads to 
a triplet ground state.3 It is generally accepted that, steric and electronic effects of the 
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substituents at the carbene carbon atom could influence the relative energy of the  and 
p orbitals and thus control the multiplicity of the ground state.  
 
1.2 Electronic structure, preparation and application of 
N-heterocyclic carbenes 
 
For a few decades, carbenes are known as very reactive intermediates and efforts to 
isolate a stable free carbene have not met with success until Arduengo et al. reported the 
first stable N-heterocyclic carbene (NHC) in 1991.4 It was prepared by deprotonation of 
1,3-diadamantylimidazolium chloride with sodium hydride and a catalytic amount of 
dimethyl sulfoxide (Scheme 1.1). This breakthrough triggered an intensive research on 
NHCs, which are recognized as bent singlet carbenes. Their stability* can be explained 
by the so-called “push-pull-effect”. The +M effect “pushes” the lone pair electrons of the 
N atoms into the empty p orbital of the carbene carbon atom and thus reduces the 
electron deficiency of the carbene center. This interaction also raises the relative energy 
of the p orbital, which leads to a larger energy gap between the  and p orbitals and thus 
stabilize the singlet ground state. In addition, the -I effect of the -electron-withdrawing 
N atoms “pulls” electrons from the carbene center, which stabilizes the  orbital and 
further increases the above-mentioned energy gap. A representative diagram illustrating 
the electronic interactions and their resonance structures of NHCs is depicted in Figure 
1.3.   
 
                                                        
* The stability mentioned here is relative. NHCs are still air- and moisture- sensitive but they are stable enough to be 



























X = N-R  
Figure 1.3. Representative electronic interactions and resonance structures of NHCs. 
 
Following Arduengo’s successful isolation of the first stable NHC which features an 
unsaturated five-membered ring with two nitrogen atoms, extensive search for additional 
stable carbenes have been carried out. To date, a large variety of stable NHCs have been 
isolated with different backbones (e.g. saturated, unsaturated or benzannulated), ring 
sizes (e.g. four-, five-, six-, or seven-membered ring), and heteroatoms (e.g., nitrogen, 
sulfur, phosphorus or boron).1 An overview of different types of stable NHCs is shown in 
Figure 1.4. Besides NHCs, acyclic diamino carbenes (ADCs) have also been reported by 
Alder shortly after the isolation of the first NHC.5 However, ADCs are not a topic of 

























R R  
Figure 1.4. Different types of stable NHCs. 
 
Amongst the types of stable NHCs reported, three major types, namely 
imidazolin-2-ylidene, benzimidazolin-2-ylidene and imidazolidin-2-ylidene, have 
attracted most research interest (Figure 1.5). Their reactivities as well as structural and 
spectroscopic properties have been studied in detail. It was found that both the saturated 
imidazolidin-2-ylidenes and the benzannulated benzimidazolin-2-ylidenes show lower 
stability than the unsaturated imidazolin-2-ylidenes. The former two have a higher 
tendency to undergo dimerization yielding electron-rich entetraamines 6 or 
dibenzotetraazafulvalene,7 respectively, if the nitrogen atoms are functionalized with 
sterically less bulky substituents, whereas no such dimerization was observed for 
imidazolin-2-ylidenes even with small N,N’-dimethyl groups.8 This can be explained by 
the larger singlet-triplet gap for unsaturated heterocycles compared to those for saturated 
or benzannulated ones.9,7b In addition, the 13C NMR spectroscopic data revealed that the 
13C NMR signal for the C2 carbon atom in a benzimidazolin-2-ylidene resonates 
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somewhere in between the typical values for the C2 resonance of unsaturated 
imidazolin-2-ylidene and saturated imidazolidin-2-ylidene. Despite the unsaturated nature 
of the five-membered carbene ring in a benzimidazolin-2-ylidene, its N1-C2-N3 angle 
determined crystallographically is actually in the range typical for saturated 
imidazolidin-2-ylidenes.7 Therefore, it appears that benzimidazolin-2-ylidenes exhibit the 
topology of an unsaturated NHC, but show spectroscopic and structural properties and 















saturated, nonaromaticunsaturated, aromatic benzannulated, aromatic
 (C2) [ppm]















Figure 1.5. Comparison of three major types of NHCs. 
 
This unique property of benzimidazolin-2-ylidenes is intriguing because it merges 
partial properties of saturated imidazolidin-2-ylidenes and unsaturated 
imidazolin-2-ylidenes. However, it is noticed that benzannulated carbenes and their 
complexes are far less established than the imidazole- or imidazoline-derived 
counterparts in literature. Hence, it is of our interest to explore the chemistry of 
benzimidazolin-2-ylidene and their transition metal complexes. The pertinent findings 
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will be presented in Chapter 2 and 3.  
A number of synthetic methods have been developed to generate stable NHCs. The two 
most commonly used methods are a) deprotonation of azolium salts and b) reductive 
desulfurization of thiones. For example, the first stable NHC was obtained by method a 
using NaH and catalytic amount of DMSO as the base (Scheme 1.1). Other 
frequently-utilized bases include KOtBu, nBuLi, Li[N(iPr)2] and M[N(SiMe3)2] (M = Li, 
K, Na). The choice of the base is determined by its relative steric bulk and basicity. On 
the other hand, the first free benzimidazolin-2-ylidene was synthesized using method b, 
as shown in Scheme 1.2.7a Molten Na/K alloy is usually required in this method to 









Scheme 1.2. Synthesis of the first benzimidazolin-2-ylidene. 
 
The relatively high stability of NHCs and the rapid development of their preparative 
methods have enabled NHCs’ applications in organic synthesis and catalysis.10 Several 
studies have shown that NHCs are powerful nucleophilic organocatalysts due to their 
high nucleophilicity and ease of structural modification. They have been employed as 
catalysts in both small molecule transformations (e.g. benzoin condensation and 
Michael-Stetter reaction) and living ring-opening polymerization. More remarkably, 
some chiral NHCs have made good achievements in asymmetric catalysis. With the 
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advantage of finely-tunable electronic and steric properties, it can be foreseen that NHCs 
will find wider and wider applications in the future.  
 













































CA = counter anion; B = NH, O, S; X = CH3, H, halogen  
Scheme 1.3. Major synthetic routes towards NHC complexes. 
 
  Following Arduengo’s discovery, a large number of NHCs have been reported in the 
past two decades. Even larger is the number of their complexes. Nowadays, NHC 
complexes cover all the transition metals as well as a large number of main-group 
elements. Versatile structures of NHC complexes bearing monodentate NHCs, bidentate 
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chelating NHCs or donor-functionalized NHCs, tripodal NHCs or pincer-type NHCs, etc, 
have been reported. Along the way a number of preparative methods towards NHC 
complexes have been established and the major ones are reviewed as follows (Scheme 
1.3): 
(a) The reaction of a free carbene with a suitable metal complex. This could be 
regarded as the most straightforward method for the preparation of NHC complexes. 
However, to apply this method, the NHCs to be introduced must be stable to a certain 
extent. Therefore, this method is less suitable for complexes bearing 
benzimidazolin-2-ylidenes or imidazolidin-2-ylidenes due to their rapid dimerization. 
(b) The reaction of an azolium salt with a suitable metal complex. This method 
involves in situ deprotonation of azolium salts in the presence of a metal complex with a 
basic ligand such as Pd(OAc)2 or [(cod)Ir(-OR)]2 (cod = cyclooctadiene). In fact, the 
first NHC complexes were obtained by Wanzlick and Öfele using this method long before 
the first free NHC was isolated.11 The major advantage of this method is that handling of 
air/moisture sensitive free carbenes can be avoided. Most of the 
benzimidazolin-2-ylidene complexes discussed in this work were prepared using this 
method.  
  (c) The cleavage of electron-rich entetraamines or dibenzotetraazafulvalenes with 
transition metals. Lappert and coworkers demonstrated that electron-rich enteraamines 
or dibenzotetraazafulvalenes can be cleaved by coordinatively unsaturated electrophilic 
metal complexes such as [PtCl2(PEt3)]2 to generated NHC complexes.12 This method 
broadens the scope of complexes bearing benzimidazolin-2-ylidenes or 
imidazolidin-2-ylidenes as these two types of NHCs normally exist in their respective 
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dimeric form.  
(d) The Ag-carbene transfer reaction. First reported by Lin and coworkers in 1998,13 
the Ag-carbene transfer method makes use of silver oxide as a basic metal-precursor to 
deprotonate azolium salts and generate silver NHC complexes. Due to the labile nature of 
the Ag-carbene bond, these complexes can serve as a carbene-transfer reagent to other 
metals such as palladium, gold and rhodium, and thus afford a wide range of metal 
complexes. This method has become a standard procedure in the synthesis of NHC 
complexes nowadays due to its mild reaction conditions, which normally gives rise to 
less decomposition and fewer by-products.  
  (e) The metal-template synthesis using isocyanide complexes as precursors. First 
discovered by Tschugajeff and Skanawy-Grigorjewa as early as 1915 14  and then 
extensively developed by Fehlhammer’s and Hahn’s groups, 15  this method uses 
isocyanide-coordinated complexes as templates to generate NHC or ADC complexes by a 
nucleophilic reaction between proton bases HX (X = OR, SR, RNH) and a coordinated 
isocyanide. Using this method, it is attempted to synthesize a mixed NHC-ADC Pd(II) 
complex in this work, which will be discussed in section 2.1.2. 
  (f) Oxidative addition of an azolium salt to a low-valent metal complex. This 
method was initially reported by Stone in 197416 and subsequently developed by Cavell 
and other groups.17 It involves oxidative addition of a carbon-X (X = alkyl, H, halogen) 
bond to a low oxidation-state metal precursor such as [Pd(PPh3)4] and [Ni(COD)2].  
These versatile synthetic methods ease the access to NHC complexes, which paved 
their way to wide applications in metal-mediated catalysis. Another reason for the 
burgeoning interest in NHC complex-mediated catalysis stems from the superior 
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properties of NHC ligands. As spectroscopic studies reveal, NHCs are principally 
-donors as well as poor -acceptors18 and are thus similar to trialkylphosphines, which 
are widely used ligands in organometallic catalysts. In addition, NHCs have an advantage 
over phosphines in that they are even more Lewis basic than electron-rich phosphines 
such as PMe3 and PCy3. Thus, metal complexes with NHCs are of relatively high 
chemical and thermal stabilities suggesting that they can potentially replace the 
well-established, but air-sensitive and environmentally problematic phosphine complexes 
in catalysis.  
  A number of studies have been conducted to investigate the catalytic activity of NHC 
complexes in various organic transformations.19 The most intensive research activities in 
this field are dedicated to the following processes: a) olefin metathesis catalyzed by 
ruthenium NHC complexes; b) C-C and C-N cross-coupling reactions catalyzed by 
palladium NHC complexes; c) hydrosilylation of alkenes and alkynes catalyzed by Pt(0) 
NHC complexes; d) oligomerization and polymerization catalyzed by nickel NHC 
complexes; e) hydrogenation of alkenes catalyzed by iridium or rhodium NHC 
complexes. Particularly, the first two topics have been the subjects of comprehensive 
reviews in recent years. Of great importance is the second generation Grubbs’ catalyst for 
olefin metathesis. It forms part of the contributions for which the inventor was awarded 
the 2005 Nobel Prize in chemistry shared with another two great chemists Chauvin and 
Schrock.20 In the second generation Grubbs’ catalyst one of the phosphine ligands in the 
first generation catalyst is substituted by a NHC ligand (Figure 1.6). Such a modification 
greatly increases the catalytic efficiency of the complex and also showcases the potential 















1st generation 2nd generation  
Figure 1.6. 1st and 2nd generation Grubbs’ catalysts.  
 
C-C and C-N cross-coupling reactions catalyzed by palladium NHC complexes is 
another topic of intensive interest in the field of NHC chemistry and the rapid progress on 
this topic has been reviewed recently by Organ et al.19a However, the vast majority of 
these catalysts contain NHCs that are derived from imidazole. Only a few studies have 
been conducted based on the benzimidazolin-2-ylidene system.21 For example, Hahn’s 
group reported on a series of pincer complexes bearing benzimidazolin-2-ylidene ligands, 
which were found to be effective catalysts in Mizoroki-Heck coupling reactions.21b-d 
Given the lack of investigation on the benzimidazolin-2-ylidene system, it is of our 
interest to study the catalytic activity of benzimidazolin-2-ylidene complexes, especially 
in C-C coupling reactions. It is generally accepted that the steric bulk of a ligand 
promotes the reductive elimination step occurring in the catalytic cycle of Heck-type C-C 
coupling reactions. Therefore, the sterically demanding 1,3-diisopropylbenzimidazolin-2- 
ylidene and 1,3-dibenzhydrylbenzimidazolin-2-ylidene are chosen as the ligands of 
interest in this work, and an in-depth investigation of the reactivity and catalytic activity 




1.4 Remote N-heterocyclic carbenes and their complexes 
  As an extension of the NHC concept discussed above, complexes bearing 
N-heterocyclic carbene ligands with a remote heteroatom (rNHC) have been reported by 
Raubenheimer and co-workers recently. In contrast to the common NHCs in which a 
carbenoid carbon is adjacent to two nitrogen atoms, rNHCs contain a carbenoid center 
which is distant from the nitrogen atoms. Computational studies on rNHCs derived from 
pyridine or quinoline have shown that these new carbenes are even stronger  donors 
than their well-known normal NHC counterparts.22 Furthermore, preliminary catalytic 
studies showed that complexes with rNHC ligands are more active in certain 
C-C coupling reactions than well-established standard NHC-containing precatalysts.22a, 23 
Despite these promising properties, rNHCs have not attracted the same degree of 
attention as normal NHCs yet. In contrast to the versatile structures known for common 
NHCs, the structure of rNHCs was limited to one-N-six-membered ring motifs derived 
from pyridine (A), quinoline (B) and acridine (C) (Figure 1.7). Although no free rNHC 
has been isolated so far, the successful preparation of rNHC complexes is still remarkable 

















Pyridin-4-ylidene Quinolin-4-ylidene Acridin-9-ylidene Pyrazolin-4-ylidene 




Given the promising properties of rNHCs and their complexes, it is of our great 
interest to study the little-investigated rNHC chemistry. Our initial focus is dedicated to 
the pyrazole-based rNHCs (type D, Figure 1.7) and their complexes, which may provide 
a more direct comparison with the most extensively-studied imidazolin-2-ylidenes and 
their respective complexes. The results regarding the pyrazole-based rNHCs and their 
complexes will be discussed in detail in Chapter 4. 
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Chapter 2. Palladium(II) and Platinum(II) Complexes with the
 1,3-Diisopropylbenzimidazolin-2-ylidene Ligand 
 





Synthesis and characterization of 1,3-diisopropylbenzimidazolium salts. In general, 
symmetrically 1,3-disubstituted benzimidazolium salts can be conveniently prepared 
from benzimidazole and suitable alkyl halides in the presence of a strong base. However, 
this methodology is limited to the use of primary alkyl halides, but less suitable for 
secondary or tertiary alkyl halides due to their tendency to undergo elimination reactions, 
which can be catalyzed by a strong base. To the best of our knowledge, except for one 
example with the ferrocenyl-substituted benzannulated carbene ligand,24 all of the other 
benzimidazolin-2-ylidene complexes reported prior to this work contain 
benzimidazole-nitrogen atoms that are bonded to a primary carbon25 or to a proton.26 A 
secondary carbon attached to the nitrogen is desirable, since it increases the steric bulk of 
the resulting benzannulated carbene ligand and therefore extends the scope of its 
application in catalysis. Thus, the 1,3-diisopropylbenzimidazolium salts iPr2-bimyH+X- 
(A: X = Br; B: X = I) are synthesized as sterically demanding carbene precursors, and 
high yields could be obtained using large excess of the corresponding alkylating agent 






H i. K2CO3, CH3CN, 1 h
ii. 3 eq. iPr-X, 1 d





A: X = Br
B: X = I
 
 




Figure 2.1. Molecular structure of A·H2O showing 50% probability ellipsoids; hydrogen 
atoms and the H2O molecule are omitted for clarity. Selected bond lengths [Å] and 
angles [°]: C1-N1 1.328(2), C1-N2 1.326(2); N1-C1-N2 110.90(14). 
 
 
The 1H NMR spectrum of salt A in CDCl3 shows a doublet at 1.88 ppm and a septet at 
5.21 ppm characteristic for the isopropyl groups. Furthermore, a downfield signal at 
11.45 ppm for the NCHN proton indicates the formation of an azolium salt. The positive 
mode ESI mass spectrum shows a base peak at m/z = 203 corresponding to the [M-Br]+ 
cation. As expected, the spectroscopic characteristics of salt B are largely similar to those 
of A, so no further comments on it are required. In addition, single crystals of the solvate 
AH2O were analyzed by X-ray diffraction for comparison purpose and its molecular 
structure is shown in Figure 2.1. 
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  Synthesis and characterization of [PdBr2(iPr2-bimy)]2. A general method for the 
preparation of Pd(II) bis(carbene) complexes involves the reaction of Pd(OAc)2 with two 
equivalents of azolium salts under in-situ deprotonation of the latter to form the 
corresponding carbene ligand. Surprisingly, initial attempts to synthesize a Pd(II) 
bis(carbene) complex by reacting Pd(OAc)2 with salt A in various organic solvents (THF, 
CH3CN and DMSO) at 90°C or in molten [N(n-Bu)4]Br as ionic liquid were 
unsuccessful and gave product mixtures with only negligible yield of the desired 
bis(carbene) complex. Even the Ag-carbene transfer method13 showed similar results. 
Instead, the novel dimeric Pd(II) benzimidazolin-2-ylidene complex [PdBr2(iPr2-bimy)]2 
(1) was isolated as the main and kinetically controlled product in all cases. Since complex 
1 is a useful precursor for a range of monocarbene complexes, an optimized synthetic 
pathway for its preparation was sought. A synthetic protocol for dimeric carbene 
complexes by equimolar reaction of an azolium salt with Pd(OAc)2 in the presence of the 
base KOtBu and excess NaI has been reported by Enders.27 This methodology proves 
successful for carbenes derived from imidazole and imidazoline. However, when this 
reaction was carried out with benzimidazolium salt A, substantial deposition of black 
palladium was observed proving this method less suitable for the preparation of 
benzimidazolin-2-ylidene analogues. It was anticipated that the formation of undesired 
black palladium was most likely due to the highly reactive base KOtBu. Therefore its use 
in further attempts was omitted. With this modification, the reaction proceeded much 
cleaner and a high yield of 93% for 1 was achieved by addition of four equivalents of 


















Scheme 2.2. Synthesis of the dimeric monocarbene Pd(II) complex 1. 
 
The formation of complex 1 was confirmed by 1H NMR spectroscopy, which shows 
the absence of the NCHN proton indicative of A. Furthermore, a significant downfield 
shift of the isopropyl CH resonance was observed upon coordination of the carbene 
ligand to the Pd(II) center from 5.21 ppm in the precursor-salt A to 6.54 ppm in 1 (H = 
1.33 ppm). The large downfield shift of these protons is presumably caused by some type 
of interaction with the Pd atom. In the literature, a few of metal-hydrogen interactions 
(X-H···M, X = C, N) including agostic,28 anagostic interactions28d,29 and hydrogen 
bonding28c, 29g, 30 have been described. Although there is no clear-cut difference among 
these types of interactions, each of them has signature spectroscopic and geometric 
properties which allow them to be distinguishable from each other (Table 2.1). In contrast 
to the upfield shift of an agostic interaction and a linear X-H···M geometry characteristic 
of hydrogen bonding, the significant downfield shift of the isopropyl C-H protons and the 
geometric parameters (Vide infra) observed for complex 1 best fit the definition of an 
anagostic interaction. Such an interaction has recently been observed in Rh(I) complexes 
of NHC ligands.31 However, the origin of such interactions is still under debate and may 




Table 2.1. Comparison of agostic, anagostic intereactions and hydrogen bonding.29d 




Bonding 3c-2ea largely electrostatic 3c-4ea 
X-H···M distance [Å] 1.8-2.2 2.3-2.9 2.65-3.5 
X-H···M angle [°] 90-130 130-170 160-180 
1H NMR chemical  
shift of X-H protons 
upfield shiftb downfield shiftb downfield shiftb 
a “e” means electron and “c” means center. b In comparison with the analogous chemical 
shift in a free ligand. 
 
 
Figure 2.2. Molecular structure of complex 1·C6H5CH3 showing 50% probability 
ellipsoids; the toluene molecule and hydrogen atoms except for H8 and H11 are omitted 
for clarity. Selected bond lengths [Å] and angles [°]: C1-N1 1.341(4), C1-N2 1.338(4), 
Pd1-C1 1.947(3), Pd1-Br1 2.5281(4), Pd1-Br2 2.4182(4), Pd1-Br1A 2.4543(4); 
N1-C1-N2 108.8(2), C1-Pd1-Br2 87.50(9), C1-Pd1-Br1A 89.26(9), Br1-Pd1-Br2 
95.413(14), Br1-Pd1-Br1A 87.857(13), Pd1-Br1-Pd1A 92.143(13). 
 
 
The dimeric complex 1 crystallized as a toluene solvate 1C6H5CH3 and its molecular 
structure is shown in Figure 2.2. Each of the two Pd(II) centers is coordinated to one 
carbene, one terminal bromo and two bridging µ-bromo ligands in an almost perfect 









crystallographic inversion center, the carbene ligands are oriented anti relative to each 
other. The carbene ring planes are oriented almost perpendicularly to the Pd2C2Br4 
coordination plane with a dihedral angle of 83.5°, which is typical for NHC complexes, 
to relieve steric congestion. The Pd-C bond length of 1.947(3) Å is in the same range 
observed for imidazolin-2-ylidene derived analogues.32 There are three types of Pd-Br 
bonds in the complex, of which the Pd1-Br1 bond trans to the carbene ligand is 
significantly longer than the other two due to the strong trans influence of the NHC. 
Compared to the precursor-salt A, the Ccarbene-N1/N2 bond lengths have slightly increased, 
which is accompanied by a slight decrease of the N-C-N angle of 2.1°. Other bond 
parameters remain largely unchanged. More importantly, in contrast to the random 
orientation of the isopropyl CH protons in salt A, all the isopropyl CH groups in complex 
1 are orientated towards the metal center giving rise to relatively short C-H···Pd distances 
of 2.664 and 2.718 Å† (cf. sum of the van der Waals radii of H and Pd = 2.83 Å), which 
is in agreement with the large downfield shift of these protons in the 1H NMR spectrum 
indicating C-H···Pd anagostic interactions.  
 
2.1.2 Reactivity studies 
 
It was found that the dimeric monocarbene complex 1 can be readily cleaved by 
addition of other ligands. Therefore, its reactivity towards a large variety of donors was 
studied in detail and a range of monocarbene complexes with various co-ligands have 
                                                        
† Conclusions derived from one isolated X-ray crystal structure can be uncertain in view of the difficulty of locating 
hydrogen atoms in X-ray molecular structures. In studying a larger number of similar structures, however, any broad 
pattern that appears is likely to be real. In fact, all the structures of 1,3-diisopropylbenzimidazolin-2-ylidene complexes 
of Pd(II) and Pt(II) reported in this chapter show the fixed orientation of the isopropyl CH protons towards the metal 


















































































6a : R = Cyclohexyl (Cy)
6b : R = n-Butyl (nBu)

















Scheme 2.3. Cleavage of 1 with various ligands. 
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Cleavage of 1 with acetonitrile. The neutral complex 
trans-[PdBr2(CH3CN)(iPr2-bimy)] (2) forms when 1 is heated in the coordinating solvent 
CH3CN. The 1H NMR spectrum of the product in CD3CN shows that complex 2 has 
formed as the sole product. The signal for the isopropyl CH protons at 6.13 ppm is still 
significantly downfield compared to the ligand precursor A indicating that the C-HPd 
anagostic interactions are maintained upon cleavage of 1 and subsequent coordination of 
the CH3CN ligand. The 1H NMR spectrum of the same product in CDCl3, on the other 
hand, shows two sets of signals corresponding to 1 and 2. Comparison of the integrals 
reveals that the two complexes are in equilibrium in a dimer/monomer ratio of 
approximately 1:1. The formation of 2 is therefore reversible and only preferred in an 




Figure 2.3. Molecular structure of complex 2 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: C1-N1 
1.348(2), C1-N2 1.349(2), Pd1-C1 1.9359(19), Pd1-Br1 2.4143(3), Pd1-Br2 2.4287(3), 
Pd1-N3 2.0814(17), C14-N3 1.130(3); N1-C1-N2 108.25(16), C1-Pd1-Br1 85.90(6), 
C1-Pd1-Br2 87.89(6), N3-Pd1-Br1 92.76(5), N3-Pd1-Br2 93.55(5), Pd1-N3-C14 




The molecular structure of complex 2 (Figure 2.3) also reveals that the isopropyl CH 
groups are pointing to the palladium center resulting in short C-HPd distances of 2.694 
and 2.695 Å, respectively. In addition, the two bromo ligands cis to the NHC are 
surprisingly bent towards this ligand [C1-Pd1-Br1 85.90(6)° and C1-Pd1-Br2 87.89(6)°] 
rather than towards the non-bulky CH3CN ligand. The distances of these bromo ligands, 
Br1 and Br2, to the Ccarbene atom amount to 2.984 and 3.049 Å, respectively, and are well 
within the sum of the van der Waals radii for carbon and bromine (3.55 Å) suggesting 
weak intramolecular interactions between the bromo ligands and the Ccarbene. To the best 
of our knowledge, such a phenomenon has not been reported for group 10 metals. 
However, Abernethy and Cowley recently reported a similar but more pronounced 
behavior of chloro ligands in the high-oxidation-state transition-metal complexes 
[V(O)Cl3(NHC)] 33  and [Ti(NMe2)2Cl2(NHC)] 34  (NHC = 1,3-dimesitylimidazolin-2- 
ylidene). The nature of this halo-carbene interaction was attributed to a form of 
backbonding to the formally vacant p-orbital of the Ccarbene atom with the electron density 









Figure 2.4. Calculated HOMO-8 orbital of [V(O)Cl3(NHC)] 33 showing the interaction 











Cleavage of 1 with benzimidazolium salt A. Interestingly, complex 1 can also be 
readily cleaved by addition of another two equivalents of salt A affording the novel 
complex (iPr2-bimyH)[PdBr3(iPr2-bimy)] (3) in the form of an ion pair. Complex 3 
contains a NHC stabilized tribromo complex-anion, the charge of which is compensated 
by the corresponding benzimidazolium cation (iPr2-bimyH)+. In that respect, complex 3 
can be regarded as a model compound possibly occurring in an ionic liquid promoted 
catalytic cycle, in which an ionic salt e.g. [N(n-Bu)4]Br (TBAB) stabilizes a 
coordinatively unsaturated metal center. The formation of complex 3 is supported by 
negative mode ESI spectrometry, which shows an isotopic envelope centered at m/z = 549 
corresponding to the complex-anion [PdBr3(iPr2-bimy)]-. 1H NMR spectroscopy 
performed on crystals of 3 in CDCl3 shows not only the presence of 3 but also signals of 
the parent compound 1, indicating that the association of salt A and thus the formation of 
3 is reversible. It is worth mentioning that such a reversible behavior is undoubtedly 
desirable, especially in catalysis, since it offers both the possibility of stabilization of 




Figure 2.5. Molecular structure of complex 3·4CHCl3 showing 50% probability 
ellipsoids; the CHCl3 molecules and hydrogen atoms except for H8, H11, H21 and H24 
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are omitted for clarity. Selected bond lengths [Å] and angles [°]: C1-N1 1.340(6), C1-N2 
1.340(7), Pd1-C1 1.951(5), Pd1-Br1 2.5042(7), Pd1-Br2 2.4284(7), Pd(1)-Br3 2.4441(7), 
C14-N3 1.321(8), C14-N4 1.337(8); N1-C1-N2 108.7(4), C1-Pd1-Br2 85.11(14), 
C1-Pd1-Br3 87.83(14), Br1-Pd1-Br2 93.06(3), Br1-Pd1-Br3 94.01(2), N3-C14-N4 
111.3(6). 
 
X-ray diffraction studies and 1H NMR spectroscopy support the presence of weak 
C-H···Pd anagostic interactions only in the complex-anion. In the counter-cation, on the 
other hand, the orientation of the N-isopropyl groups is random. The molecular structure 
of complex 3 depicted in Figure 2.5 also reveals intramolecular Ccarbene···Br interactions 
with distances of 3.069 and 2.983 Å, respectively. 
Cleavage of 1 with triphenylphosphine. Neutral and mixed NHC-phosphine 
complexes of palladium(II) derived from imidazole,35 imidazoline36 and even pyrazole37 
have been reported to be active catalyst precursors for C-C couplings and amide 
-arylations. But no analogues containing a benzimidazolin-2-ylidene ligand are known. 
Hence, the cleavage of parent complex 1 with triphenylphosphine to form the mixed 
phosphine-benzimidazolin-2-ylidene complexes cis- and trans-4 was investigated. The 
reaction is rapid affording trans-[PdBr2(iPr2-bimy)(PPh3)] (trans-4) as the kinetically 
controlled and initial major product, which slowly isomerizes to cis-4. The 1H NMR 
spectrum of trans-4 in CDCl3 shows a characteristic multiplet at 6.03 ppm for the C-H 
protons and a doublet at 1.76 ppm for the Me-groups of the N-isopropyl substituents. The 
C-H protons of the cis-isomer, on the other hand, resonate at higher field with a chemical 
shift of 5.84 ppm. Furthermore, two doublets of equal intensity are found at 1.66 and 
0.87 ppm indicating two inequivalent Me-groups. This observation is in agreement with a 











Figure 2.7. Concentration/time diagram (amount of cis-4 [%] vs time [min]) for the 
conversion of trans-4 to cis-4 in CD2Cl2 () and CD3CN (■).  
 
Due to these distinct differences, the relatively slow trans-cis isomerization can be 
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easily monitored by 1H NMR spectroscopy. Figure 2.6 depicts the time-dependent 1H 
NMR spectra in the range of 5.75–6.20 ppm (isopropyl C-H group) recorded in CD2Cl2. 
The predominant species after 5 min (~0.08 h) is trans-4 (6.03 ppm), which slowly 
isomerizes to cis-4 (5.84 ppm) with a ~50% conversion after 16 h. After 46 h most of 
trans-4 has transformed into cis-4. The same isomerization is much faster when 
monitored in CD3CN revealing that the rate of conversion is solvent-dependent and a 
comparison of the resulting reaction profiles is shown in Figure 2.7. The thermodynamic 
preference of cis-4 over trans-4 can be explained by the transphobia effect, a term 
proposed by Vicente and co-workers38 for the difficulty of placing a phosphine ligand 
trans to carbon donors such as aryl or aroyl in Pd complexes. Apparently, the 
isomerization of trans-4 to cis-4 suggests that this transphobia is also valid for 
carbene-phosphine pairs. 
Complete conversion to cis-4 in a lab-scale experiment can be achieved by refluxing 
the reaction mixture in CH2Cl2 overnight. The molecular structure of cis-4 is depicted in 
Figure 2.8. The Pd-C bond of 1.978(3) Å is significantly longer than that found in the 
parent dimer 1 [1.947(3) Å], which may be due to both steric repulsion and a less Lewis 
acidic metal center induced by the coordination of the -donating phosphine ligand. This 
also explains the weaker C-H···Pd interactions with distances of 2.702 and 2.773 Å. 
Furthermore, the Pd-Br2 bond trans to the NHC [2.4815(4) Å] is slightly longer than the 
Pd-Br1 bond trans to the phosphine [2.4761(4) Å] confirming a slightly stronger trans 







Figure 2.8. Molecular structure of complex cis-4 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: C1-N1 
1.342(4), C1-N2 1.343(4), Pd1-C1 1.978(3), Pd1-P1 2.2624(8), Pd1-Br1 2.4761(4), 
Pd1-Br2 2.4815(4); N1-C1-N2 108.4(3), C1-Pd1-Br1 84.13(8), C1-Pd1-P1 91.61(9), 
Br1-Pd1-Br2 92.626(14), P1-Pd1-Br2 91.50(2). 
 
 
Cleavage of 1 with pyridyl and different bipyridyl ligands. It is known that 
aromatic N-heterocycles have some unique electronic properties as classical ligands in 
coordination compounds. For instance, they can provide the opportunity of  
backbonding and thereby may affect the delocalization of electrons in their complexes.39 
Hence, it was of interest to investigate the cleavage of 1 with pyridyl or bipyridyl types of 
ligands. The resulting linear dinuclear Pd(II) complexes containing bis(4-pyridyl) linkers 
can be regarded as potential building blocks towards supramolecular structures and 
coordination polymers. As shown in Scheme 2.3, complex 5a forms when 1 is stirred in 
pyridine and complexes 5b-d form in good yield, respectively, when 1 is treated with one 
equivalent of the corresponding bridging ligand. It is noteworthy that the equimolar 
stoichiometry of reagents is important for the formation of 5b-d. When complex 1 and 
two equivalents of the bridging ligand were dissolved in CDCl3, three sets of signals were 
Chapter 2 
 29
observed in the 1H NMR spectrum. These signals correspond to the bridged complex, the 
unbridged complex and the free ligand distinct in their 2,6-py-H resonances. The desired 
bridged complexes 5b-d show 2,6-py-H resonances, which are generally shifted 
downfield by 0.52-0.57 ppm compared to those of the corresponding free ligands with the 
most highfield values. The unbridged complex shows two intermediate chemical shifts 
with the resonance for the coordinated pyridine ring being more downfield by ~0.5 ppm 
compared to that for the uncoordinated pyridine ring. A comparison of their integrals 
revealed that the ratios of bridged complex : unbridged complex : free ligand are ~ 1:2:1 




Figure 2.9. Molecular structure of complex 5a; hydrogen atoms and one of the 
disordered pyridine rings are omitted for clarity. Selected bond lengths [Å] and angles [°]: 
C1-N1 1.352(5), C1-N2 1.342(5), Pd1-C1 1.953(4), Pd1-N3 2.113(3) 2.154(3), Pd1-Br1 
2.4113(7), Pd1-Br2 2.4310(6); N1-C1-N2 107.7(3), C1-Pd1-Br1 86.77(10), C1-Pd1-Br2 
86.63(10), N3-Pd1-Br1 91.23(12) 96.13(12), N3-Pd1-Br295.83(12) 90.29(12). 
 
The structural and spectroscopic data show that the coordination of pyridyl or bipyridyl 
ligands does not affect the intramolecular C-H···Pd and Ccarbene···Br interactions to any 
great extent and no detailed discussion is required. The molecular structures of complexes 
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5a-b are shown in Figure 2.9 and 2.10, respectively, as representatives. Interestingly, 
there are two independent molecules in the solid state of complex 5b. As depicted in 
Figure 2.10, one of them has two coplanar pyridine rings while the other has the two 
pyridine rings twisted with a torsion angle of 46.2°. There is no preference for any of the 






Figure 2.10. Molecular structures of the two independent molecules in the solid state of 
complex 5b2THF showing 50% probability ellipsoids; hydrogen atoms and the THF 
molecules are omitted for clarity. Upper: with the two coplanar pyridine rings; selected 
bond lengths [Å] and angles [°]: C19-N4 1.336(10), C19-N5 1.341(10), Pd2-C19 
1.955(8), Pd2-N6 2.101(7), Pd2-Br3 2.4313(12), Pd2-Br4 2.4304(12); N4-C19-N5 
108.4(7), C19-Pd2-Br3 89.0(2), C19-Pd2-Br4 86.8(2), N6-Pd2-Br3 92.8(2), N6-Pd2-Br4 
91.4(2). Lower: with the two twisted pyridine rings; selected bond lengths [Å] and angles 
[°]: C1-N1 1.346(9), C1-N2 1.321(9), Pd1-C1 1.959(7), Pd1-N3 2.102(6), Pd1-Br1 
2.4238(11), Pd1-Br2 2.4293(12); N1-C1-N2 109.1(6), C1-Pd1-Br1 88.0(2), C1-Pd1-Br2 




The electronic properties of complexes 5a-d were studied by UV-vis spectroscopy and 
cyclic voltammetry. The UV-vis absorption spectra for these complexes and their 
precursor complex 1 measured in CH2Cl2 are depicted in Figure 2.11. Complexes 5a-c 
show very weak absorption bands at 355-370 nm corresponding to a metal-to-ligand 
charge-transfer (MLCT).40 Furthermore, the spectra of complexes 1 and 5a-b exhibited 
absorbance maxima at ca. 240, 275 and 280 nm, which are assigned to intraligand * 
transitions. However, for complexes 5c-d, the highest energy transitions are blue-shifted 
and centered at ca. 230 nm. Complex 5d also shows two intense red-shifted bands at 306 
and 317 nm probably due to the additional double bond in the bridging ligand, which 
results in an extended conjugation. No luminescence was observed from any of these 




Figure 2.11. UV-vis spectra of complexes 5a-d and their parent complex 1. 
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  Cyclic voltammograms (CV) of complexes 5a-d were recorded in CH3CN. The 
dinuclear complexes 5b-d behave rather similarly to the mononuclear complex 5a. All 
CVs are nearly identical and each exhibits only an irreversible reduction wave at about 
-1375 mV versus [Cp2Fe]0/[Cp2Fe]+, possibly corresponding to the reduction of Pd(II) to 
Pd(0) species and subsequent decomposition. The fact that only one reduction wave was 
observed for each of the dinuclear species leads us to propose that no strong 
intramolecular communication of the Pd centers exist in these complexes.  
Cleavage of 1 with isocyanide ligands. Although isocyanides (C≡N-R) are versatile 
ligands in organometallic chemistry, their role has always been overshadowed by the 
prominent CO ligand. Compared to the latter, isocyanides exhibit stronger -donor and 
weaker -acceptor character, which can be tuned by the substituent R and the complex 
fragment they are coordinated to. Thus the metal fragment has also substantial influence 
on the reactivity and stability of coordinated isocyanide ligands. Therefore, it became of 
interest to study the behavior of isocyanides coordinated to a Pd(II) center supported by a 
benzimidazolin-2-ylidene ligand. As shown in scheme 2.3, the desired mixed 
NHC-isocyanide complexes [PdBr2(iPr2-bimy)(CN-R)] (6a: R = Cy; 6b: R = nBu; 6c: 
R = Xyl) were obtained in high yields by stirring 1 with two equivalents of the respective 
isocyanide ligand in dry THF at ambient temperature under a nitrogen atmosphere for 5 h. 
In all three cases, the product was obtained as an inseparable mixture of trans- and 
cis-isomers as indicated by two sets of signals in their 1H and 13C NMR spectra. Similar 
to the case of trans-/cis-4, the methyl groups of the isopropyl substituents in 
trans-isomers give rise to one doublet, whereas those in cis-isomers give rise to two 
doublets, allowing for a differentiation of these isomers. As expected, 13C NMR 
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spectroscopy also revealed two carbene signals. Those in the trans-isomers resonate at 
~168 ppm, which are generally more downfield than those at ~164 ppm found for the 
cis-isomers. A further comparison of the former with the analogous resonances in other 
complexes of the type trans-[PdBr2(iPr2-bimy)2L]n- {L = CH3CN, n = 0 (2); L = Br-, n = 1 
(3); L = “Py”, n = 0 (5a-d)} revealed a trend. As shown in Table 2.2, the carbene 
resonance shifts downfield as the -donating ability of the trans ligand L increases. In 
this series, the weakest -donor, CH3CN, leads to the most upfield, whereas coordination 
of the strongest -donor, isocyanide, results in the most downfield 13C chemical shift. In 
between, the bromo ligand is found to be a stronger -donor than pyridyl-based ligands. 
Such a correlation has also been reported by Herrmann and more recently by Baker for 
other NHC complexes.41  
 
Table 2.2. Comparison of carbene resonances for complexes of the type 
trans-[PdBr2(iPr2-bimy)2L]n-. 
 
Complex (L) Ccarbene [ppm] 
2 (CH3CN) 158.4b 
5a-d (“Py”) 159.4-160.0d 
3 (Br-) 165.6c 
6a-c (isocyanide) 168.8-169.1c 
aH = H(CHMe2 in complex) - H(CHMe2 in salt A). bMeasured in CD3CN. cMeasured in 
CDCl3. dMeasured in CDCl3 with exception for complex 5d (in CD2Cl2). 
 
In addition, the aromatic protons of the benzimidazolin-2-ylidene ligand also give rise 
to two sets of signals in the 1H NMR spectra with those for the trans-isomers being more 
upfield than those for the cis-isomers. A comparison of their integrals revealed that the 
trans form is generally the major product with trans:cis ratios of ~3:1 (6a), ~3.5:1 (6b) 
and ~8:1 (6c). These ratios remained largely unchanged over a few days as monitored by 
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1H NMR spectroscopy in CDCl3. However, prolonging the reaction time from 5 h to 5 d 
-ceteris paribus- afforded different trans:cis ratios of ~0.2:1 (6a), ~9.7:1 (6b) and ~4.9:1 
(6c). Interestingly, the supposedly most bulky and donating isocyanide ligand (CN-Cy) 
leads preferably to the cis-isomer in CDCl3 solution, whereas the least bulky one 
(CN-nBu) prefers to form the trans-isomer. Surprisingly, the isomer-ratio for complexes 
formed with the least donating, but also somewhat bulky aromatic isocyanide (CN-Xyl) 
is found in between those of the aliphatic ones, indicating that this isomerization is not 
simply driven by the stereoelectronic properties of the isocyanide ligands. Instead, the 
fine interplay between different polarities of the geometric isomers and those of the 
solvent used should influence their distribution to a great extent.  
 
Table 2.3. ~(CN) and ~(CN)b for complexes 6a-6ca. 
 
 6a 6b 6c
~(CN) 2234 2229 2194
~(CN) 94 79 74 
a Measured in KBr pellet (cm-1). b ~(CN) = ~(CN)complex - ~(CN)free ligand 
 
Complexes 6a-c all show a strong CN IR absorption band in the range of 
2234-2194 cm-1, which is shifted to higher frequency with respect to that of the 
corresponding free isocyanides, indicating successful coordination of the isocyanide 
ligands. It may be worth noting that, although the NMR data clearly shows the presence 
of trans-/cis-isomers in solution, only one CN vibration band was observed for each pair 
of isomers both in CHCl3 solution and in KBr pellet. It was found that the CN-R 
stretching frequency decreases in the order of Cy > nBu > Xyl (Table 2.2), which may be 
explained by a higher CN bond order due to the more electron-donating cyclohexyl 
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substituent compared to the other two.42 The same trend was observed when comparing 
~(CN) (Table 2.3). 
Single crystals of 6a-c suitable for X-ray diffraction analysis were obtained by 
diffusion of pentane into a chloroform solution (6a) or by evaporation of a 
dichloromethane/hexane solution (6b) or a THF solution (6c). Their molecular structures 
are depicted in Figure 2.12. Interestingly, complexes cis-6a and trans-6a crystallized 
concurrently as needles and square blocks, respectively. On the other hand, complex 6b 
crystallized as cis- while complex 6c crystallized as trans-isomer. The Pd-CCN bonds in 
complex cis-6a and cis-6b are 1.930(4) and 1.939(3) Å, respectively. These bond 
distances are notably shorter than that found in the complex trans-6a [2.020(9) Å] and 
trans-6c [2.000(2) Å], in which the isocyanide ligand experiences the strong trans 
influence of a NHC ligand. The CN bonds in all isocyanide complexes 6a-c fall in the 
narrow range of 1.130-1.145 Å indicating triple-bond-character and thus negligible 
-back donation from the metal. In agreement with this, all isocyanide ligands display a 
nearly-linear geometry with CN-C angles ranging from 174.1(2)° to 179.4(11)°. It 
should be noted that linearity of coordinated isocyanide ligands alone does not 
necessarily rule out -back donation from the metal center to the isocyanide ligands as 










Figure 2.12. Molecular structures of complexes cis-6a (a), trans-6a (b), cis-6b (c) and 
trans-6c (d) showing 50% probability ellipsoids; hydrogen atoms are omitted for clarity. 
Selected bond lengths [Å] and angles [°]: cis-6a: N1-C1 1.348(5), N2-C1 1.324(5), 
Pd1-C1 1.979(4), Pd1-C14 1.930(4), Pd1-Br1 2.4347(5), Pd1-Br2 2.4556(5), N3-C14 
1.134(5), N3-C15 1.459(5); C14-Pd1-C1 86.45(15), C14-Pd1-Br2 89.84(11), C1-Pd1-Br1 
88.22(10), Br1-Pd1-Br2 95.49(2), N1-C1-N2 108.8(3), C14-N3-C15 175.4(4). trans-6a: 
N1-C1 1.350(11), N2-C1 1.346(11), Pd1-C1 1.984(9), Pd1-C14 2.020(9), Pd1-Br1 
2.4072(16), Pd1-Br2 2.4312(14), N3-C14 1.130(12), N3-C15 1.452(13); Br1-Pd1-C1 
86.7(3), C14-Pd1-Br1 89.6(3), C1-Pd1-Br2 87.9(3), C14-Pd1-Br2 95.9(3), N1-C1-N2 
108.4(7), C14-N3-C15 179.4(11). cis-6b: N1-C1 1.336(3), N2-C1 1.346(3), Pd1-C1 
1.978(3), Pd1-C14 1.939(3), Pd1-Br1 2.4422(4), Pd1-Br2 2.4745(3), N3-C14 1.133(4), 
N3-C15 1.444(4); C14-Pd1-C1 88.68(11), C14-Pd1-Br2 90.92(8), C1-Pd1-Br1 85.53(7), 
Br1-Pd1-Br2 94.874(13), N1-C1-N2 108.6(2), C14-N3-C15 178.0(3). trans-6c: N1-C1 
1.347(3), N2-C1 1.349(3), Pd1-C1 1.992(2), Pd1-C14 2.000(2), Pd1-Br1 2.4263(3), 
Pd1-Br2 2.4278(3), N3-C14 1.145(3), N3-C15 1.405(3); C14-Pd1-Br1 91.71(7), 
C14-Pd1-Br2 91.11(7), C1-Pd1-Br1 88.03(6), C1-Pd1-Br2 89.23(6), N1-C1-N2 
107.75(17),C14-N3-C15 174.1(2). 
 
It has been well documented that coordinated isocyanides with ~(CN) values greater 
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than 40 cm-1 can undergo nucleophilic attack by amines or other nucleophiles to give 
carbene complexes.44 Thus, it is of our interest to explore the possibility of using the 
mixed Pd(II) NHC-isocyanide complexes as potential metal-templates to synthesize 
mixed Pd(II) NHC-ADC complexes which are not known so far. Crociani and coworkers 
have reported that aromatic isocyanides undergo nucleophilic attack much more easily 
than aliphatic ones due to the higher electron susceptibility induced by the 
electron-withdrawing aromatic groups.45 Therefore, complex 6c was chosen as the 
supposedly most reactive compound to test this possibility. 2,6-Dimethylaniline was 
selected as the nucleophile in order to form a symmetrical acyclic carbene ligand and thus 































Scheme 2.4. Synthesis of the mixed NHC-ADC complex 7. 
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As depicted in Scheme 2.4, the equimolar reaction of 6c with 2,6-dimethylaniline in 
CH2Cl2 at ambient temperature overnight, followed by removal of the solvent in vacuo 
and recrystallization from hexane yielded single crystals of the desired mixed NHC-ADC 
complex [PdBr2(iPr-bimy)(ADC)] (7) and N,N’,N”-tris(2,6-dimethylphenyl)-guanidine (8) 
in very low yields.‡ The majority of the starting material 6c remained unreacted as 
evidenced by the 1H NMR spectrum of the reaction mixture. 
To the best of our knowledge, complex 7 represents so far the first Pd(II) complex 
which combines a cyclic and an acyclic carbene ligand. Figure 2.13a shows the crystal 
structure of complex 7 in which the palladium center is surrounded by two bromo, one 
benzimidazolin-2-ylidene and one acyclic diamino carbene ligands in a trans fashion. 
The Pd-CNHC bond amounts to 2.024(5) Å and is slightly longer than that of 2.017(2) Å in 
the homo-bis(carbene) complex trans-[PdBr2(iPr-bimy)2] (see Section 2.2.1), which is in 
accord with acyclic diamino carbenes being generally stronger -donors than 
benzimidazolin-2-ylidenes.46 The Pd-CADC bond length of 2.047(5) Å is comparable with 
the reported value for a trans-bis(ADC) Pd(II) complex.47 In the crystal packing, the two 
aromatic substituents of the acyclic carbene ligand are oriented such that each of them is 
aligned parallel to the aromatic substituents of a neighbouring molecule, as depicted in 
Figure 2.13b. The interplanar distances amount to 3.582 and 3.682 Å, respectively, 
indicating - stacking interactions with intercentroid distances between the stacked aryl 
rings of 4.000 and 4.354 Å. 
 
                                                        





         (b)  
 
Figure 2.13. (a): Molecular structure of complex 7 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: N1-C1 
1.342(6), N2-C1 1.348(7), Pd1-C1 2.024(5), Pd1-C14 2.047(5), Pd1-Br1 2.4369(7), 
Pd1-Br2 2.4224(7), N3-C14 1.350(6), N4-C14 1.303(6); C14-Pd1-Br1 89.74(14), 
C14-Pd1-Br2 93.81(13), C1-Pd1-Br1 86.48(14), C1-Pd1-Br2 89.92(14), N1-C1-N2 
106.5(5), N3-C14-N4 115.5(5). (b): Packing diagram of complex 7 along b axis. (c): 
Molecular structure of compound 8 showing 50% probability ellipsoids; hydrogen atoms 
are omitted for clarity. Selected bond lengths [Å] and angles [°]: N(1)-C(1) 1.273(3), 
N(3)-C(1) 1.365(3), N(2)-C(1) 1.367(3); N(1)-C(1)-N(3) 125.6(2), N(3)-C(1)-N(2) 
113.8(2), N(1)-C(1)-N(2) 120.6(2), C(1)-N(3)-C(18) 126.5(2), C(1)-N(1)-C(2) 119.5(2), 
C(1)-N(2)-C(10) 124.1(2). 
 
The N,N’,N”-tris(2,6-dimethylphenyl)-guanidine (8) obtained in this reaction may be 
formed through condensation of 2,6-dimethylaniline and 1,3-bis(2,6-dimethylphenyl)- 
urea, which in turn could have formed by air-oxidation of the acyclic carbene ligand. The 
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molecular structure of compound 8 was determined by X-ray diffraction analysis and 
depicted in Figure 2.13c. Interestingly, the central CN3 unit is surrounded by three 
nearly-perpendicular 2,6-dimethylphenyl groups to generate an almost three-fold 
symmetry around the central carbon atom. Such an arrangement is similar to that found 
for N,N’,N”-tris(2,6-diisopropylphenyl)-guanidine.48 
Efforts were made to improve the yield of 7 by prolonging the reaction time, increasing 
the reaction temperature, using excess 2,6-dimethylaniline or changing the solvent to 
higher boiling toluene. Unfortunately, all these attempts led to a complicated reaction 
mixture from which no complex 7 could be isolated. Instead, the simple aniline-complex 
[PdBr2(iPr-bimy)(2,6-dimethylaniline)] was found to be the major product after 
comparing the 1H NMR spectrum of the product mixture with that of an authentic sample 
prepared by reacting complex 1 with 2 equiv of 2,6-dimethylaniline. Apparently, a Pd(II) 
centered ligand substitution is preferred over nucleophilic attack on the coordinated 
isocyanide. A similar reactivity was also observed with hydrazine, which is a widely-used 
bifunctional nucleophile to generate chelating ADC ligands.47,49 As depicted in Scheme 
2.5, the reactions of complex 6c with 1 or 2 equiv of hydrazine both yielded the 




































Scheme 2.5. Synthesis of complex 9. 
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The formation of complex 9 was corroborated by its positive mode ESI mass spectrum 
which shows a base peak centered at m/z = 889 corresponding to the [M-Br]+ fragment. 
In the 1H NMR spectrum, the hydrazine protons resonate as a singlet at 4.72 ppm. 
Moreover, the carbene signal in the 13C NMR spectrum appears at 159.9 ppm, which is 
comparable with the values for 1,3-diisopropylbenzimidazolin-2-ylidene Pd(II) 
complexes containing bipyridyl type of ligands as N-donor bridges (5b-d).  
 
 
Figure 2.14. Molecular structure of complex 9·2CHCl3 showing 50% probability 
ellipsoids; solvent molecules and hydrogen atoms are omitted for clarity. Selected bond 
lengths [Å] and angles [°]: N1-C1 1.340(10), N2-C1 1.344(11), Pd1-C1 1.958(8), Pd1-N3 
2.133(8), Pd1-Br1 2.4187(12), Pd1-Br2 2.4324(12); N3-Pd1-Br1 92.3(2), N3-Pd1-Br2 
90.3(2), C1-Pd1-Br1 90.5(2), C1-Pd1-Br2 87.0(2), N1-C1-N2 108.2(7), Pd1-N3-N3A 
118.2(8). 
 
The identity of complex 9 was further confirmed by single crystal X-ray diffraction. To 
the best of our knowledge, complex 9 is the first hydrazine-bridged Pd(II) complex to be 
crystallographically characterized. As shown in Figure 2.14, each of the palladium 
centers adopts a nearly perfect square planar geometry and they are arranged trans to 
each other with respect to the N-N bond of the hydrazine bridge. The Pd-N bond lengths 
of 2.133(8) Å and are comparable to reported values for other Pd(II)-hydrazine 
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complexes.50 Finally, the two carbene ring planes are oriented almost perpendicularly 
with a dihedral angle of 85.5°. 
The difficulty encountered in the preparation of a mixed NHC-ADC complex is 
probably due to the insufficient electron susceptibility of the coordinated isocyanide in 6c, 
which is in turn caused by the strong -donating and poor -accepting nature of the 
carbene ligand. The replacement of the bromo ligands in 6c with less electron-donating 
ligands such as trifluoroacetate should result in a more Lewis acidic metal center, which 
may increase the susceptibility of the isocyanide ligand for nucleophilic attack. Therefore, 
the trifluoroacetato complex (10) was prepared via a salt-metathesis by reacting complex 
6c with 2 equiv of AgO2CCF3 in acetonitrile at ambient temperature (Scheme 2.6). It is 
worth mentioning that only cis-10 was obtained in a quantitative yield, although a 
mixture of trans- and cis-6c was reacted. Apparently, the breaking of the Pd-Br bond and 
the subsequent coordination of the weaker trifluoroacetato ligand favor a cis arrangement 
due to the strong trans influence of the benzimidazolin-2-ylidene and isocyanide ligands. 
Complex cis-10 shows decreased stability compared to its precursor complex 6c. Upon 
standing in solution, cis-10 slowly decomposes to yield palladium black within a few 





























The 1H NMR spectrum of cis-10 in CDCl3 shows two doublets of equal intensity at 
1.82 and 1.75 ppm, indicative of the cis geometry. Furthermore, the 13C NMR spectrum 
shows two quartets at 162.4 and 161.6 ppm with 2J(C,F) = 37.6 and 38.5 Hz, respectively, 
for the CO groups and another two quartets at 116.0 and 115.5 ppm with 1J(C,F) = 290.0 
and 290.5 Hz, respectively, for the CF3 groups. The observation of two sets of quartets is 
also consistent with a cis geometry. However, only one singlet was observed at 2.0 ppm 
in the 19F NMR spectrum. The carbene carbon in complex cis-10 resonates at 155.9 ppm, 
which is shifted significantly highfield compared to that in the precursor complex 6c. 
Finally, two broad 13C NMR signals at 127.9 and 125.1 ppm are assigned to the two 
carbon atoms adjacent to the nitrogen atom in the isocyanide ligand, respectively. 
 
 
Figure 2.15. Molecular structure of complex cis-10·CH2Cl2 showing 50% probability 
ellipsoids; solvent molecules and hydrogen atoms are omitted for clarity. Selected bond 
lengths [Å] and angles [°]: Pd1-C1 1.964(2), Pd1-C14 1.911(3), Pd1-O1 2.0494(19), 
Pd1-O3 2.0419(18), N1-C1 1.341(3), N2-C1 1.349(3), N3-C14 1.144(3), N3-C15 
1.401(3); C14-Pd1-O1 97.02(10), C14-Pd1-C1 86.94(10), C1-Pd1-O3 91.41(9), 
O1-Pd1-O3 84.41(8), N1-C1-N2 108.0(2), C14-N3-C15 179.0(3). 
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As indicated by 1H and 13C NMR spectroscopy in solution, a cis configuration was 
found by X-ray diffraction study on single crystals of cis-10 (Figure 2.15) as well. Both 
the Pd-Ccarbene [1.964(2) Å] and the Pd-CCN [1.911(3) Å] bonds are shorter than the 
corresponding ones in the precursor complex 6c, confirming a more Lewis acidic metal 
center. The Pd1-O1 bond [2.0494(19) Å] trans to the carbene ligand is longer than the 
Pd1-O3 bond [2.0419(18) Å] trans to the isocyanide ligand, indicating again a stronger 
trans influence of the former. Upon bromo-trifluoroacetato metathesis, the coordinated 
carbon atom in the isocyanide ligand indeed became more electrophilic, which is also 
evidenced by the IR spectrum of cis-10 where a strong CN vibration band is observed at 
a higher wave number of 2214 cm-1 (cf. 2194 cm-1 in complex 6c). Having confirmed the 
increased electron susceptibility of the coordinated isocyanide in cis-10, an attempt to 
generate a mixed NHC-ADC complex by reacting cis-10 with one equiv of 
2,6-dimethylaniline in CH2Cl2 at ambient temperature was conducted. However, the 1H 
NMR spectrum of the reaction mixture again revealed a rather incomplete and 
complicated reaction. Attempts to separate unreacted complex cis-10 from the other 
products were hampered by decomposition of the reaction mixture to palladium black 
upon workup. 
Cleavage of 1 with different NHC ligands. NHCs have gained popularity as a new 
class of ancillary ligands in organotransition metal chemistry1 and catalysis19 mainly due 
to their strong σ-donating ability, which commonly surpasses those of tertiary phosphines. 
The evaluation of stereoelectronic effects of phosphines pioneered by Tolman has made 
major impact on their use as ligands in catalysis.51 Similarly, the electronic properties of 
NHCs are generally determined by measuring the CO IR stretching frequencies in low 
Chapter 2 
 45
valent mixed NHC-carbonyl complexes such as [Ni(CO)3NHC]52 or [MX(CO)2(NHC)] 
(M = Ir(I)53 or Rh(I),54 X = halide). In these systems, it is assumed that the amount of 
-back-donation to CO is directly related to the donor strength of the NHC. On the other 
hand, non-negligible -back-donation from the electron rich metal to the NHC competing 
with that to the CO has not been accounted for, although this may contribute to 
inconsistent results. Other drawbacks are associated with the preparation of the respective 
complexes, which either requires the handling of highly air/moisture sensitive 
compounds such as free NHCs and extremely toxic [Ni(CO)4] or the use of expensive Rh 
and Ir-precursors as well as highly toxic CO gas. Alternative experimental methods for 
characterizing the donor strength of NHCs include calorimetric 55  and cyclic 
voltammetric (CV) studies.53b,56 Although these methods can provide valuable insights 
for the characterization of NHCs, they are encumbered by complicated synthetic and 
analytical routes. It is also surprising that there is no system that allows such 
determination on palladium, which is one of the most commonly used metals in NHC 
chemistry. Therefore, it is of our interest to develop a convenient, safe and 
non-destructive new technique for the evaluation and comparison of the electronic 
properties among common types of NHCs based on a carbonyl-free palladium(II) system. 
It was observed earlier that the 13C NMR chemical shift of the carbene carbon in 
complexes of the type trans-[PdBr2(iPr2-bimy)L]n- is sensitive to donor strength of the 
transoid ligand L. Thus, it is anticipated that an extension to complexes of the type 
trans-[PdBr2(iPr2-bimy)(NHC)] bearing various NHC co-ligands should enable the NMR 
spectroscopic determination of their relative donor abilities by evaluating the carbene 
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Scheme 2.7. Synthesis of hetero-bis(carbene) Pd(II) complexes 11a-i and the respective 
azolium salts used. 
 
Therefore, a total of 9 §  new hetero-bis(carbene) complexes 11a-i were 
straightforwardly prepared by a simple one-pot reaction of the dimeric monocarbene 
complex [PdBr2(iPr2-bimy)]2 (1) with Ag-carbene species obtained from the reaction of 
                                                        
§ Out of the 9 complexes, four (11a-d) were synthesized by a UROPS student, Yang Jie An. For experimental and 
crystallographic details, see his UROPS report “Towards the development of phosphine free catalysis”, Department of 
Chemistry, National University of Singapore, 2007-2008. The HMBC NMR experiments and 13C-labelling reactions on 
complexes 11c/d were done by me to verify the assignments of the two carbenoid signals in each complex.  
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Ag2O and azolium bromides in order to avoid halide scrambling (Scheme 2.7). This 
reaction afforded mainly trans-complexes, which beautifully serves the purpose.**  
To compare common 5-membered NHCs derived from different types of heterocycles 
and to eliminate any additional steric or electronic interferences, 4 identically 
N,N’-dibenzyl substituted carbene precursors derived from imidazoline (I·H+Br-), 
imidazole (II·H+Br-), benzimidazole (III·H+Br-) and triazole (IV·H+Br-) were chosen. The 
desired hetero-bis(carbene) complexes 11a-d bearing NHCs I-IV were obtained as air- 
and moisture stable yellow solids in moderate to excellent yields of 60-95%. In general, 
the complexes are very soluble in common organic solvents with the exception of 
non-polar hexane and toluene. Their formation was confirmed by positive mode ESI mass 
spectrometry, which shows [M-Br]+ cations due to loss of one bromo ligand.  
The good solubility of the complexes gave rise to well resolved 13C NMR spectra. As 
mentioned earlier, a stronger donating co-ligand should lead to a more downfield shift of 
the 13Ccarbene resonances of the constant iPr2-bimy ligand. Moreover, it is commonly 
agreed that -back-donation to NHCs in Pd(II) complexes is negligible due to the more 
Lewis acidic metal centre as compared to the carbonyl-based systems mentioned above. 
Even when an extremely strong co-donor would enable such back-donation to iPr2-bimy, 
its resulting paramagnetic term would nevertheless contribute to a downfield shift of the 
respective carbene signal in line with the proposed concept. Obviously, 2 carbene signals 
are expected for each hetero-bis(carbene) complex and a differentiation may be difficult, 
in cases where their chemical shifts fall in a narrow range (e.g. in complex 11d). This 
problem, however, can be elegantly solved by conducting HMBC NMR experiments, in 
                                                        
** In some cases, minor or trace amounts of the respective cis-isomers were observed. However, their amount did not 
increase upon heating or prolonged stirring and they could be removed by recrystallization. 
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which cross peaks correlating the carbene carbon with protons in the respective 
N-substituent or ligand backbone allow for an unambiguous assignment of the correct 
carbene donors. Furthermore, the feasibility of 13C labelling the carbene donor in the 
iPr2-bimy ligand was also explored. For this purpose, H13COOH can be condensed with 
1,2-phenylenediamine to give 13C labelled benzimidazole. Dialkylation of the latter with 
an excess of isopropyl bromide affords 1,3-diisopropylbenzimidazolium bromide 
(Scheme 2.8) as an precursor to 13C labelled complex 1. It may be worth mentioning, that 
with this 13C enrichment, the previously unresolved carbene signal in complex 1 could 
now be detected easily at 157.1 ppm. Subsequently, the 13C labelled complex 1 offers 
access to 13C labelled hetero-bis(carbene) complexes, in which the NMR spectroscopic 
detection of the iPr2-bimy 13Ccarbene signal can even be accomplished by a single scan due 
















Scheme 2.8. Synthesis of 13C labeled 1,3-diisopropylbenzimidazolium bromide. 
 
Table 2.4 summarizes all carbenoid signals of complexes 11a-i. A comparison of these 
signals in complexes 11a-d indeed shows decreasing donor ability for the NHC 
co-ligands in the order I > II > III > IV.  The relevant 13C NMR data in this series differ 
by 3.5 ppm, which is much more significant as compared to a difference of only 6-7 cm-1 
on an IR scale (~2000 cm-1) determined on a similar series using a Rh-CO system.54b The 
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correlation is remarkable considering the simplicity of the system, and the resulting trend 
is reasonable when the inductive effects of the varying backbones adjacent to the NCN 
moiety are considered. Clearly, the greater +I-effect of 2 sp3 carbon atoms in saturated I 
over 2 sp2 carbon atoms in unsaturated II should translate into a stronger carbene donor 
of the former. Benzannulation in III further weakens the +I-effect, and introduction of an 
electronegative nitrogen atom in IV even results in an –I-effect giving rise to the weakest 
donor. Notably, carbonyl based systems have not been useful for differentiating the donor 
abilities of saturated imidazolidin-2-ylidenes versus the unsaturated imidazolin-2- 
ylidenes. In some cases, unsaturated NHCs were unexpectedly determined to be even 
stronger donors than saturated NHCs.52,53  
 
Table 2.4. Summary of all carbenoid chemical shifts of complexes 11a-i. 
Complex Yield Ccarbene (iPr2-bimy)a Ccarbene (I-SIPr)a 
trans-[PdBr2(iPr2-bimy)(I)] (11a) 60 180.1 199.2 
trans-[PdBr2(iPr2-bimy)(II)] (11b) 63 179.0 172.0 
trans-[PdBr2(iPr2-bimy)(III)] (11c) 95 178.3c 185.1 
trans-[PdBr2(iPr2-bimy)(IV)] (11d) 83 176.6b,c 176.3 
trans-[PdBr2(iPr2-bimy)(V)] (11e) 95 178.3b 173.4 
trans-[PdBr2(iPr2-bimy)(IMes)] (11f) 98 177.2c 175.5 
trans-[PdBr2(iPr2-bimy)(SIMes)] 98 177.6 204.0 
trans-[PdBr2(iPr2-bimy)(IPr)] (11h) 75 177.5c 178.2 
trans-[PdBr2(iPr2-bimy)(SIPr)] (11i) 43 177.6 206.3 
trans-[PdBr2(iPr2-bimy)2] (12)d 60 180.6 - 
a Measured in CDCl3 and internally referenced to the solvent signal at 77.7 ppm relative to TMS.  
b Determined by 13C labeled iPr2-bimy. c Determined by HMBC NMR spectroscopy. d See Section 
2.2.1. 
 
Previously, it was also reported that N-substituents do not affect the donor abilities in 
these NHCs. In order to verify this statement, the sensitivity of this method for the 
Chapter 2 
 50
determination of substituent effects in saturated and unsaturated NHCs was tested. For 
this purpose, the four currently most popular carbenes IMes, SIMes, IPr and SIPr 
bearing aromatic N-substituents were chosen. In addition, carbene V, which has one 
N-benzyl and one N-mesityl substituent in order to close the gap between IMes and 
carbene II, was also included. The corresponding hetero-bis(carbene) complexes 11e-i 
were synthesized in the same way as 11a-d. A comparison of the 13Ccarbene signals for the 
constant iPr2-bimy ligand in complexes 11e and 11f with that in 11b revealed an 
surprising and rather dramatic influence of the N-substituents on the donor ability of 
NHC ligands in Pd(II) complexes. The stepwise substitution of benzyl with mesityl 
groups going from II (179.0 ppm) to V (178.3 ppm) and finally to IMes (177.2 ppm), 
leads to a stepwise highfield shift corroborating decreasing donor ability of the carbenes 
in the order II > V > IMes. Again this observation is reasonable and can be explained by 
the greater +I effect of alkyl versus aryl substituents. It is also interesting to note that 
carbene V and III have supposedly the same donor strength. Thus, the change of 1 
substituent from benzyl to mesityl in imidazolin-2-ylidenes has a comparable effect as a 
benzannulation. Finally, comparison of the relevant signals in complexes 11f-i again 
confirms that saturated NHCs are in general stronger donors than their unsaturated 
analogues, which is also in line with computational studies.57 For the more popular 
carbenes the order of decreasing donor strength has been established as 
SIPr ≈ SIMes > IPr > IMes. Notably, the change from saturated to unsaturated NHCs 
bearing N-aryl groups has smaller impact on the electronic properties than for those with 
N-alkyl substituents. A likely reason is the presence of 2 opposing effects in SIMes/SIPr 
(i.e. donating effect of the backbone and withdrawing effect from the aryl groups). Finally, 
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a comparison of the relevant signals (180.6 ppm) in the homo-bis(carbene) complex 
trans-[PdBr2(iPr2-bimy)2] (trans-12) (see Section 2.2.1) with complex 11c, corroborates 
strong substituent effects also in benzimidazolin-2-ylidenes. Replacement of both benzyl 
groups in III with isopropyl substituents results in an increased donor strength even 
superior to that of saturated carbene I (Figure 2.16).  
 
 
Figure 2.16. Donor ability of NHCs on the “palladium scale”. 
 
Having determined the donor strengths in various NHCs, it was of interest to 
investigate any possible correlation to the Pd-carbene bond distances. Thus, the molecular 
structures of most hetero-bis(carbene) complexes with the exception of 11d have been 
successfully determined by single crystal X-ray diffraction. As found by NMR 
spectroscopy in solution, all complexes adopt a square-planar geometry with the 2 
different carbene ligands in trans position. As representatives only the molecular 
structures of complexes 11a and 11e are depicted in Figure 2.17. It was found that the 
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relevant Pd-C1 (iPr2-bimy) bond lengths [2.022(6) Å for 11a, 2.020(3) Å for 11b and 
2.014(3) Å for 11c] in complexes with similar steric surrounding are essentially the same 
within the error margin, suggesting this bond parameter is not very sensitive to the 
change of donor strength of NHCs coordinating to the Pd(II) center.  
 
 
Figure 2.17. Molecular structures of complexes 11a (left) and 11e (right) showing 50% 
probability ellipsoids; hydrogen atoms are omitted for clarity. Selected bond lengths [Å] 
and angles [°]: 11a: Pd1-C1 2.022(6), Pd1-C14 2.041(6), Pd1-Br1 2.4348(8), Pd1-Br2 
2.4383(8), N1-C1 1.360(8), N2-C1 1.360(7), N3-C14 1.332(8), N4-C14 1.332(8); 
C1-Pd1-Br1 88.53(17), C1-Pd1-Br2 90.27(17), C14-Pd1-Br1 90.59(17), C14-Pd1-Br2 
90.69(17), N2-C1-N1 106.7(5), N4-C14-N3 109.2(6). 11e: Pd1-C1 2.018(4), Pd1-C14 
2.027(4), Pd1-Br1 2.4412(5), Pd1-Br2 2.4362(5), N1-C1 1.339(5), N2-C1 1.349(5), 
N3-C14 1.351(5), N4-C14 1.346(5); C1-Pd1-Br1 88.15(12), C1-Pd1-Br2 88.68(12), 
C14-Pd1-Br1 89.26(12), C14-Pd1-Br2 94.50(12), N1-C1-N2 107.4(4), N3-C14-N4 
104.5(4). 
 
2.1.3 Catalytic studies in Suzuki-Miyaura coupling 
 
  In addition to the reactivity studies of the monocarbene dimeric complex 
[PdBr2(iPr2-bimy)]2 (1), a preliminary catalytic study to test its catalytic activity in the 
Suzuki-Miyaura reaction was also carried out. The coupling of activated 
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4-bromobenzaldehyde with phenylboronic acid with 0.5 mol% catalyst loading (1 mol% 
[Pd]) and a reaction time of 6 h at ambient temperature was chosen as a standard test 
reaction to study the effect of various solvents.  
 










Entry Solvent Yield [%]b 
1 H2O 100c 
2 CH3CN/H2O (1:1 in volume) 
l )
100c 
3 Toluene 98c 
4 CH3CN 39c 
5 H2O 96d 
6 CH3CN/H2O (1:1 in volume) 76d 
a Reaction conditions: 1 mmol of 4-bromobenzaldehyde; 1.2 mmol of phenylboronic acid; 3 ml of 
solvent; 1.5 equivalents of K2CO3; 0.5 mol% of 1. b Yields were determined by 1H NMR 
spectroscopy for an average of two runs. c Reactions were carried out under a nitrogen 
atmosphere. d Reactions were carried out in air.  
 
The results summarized in Table 2.5 indicate the better catalytic activity of 1 in pure 
water compared to in toluene, acetonitrile and acetonitrile/water mixture. This finding is 
especially remarkable, since the efficient coupling reaction in aqueous media usually 
requires higher temperatures,58 microwave heating59 or higher catalyst loading60. On the 
other hand, the use of pure acetonitrile resulted in only poor yield (Entry 4) suggesting 
that CH3CN is a poor solvent for this coupling reaction and thus complex 
[PdBr2(CH3CN)(iPr2-bimy)] (2) is probably a less suitable catalyst precursor for this 
reaction. Furthermore, a drop in yield was observed when the coupling was carried out 
under air compared to under nitrogen. Again, the involvement of acetonitrile led to a 
lower yield (Entry 6). 
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Table 2.6 shows the results for the coupling of other substrates with phenylboronic acid 
in pure water. The reactions of non-activated 4-bromotoluene and 4-bromoanisole 
proceed only at elevated temperature (85 ºC), but with lower yields of 55% (Entry 2) and 
28% (Entry 4), respectively. Noteworthy is that the addition of [N(n-Bu)4]Br (TBAB) 
leads to a substantial improvement and the two substrates can be coupled in quantitative 
yields (Entry 3/5).58a These results suggest that a tribromo-complex similar to 
(iPr2-bimyH)[PdBr3(iPr2-bimy)] (3) is probably a better catalyst precursor. With the 
addition of TBAB, 4-chloroacetophenone and 4-chlorobenzaldehyde can also be coupled 
with yields of 66% and 18% (Entry 6/7), respectively. However, it is still unclear why the 
yields for the coupling of the two activated aryl chlorides with phenylboronic acid are so 
different.  
 
Table 2.6. Air-Free Suzuki-Miyaura reactions catalyzed by 1 in aqueous mediaa. 
 
X = Br, Cl





Entry Aryl halide t [h] Temp [ºC] Yield [%]b 
1 4-bromoacetophenone 6 RT 89 
2 4-bromotoluene 12 85 55 
3 4-bromotoluene 12 85 100c 
4 4-bromoanisole 12 85 28 
5 4-bromoanisole 12 85 100c 
6 4-chlorobenzaldehyde 12 85 18c 
7 4-chloroacetophenone 12 85 66c 
a Reaction conditions: 1 mmol of aryl halide; 1.2 mmol of phenylboronic acid; 3 ml of water; 1.5 
equivalents of K2CO3; 0.5 mol% of 1. b Yields were determined by 1H NMR spectroscopy for an 




2.2 Synthesis and catalytic studies of mononuclear bis(carbene) Pd(II) 




In connection with the previous research in our group and for the purpose of 
investigating the electronic and steric effects of the carbene ligand on the Mizoroki-Heck 
reaction, the initially targeted bis(carbene) Pd(II) complex [PdBr2(iPr2-bimy)2] (12) is still 
essential, and it was finally obtained as the thermodynamically stable product by reacting 
Pd(OAc)2 with two equivalents of salt A at elevated temperature (120 °C) in DMSO 














120 °C, 3 h
100 , overnight
trans-12: X = Br














Scheme 2.9. Synthesis of the bis(carbene) Pd(II) complexes trans-12, trans-13 and 
cis-14.  
 
Complex trans-12 can be readily separated due to its insolubility in DMSO. On the 
other hand, the filtrate is a mixture as indicated by its 1H NMR spectrum, which shows 
three sets of signals. These signals may correspond to the dimeric complex 1, trans-12 
and its cis-isomer based on comparison with the 1H NMR spectra of the isolated first two 
complexes. In combination with the previous results reported by our group,61  this 
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tentative assignment is also supported by the observation that upon prolonged standing of 
the mixture a second crop of trans-12, which may have been converted from its 
cis-isomer, precipitated out.  
In the 1H NMR spectrum, the resonance of the NCHN proton is absent suggesting the 
formation of trans-12. In addition, the isopropyl CH resonance is shifted downfield upon 
coordination from 5.21 ppm in the precursor-salt A to 6.25 ppm in trans-12, which again, 
indicates possible but less pronounced intramolecular C-H···Pd anagostic interactions 
compared to those in complex 1. The 13C NMR spectrum shows the carbene carbon 
resonance at 180.6 ppm, which is well within the reported range for trans-configured 
benzimidazolin-2-ylidene Pd(II) complexes.13, 61 A comparison of this chemical shift with 
the analogous resonance in other bis(carbene) complexes of the type 
trans-[PdBr2(iPr2-bimy)(NHC)] (11a-i) suggests that iPr2-bimy is a very strongly 




Figure 2.18. Molecular structures of complexes trans-12 (left) and trans-13 (right) 
showing 50% probability ellipsoids; hydrogen atoms are omitted for clarity. Selected 
bond lengths [Å] and angles [°]: trans-12: N1-C1 1.344(3), N2-C1 1.347(3), Pd1-C1 
2.017(2), Pd1-Br1 2.4260(3); C1-Pd1-Br1 90.63(6), C1-Pd1-Br1A 89.37(6), N1-C1-N2 
107.2(2). trans-13: N1-C1 1.348(3), N2-C1 1.350(3), Pd1-C1 2.018(3), Pd1-I1 2.5906(3); 
C1-Pd1-I1 89.15(7), C1-Pd1-I1A 90.85(7), N1-C1-N2 107.4(2). 
 
The molecular structure of complex trans-12 (Figure 2.18) reveals the expected trans 
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arrangement of the two carbene ligands. Both carbene ring planes are oriented almost 
perpendicular to the PdC2Br2 plane with a torsion angle of 88.0°. More importantly, the 
Pd-C bonds in trans-12 [2.017(2) Å] are longer than those [1.947(3) Å] in the dimeric 
[PdBr2(iPr2-bimy)]2 complex (1). This is in line with the increasing steric bulk as well as 
the less Lewis acidic palladium center resulting from the coordination of an additional 
carbene ligand. It is also noteworthy that the C-H protons of the isopropyl groups are all 
oriented towards the metal center with relatively short C-H···Pd distances of 2.685 and 
2.714 Å, supporting the presence of intramolecular C-H···Pd anagostic interactions.  
In order to investigate the effects of different halo ligands on the Mizoroki-Heck 
coupling reaction, complex trans-13 was also prepared in analogy to trans-12 using 
Pd(OAc)2 and two equivalents of salt B (Scheme 2.9). The molecular structure of 
trans-13 is shown in Figure 2.18. No significant differences from the above discussed 
trans-12 are found in the structural characterizations of trans-13. Therefore, further 
comments on it are not necessary. 
The mixed di(trifluoroacetato)-bis(carbene) complex 14 was prepared via a salt 
metathesis in order to investigate the effects of co-ligands and trans/cis configurations in 
bis(carbene) Pd(II) complexes on the Mizoroki-Heck coupling reactions. As depicted in 
Scheme 2.9, the novel complex 14 was isolated as a cis-isomer by reacting the precursor 
complex trans-12 (or trans-13) with two equivalents of AgO2CCF3 in CH3CN at ambient 
temperature. In agreement with the formation of cis-[Pd(O2CCF3)2(iPr2-bimy)(CN-Xyl)] 
(cis-10) from a mixture of cis-/trans-[PdBr2(iPr2-bimy)(CN-Xyl)] (6c), it is noteworthy 
that the formation of cis-14 from trans-12 or trans-13, again, supports the proposal that 
the breaking of the Pd-Br bond and the subsequent coordination of the more labile 
Chapter 2 
 58
trifluoroacetato ligand thermodynamically favors a cis arrangement due to the strong 
trans influence of the benzimidazolin-2-ylidene ligand. Therefore, this 
halo/trifluoroacetato ligand substitution could be regarded as a selective method for the 
synthesis of cis-configured benzimidazolin-2-ylidene complexes. The 1H NMR spectrum 
of complex cis-14 shows two doublets of equal intensity at 1.72 and 1.33 ppm, 
suggesting two inequivalent Me-groups and thus a cis configuration. Correspondingly, 
two singlets at 21.4 and 20.3 ppm for the Me-groups are found in the 13C NMR spectrum. 
Furthermore, the 13C NMR spectrum shows a significant upfield shift of the carbene 
carbon resonance from 180.0 ppm in trans-12 to 164.8 ppm in cis-14. A similar upfield 
shift was also observed for transformation of cis-/trans-6c to cis-10. 
 
 
Figure 2.19. Molecular structure of complex cis-14 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: N1-C1 
1.352(5), N2-C1 1.349(5), Pd1-C1 1.975(4), Pd1-O1 2.067(3); C1A-Pd1-O1 91.43(14), 





The molecular structure of cis-14 depicted in Figure 2.19 shows the expected cis 
configuration as indicated by 1H and 13C NMR spectroscopy in solution. The two 
trifluoroacetato ligands coordinate in a monodentate fashion with their pendent oxygen 
atoms found in anti conformation. More importantly, the Pd-C bonds in cis-14 
[1.975(4) Å] are shorter than those found in trans-configured analogues (~2.04 Å),62 
reflecting a strong trans influence of the carbene ligands and a preference for the cis 
arrangement. Remarkably, the dihedral angle between the carbene ring plane and the 
PdC2O2-coordination plane has significantly decreased from 88.0° in the precursor 
trans-12 to 60.7° in cis-14 in order to minimize ligand-ligand repulsion. 
 
2.2.2 Catalytic studies in Mizoroki-Heck coupling 
 
In a recent study, the catalytic activity of Pd(II) bis(benzimidazolin-2-ylidene) 
complexes with non-bulky N-methyl substituents in the Mizoroki-Heck reaction has been 
reported by our group.61 In connection with that, the catalytic activities of the bis(carbene) 
complexes trans-12, trans-13 as well as cis-14 were investigated in the Mizoroki-Heck 
coupling reactions. In addition, the mixed carbene-phosphine complex cis-4 was also 
included in this study for comparison. The coupling of aryl bromides and chlorides with 
tert-butyl acrylate in DMF with 1 mol% catalyst loading and a reaction time of 24 h was 
chosen as a standard test reaction. The results are summarized in Table 2.7. Entries 1-4 
show that all four complexes can couple activated 4-bromobenzaldehyde in quantitative 
yield at 120 ºC. However, the coupling reactions of deactivated 4-bromoanisole and 
activated aryl chlorides are more difficult, and require the addition of [N(n-Bu)4]Br and a 
higher temperature of 140 ºC to afford moderate to good conversions (Entries 5-16). 
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Reactions catalyzed by complex trans-13 showed overall the best yields. The slight 
superiority of trans-13 over trans-12 can be attributed to its higher stability, which may 
lead to a higher concentration of active catalyst. 
 














Entry Catalyst Aryl halide Temp [ºC] Yield (%)b 
1 trans-12 4-bromobenzaldehyde 120 100 
2 trans-13 4-bromobenzaldehyde 120 100 
3 cis-14 4-bromobenzaldehyde 120 100 
4 cis-4 4-bromobenzaldehyde 120 100 
5c trans-12 4-bromoanisole 140 72 
6c trans-13 4-bromoanisole 140 79 
7c cis-14  4-bromoanisole 140 71 
8c cis-4 4-bromoanisole 140 75 
9c trans-12 4-chlorobenzaldehyde 140 90 
10c trans-13 4-chlorobenzaldehyde 140 93 
11c cis-14 4-chlorobenzaldehyde 140 91 
12c cis-4 4-chlorobenzaldehyde 140 88 
13c trans-12 4-chloroacetophenone 140 82 
14c trans-13 4-chloroacetophenone 140 83 
15c cis-14 4-chloroacetophenone 140 69 
16c cis-4 4-chloroacetophenone 140 51 
a Reaction conditions generally not optimized. b Yields were determined by 1H NMR spectroscopy 
for an average of at least two runs. c With addition of 1.5 equivalents of [N(n-Bu)4]Br. 
 
It is worth to mention that the mixed carbene-phosphine complex cis-4, in contrast to 
the results reported by Herrmann et al.,35b did not exhibit a better catalytic activity than 
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the bis(carbene) complexes 12-14. Instead, cis-4 afforded the lowest yield in the coupling 
reactions of aryl chlorides (Entries 9-16). This may be due to its lower stability compared 
to the bis(carbene) complexes under the relatively harsh conditions and thus leading to 
the more rapid decomposition of the catalyst. In addition, the kinetic study performed on 
the coupling of 4-bromobenzaldehyde with tert-butyl acrylate employing 1 mol% 
trans-13 as the precatalyst revealed a very slow reaction with less than 5 % yield after 3 h. 
This slow process is unexpected in comparison with the same reaction catalyzed by 
trans-diiodo-bis(1,3-dimethylbenzimidazolin-2-ylidene)palladium(II) where a complete 
conversion was achieved within 90 min.61 The big difference between the catalytic 
reaction rates may be due to the different substituents on the nitrogen atoms of the ligands. 
The isopropyl substituents are more electron donating than the methyl groups and thus 
lead to a more difficult reduction of the Pd(II) precatalyst to the catalytically active Pd(0) 
species. 
 
Table 2.8. The effects of sodium formate and trans/cis configuration on the 












O120 °C, 4 h  
 
Entry Catalyst Yield (%)a 
1 trans-12 6 
2 cis-4 14 
3b trans-12 18 
4b trans-13 16 
5b cis-14 58 
6b cis-4 50 




As expected, the catalytic reaction can be accelerated by the addition of sodium 
formate which helps the reduction of Pd(II) to Pd(0) (Entry 1 vs Entry 3 and Entry 2 vs 
Entry 6 in Table 2.8). Furthermore, the results summarized in Table 2.8 indicate the 
reactions catalyzed by complex cis-14 or cis-4 (Entry 5/6) are generally faster than those 
catalyzed by trans-12 or trans-13 (Entry 3/4) under the same conditions. This result is in 
line with the easier dissociation of the halo or carboxylato ligands in cis-configured 
complexes, in which the strong trans effect of the carbene or phosphine ligand weakens 
the Pd-halo or Pd-carboxylato bonds and therefore facilitates the reduction of Pd(II) to 
Pd(0).61 
 
2.3 Synthesis and reactivity studies of Pt(II) complexes 
 
In contrast to the extensive studies on palladium NHC complexes, less attention has 
been paid to the synthesis of platinum NHC complexes and their use in catalysis.17a, 63 In 
particular, platinum complexes bearing benzimidazolin-2-ylidenes are surprisingly 
rare.26,64 Hence, it is of our interest to extend the use of 1,3-diisopropylbenzimidazolin-2- 
ylidene to platinum chemistry. 
 
2.3.1 Synthesis of the monocarbene complex [PtBr2(iPr2-bimy)(DMSO)] and the 
bis(carbene) complex [PtBr2(iPr2-bimy)2] 
 
Recently, Strassner and coworkers reported a general synthetic method towards 
platinum(II) complexes bearing chelating dicarbene ligands, which involves in-situ 
deprotonation of diimidazolium salts with commercially available Pt(acac)2 (acac = 
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acetylacetonate) in DMSO. 65  Surprisingly, our attempt to synthesize a Pt(II) 
bis(benzimidazolin-2-ylidene) complex using this method proved unsuccessful. The 
reaction of Pt(acac)2 with two equivalents of 1,3-diisopropylbenzimidazolium bromide 
(A) in DMSO at 90 C gave a reaction mixture, from which only the DMSO coordinated 
monocarbene complex cis-[PtBr2(iPr2-bimy)(DMSO)] (cis-15) was isolated in a low yield 
of 18% together with unreacted starting materials. The desired bis(carbene) complex 
could not be obtained. To avoid the formation of DMSO-complex cis-15, the reaction was 
carried out in acetonitrile under reflux conditions. However, no carbene complexes were 
detected, and again, ~90% of Pt(acac)2 was recovered. The reaction of PtBr2 with A in 
the presence of NaOAc as an external base in acetonitrile under reflux was also attempted 
to no avail even after 30 h. The failure of these attempts are probably due to the difficulty 
in the deprotonation of salt A resulting from the +I-effect and the steric bulk of the 
N-isopropyl substituents as observed in the formation of Pd(II) bis(carbene) complex of 
the same ligand (trans-12). It also demonstrates the different reactivity of 



























Scheme 2.10. Synthesis of Pt (II) complexes cis-15 and trans-16. 
 
Only the reaction of PtBr2 with two equivalents of A and NaOAc as an external base in 
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DMSO, as illustrated in Scheme 2.10, afforded the bis(carbene) complex 
trans-[PtBr2(iPr2-bimy)2] (trans-16), however, as a minor product in only 3% yield. As 
the major product, the mixed monocarbene-DMSO complex cis-15 was isolated in an 
improved yield of 55%. Isolation of trans-16 was straightforward and involved only a 
simple filtration step due to its low solubility in DMSO. It is also only sparingly soluble 
in DMF, but can be dissolved in halogenated solvents. The DMSO filtrate, on the other 
hand, contained mainly the monocarbene complex cis-15. The preferred formation of 
cis-15 over trans-16 in this reaction is presumably due to the steric bulk of the isopropyl 
substituents as well as the affinity of the relatively soft DMSO-sulfur atom for the soft 
Pt-center, which in turn hampers the attack of a second carbene ligand. Complex cis-15 
shows better solubility than trans-16 in most polar organic solvents such as CHCl3, 
CH2Cl2, CH3CN, DMF and DMSO. In an attempt to optimize the synthesis of cis-15, the 
reaction of PtBr2 with one equiv of A and NaOAc in DMSO was carried out. However, 
this reaction afforded cis-15 in a very low yield of 7% together with an unexpected ionic 
Pt(IV) complex (iPr2-bimyH)2[PtBr6] (X1). The identity of the latter was confirmed by 
X-ray diffraction analysis (Figure 2.20) and ESI MS spectrometry. Its ESI MS spectrum 
shows an isotopic pattern centered at m/z = 1284 corresponding to the 
{(iPr2-bimyH)3[PtBr6]}+ fragment in the positive mode and isotopic clusters centered at 
m/z = 337.8 and 876 corresponding to the [PtBr6]2- and {(iPr2-bimyH)[PtBr6]}- fragments, 
respectively, in the negative mode. The oxidation of Pt(II) to Pt(IV) may be due to the 





Figure 2.20. Molecular structures of complex X1 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Pt-Br1 
2.4690(6), Pt-Br2 2.4628(5), Pt-Br3 2.4669(5), C1-N1 1.338(6), C1-N2 1.312(7); 
Br2-Pt1-Br3A 89.87(2), Br2-Pt1-Br3 90.13(2), Br2-Pt(1)-Br1A 89.71(2), Br2A-Pt1-Br1A 
90.29(2), Br3A-Pt1-Br1A 89.934(19), Br3-Pt1-Br1A 90.066(19), Br2-Pt1-Br1 90.29(2), 
N1-C1-N2 111.1(4). 
 
The formation of cis-15 and trans-16 was confirmed by 1H NMR spectroscopy. The 
absence of the NCHN proton characteristic for salt A in the spectra of both cis-15 and 
trans-16 indicates a successful coordination of the carbene ligand iPr2-bimy to the 
platinum(II) centers. In addition, both complexes exhibit interesting C-H···Pt anagostic 
interactions as indicated by significant downfield shifts of their isopropyl C-H resonances 
upon coordination from 5.21 ppm in the precursor-salt A to 6.27 ppm in cis-15 and to 
6.52 ppm in trans-16, respectively. These C-H···Pt interactions are also corroborated by 
the geometric parameters observed in the solid state structures of the two complexes 
(Vide infra). Noteworthy, such anagostic interactions seem to be characteristic for this 
ligand as they have also been observed in a wide range of Pd(II) and Ni(II)66 complexes. 
A comparison of the isoelectronic and isostructural analogues trans-[MX2(iPr2-bimy)2]n+ 
(M = Ni, Pd, Pt, X = Br, n = 0; M = Au, X = I, n = 1) shows a decrease of anagostic 
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interactions in the order Ni(II) (H = 2.18 ppm) > Pt(II) (H = 1.32 ppm) > Pd(II) 
(H = 1.04 ppm) >> Au(III) (H = -0.15 ppm) (H = Hcomplex - Hsalt A). 
Interestingly, this observation may be related to the Shannon effective ionic radii67 of 
these d8 ions in square-planar geometry, which increase in the order 0.49 Å {Ni(II)} < 
0.60 Å {Pt(II)} < 0.64 Å {Pd(II) < 0.68 Å {Au(III)}. The strong donation of the carbene 
ligand to the smallest Ni(II) ion would result in the least Lewis acidic metal center, which 
translates into the observed strongest anagostic interaction. The most Lewis acidic Au(III) 
complex, on the other hand, does not show any C-HM interaction in solution at all, as 
corroborated by a slight upfield shift of the corresponding C-H proton.68   
The 1H NMR signal for the methyl groups of the DMSO ligand in cis-15 arises at 
3.61 ppm as a singlet with platinum satellites of 3J(Pt,H) = 21.5 Hz. Such a chemical shift 
and coupling constant are typical for sulfur-bonded sulfoxide complexes.69 The 13C 
NMR signal of these methyl groups appearing at 47.1 ppm also shows pronounced 
coupling to the platinum atom with 2J(Pt,C) = 70.57 Hz. Coordination of the DMSO 
molecule in cis-15 is further confirmed by a strong S=O stretching band at 1134 cm-1 in 
the IR spectrum (cf. 1050 cm-1 for free DMSO).69  
Furthermore, two doublets of equal intensity at 1.75 and 1.74 ppm are observed for the 
CH3-groups of the carbene ligand in the 1H NMR spectrum of cis-15 and two singlets at 
20.6 and 20.4 ppm for these groups are found in the 13C NMR spectrum, pointing to a cis 
configuration. In contrast, these Me-groups are equivalent in complex trans-16 giving 
rise to only one doublet at 1.81 ppm and confirming the trans configuration of this 
complex. Moreover, there is also a notable difference in the 13C NMR resonances of the 
isopropyl C-H groups in the two complexes. Although their chemical shifts are found in 
Chapter 2 
 67
the same range with values of 54.3 ppm for cis-15 and 53.1 ppm for trans-16, 
respectively, only the former shows Pt-satellites with a constant of 3J(Pt,C) = 31.2 Hz. 
Finally, the carbene signals in cis-15 and trans-16 resonate at 153.6 and 176.5 ppm, 
respectively. The absence of Pt satellites for the carbene signal in NHC complexes is 
common and likely due to the low intensity of this signal.70 Furthermore, the carbene 
resonance in trans-16 appears more upfield compared to that of the palladium analogue 
trans-[PdBr2(iPr2-bimy)2] (180.0 ppm). A similar but more pronounced upfield shift of 
the carbene resonance upon replacement of Pd by Pt has been reported by others.70, 71  
 
 
Figure 2.21. Molecular structures of complexes cis-152CHCl3 (left) and trans-16 (right) 
showing 50% probability ellipsoids; solvent molecules and hydrogen atoms except for 
those involved in anagostic interactions are omitted for clarity. Selected bond lengths [Å] 
and angles [°]: cis-152CHCl3: Pt1-C1 1.979(6), Pt1-Br1 2.4294(10), Pt1-Br2 2.4628(9), 
Pt1-S1 2.196(2), C1-N1 1.348(5), S(1)-O(1) 1.446(6); C1-Pt1-Br1 85.67(19), C1-Pt1-S1 
92.18(19), Br1-Pt1-Br2 90.12(4), S1-Pt1-Br2 92.03(6), N1-C1-N1A 108.0(5). trans-16: 
Pt1-C1 2.015(4), Pt1-Br1 2.4268(4), C1-N1 1.354(4), C1-N2 1.357(4); C1-Pt1-Br1 
89.38(10), C1-Pt1-Br1A 90.62(10), N1-C1-N2 106.8(3).   
 
Single crystals suitable for X-ray diffraction were obtained from a CHCl3 solution for 
cis-15 or from a CH2Cl2 solution for trans-16. Their molecular structures are depicted in 
Figure 2.21. Complex cis-15 shows the expected square planar arrangement around the 
platinum center with the NHC and DMSO ligands cis to each other. The latter 
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coordinates to the platinum center through the sulfur atom, as indicated by the 1H NMR 
and IR spectra. Upon coordination, the sulfur atom in the DMSO molecule adopts a 
tetrahedral configuration with angles ranging from 102.0(6) to 117.0(3)°. The carbene 
ring plane is perfectly perpendicular to the PtCSBr coordination plane with a dihedral 
angle of 90 °C due to symmetry. The Pt-Ccarbene12, 64a, 65, 72 and Pt-S73 bond lengths 
amount to 1.979(6) and 2.196(2) Å, respectively, and are in the expected range. 
Furthermore, the Pt-Br2 bond trans to the NHC [2.4628(9) Å] is longer than the Pd-Br1 
bond trans to the DMSO [2.4294(10) Å] confirming a stronger trans influence of the 
NHC. 
In complex 16 the platinum center is coordinated by two carbene and two bromo 
ligands in a trans fashion. Both carbene ring planes are oriented almost perpendicular to 
the PtC2Br2 plane with a dihedral angle of 87.72°. The Pd-C bonds in trans-16 amount to 
2.015(4) Å and are, as expected, longer than that in cis-15. Finally, it is noteworthy that 
all C-H protons of the isopropyl groups in both cis-15 and trans-16 show a fixed 
orientation towards the metal center, resulting in relatively short C-H···Pt distances of 
2.747 Å in the former and 2.734 and 2.706 Å in the latter complex, respectively. These 
structural properties support the C-H···Pt anagostic interactions indicated by 1H NMR 
spectroscopy.  
 
2.3.2 Reactivity studies of [PtBr2(iPr2-bimy)(DMSO)] 
 
Cis-15 is stable in coordinating solvents such as CH3CN and DMF. However, in the 
presence of stronger donors, the DMSO ligand can be easily replaced. This is 





































Scheme 2.11. Synthesis of Pt(II) complexes trans-17, cis-17 and trans-18. 
 
When cis-15 and one equivalent PPh3 were dissolved in CH2Cl2 at room temperature, 
complex trans-[PtBr2(iPr2-bimy)(PPh3)] (trans-17) was first formed, as indicated by 1H 
and 31P NMR spectroscopy. Trans-17 was found to slowly convert to its 
thermodynamically more stable cis-isomer. However, this isomerization process is 
sluggish at ambient temperature. An attempt to facilitate this process was made by 
refluxing in CH2Cl2. But even after 15 h this trans/cis isomerization did not achieve 
completeness and a mixture of trans-17 and cis-17 was obtained in a ratio of 1.6:1, as 
suggested by the integration of their 1H NMR signals. In contrast, a faster isomerization 
was observed for the palladium analogue (trans-/cis-4) where the trans-complex 
completely converts to its cis-isomer in CH2Cl2 under reflux after 15 h. The slower 
isomerization process for Pt(II) mixed carbene-phosphine complexes compared to their 
palladium analogues has also been reported by Lappert for trialkylphosphines.74 These 
slower isomerizations may be attributed to the less pronounced transphobia effect 
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between the pair of NHC/PPh3 for platinum than palladium.38b However, cis-17 can be 
isolated from the product mixture due to its lower solubility in THF than trans-17. On the 
other hand, isolation of pure trans-17 was not feasible due to its aforementioned 
isomerization to cis-17.  
The formation of cis-17 was supported by its positive mode FAB mass spectrum where 
a peak at m/z = 739 corresponding to [M-Br]+ fragment was observed. The 1H NMR 
spectrum of cis-17 in CDCl3 shows a characteristic multiplet at 6.09 ppm for the C-H 
proton and two doublets of equal intensity at 1.63 and 0.86 ppm for the Me-groups of the 
N-isopropyl substituents. In its 31P NMR spectrum, a single peak at 10.0 ppm with 
platinum satellites of 2J(Pt,P) = 3848 Hz was observed, confirming the successful 
substitution of DMSO by PPh3. Furthermore, the 13C NMR resonance of the carbene 
atom in cis-17 appears at 161.0 ppm as a doublet due to its coupling to the phosphine 






Figure 2.22. Molecular structures of complexes cis-17 (a) and trans-18THF (b) showing 
50% probability ellipsoids; solvent molecules and hydrogen atoms except for those 
involved in anagostic interactions are omitted for clarity. Selected bond lengths [Å] and 
angles [°]: cis-17: Pt1-C1 1.973(4), Pt1-Br1 2.4815(5), Pt1-Br2 2.4815(5), Pt1-P1 
2.2327(11), C1-N1 1.354(5), C1-N2 1.345(5); C1-Pt1-Br2 84.71(12), C1-Pt1-P1 
93.06(12), Br1-Pt1-Br2 90.490(18), Br1-Pt1-P1 91.61(3), N1-C1-N2 107.4(4); 
trans-18THF: Pt1-C1 1.958(4), Pt1-Br1 2.4253(5), Pt1-Br2 2.4188(5), Pt1-N3 2.085(4); 
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C1-Pt1-Br1 90.60(12), C1-Pt1-Br2 89.19(12), Br1-Pt1-N3 89.98(10), Br2-Pt1-N3 
90.31(10), N1-C1-N2 106.9(4).  
 
Single crystals of cis-17 were obtained from a CH2Cl2/hexane solution and its 
molecular structure is depicted in Figure 2.22a. The platinum center in cis-17 is 
surrounded by one carbene, one phosphine and two bromo ligands in a nearly perfect 
square planar fashion with the former two cis to each other. The Pt-Ccarbene and Pt-P bond 
lengths amounting to 1.973(4) and 2.2327(11) Å, respectively, are unexceptional.72 It is 
maybe worth mentioning, that the commonly observed stronger trans influence of NHCs 
over tertiary phosphine ligands is not demonstrated in cis-17 as the two Pt-Br bonds are 




Figure 2.23. Time-dependent 1H NMR spectra illustrating the reaction of cis-15 with 
equivalent pyridine. 
 
In contrast to the reaction of cis-15 with PPh3, the substitution of DMSO by pyridine 
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yielded only the trans configured product trans-[PtBr2(iPr2-bimy)(pyridine)] (trans-18). 
When one equivalent of pyridine was added into a solution of cis-15 in CDCl3 at ambient 
temperature, only signals corresponding to cis-15, trans-18, unreacted pyridine and 
released DMSO were present in the spectra. Figure 2.23 shows the time-dependent 1H 
NMR spectra in the range of 6.76–6.12 ppm (C-H resonances of N-isopropyl groups), 
illustrating the progress of the reaction. This reaction is irreversible and complete after 
~18 h. No changes were found in the 1H NMR spectrum afterwards, suggesting that no 
trans-cis isomerization took place under these conditions. This observation is in line with 
a weaker trans influence of the pyridine ligand compared to PPh3. The 1H NMR spectrum 
of trans-18 shows the presence of the pyridine ligand, of which the 2,6-py-H resonance is 
shifted downfield by 0.5 ppm compared to that of the free pyridine. Upon ligand 
substitution, the C-H resonances of the N-isopropyl groups shift downfield to 6.59 ppm 
(cf. 6.27 ppm in cis-15) probably pointing to a more electron rich Pt center, which 
strengthens anagostic interactions. The 13C NMR signal of the carbene atom in trans-18 
appears at 149.7 ppm, which is more upfield by 9.8 ppm than that found in the palladium 
analogue trans-[PdBr2(iPr2-bimy)(pyridine)] (5a). 
The formation of trans-18 was further confirmed by X-ray diffraction analysis on 
single crystals obtained by slow evaporation of a concentrated THF solution. Its 
molecular structure depicted in figure 2.22b shows the expected trans configuration with 
a nearly perfect square planar coordination geometry. The Pt1-N3 bond length of 
2.085(4) Å is in the expected range. The fixed orientation of the C-H protons of the 
N-isopropyl substituents towards the platinum center results in short C-H···Pt distances of 
2.720 and 2.728 Å, again suggesting the C-H···Pt anagostic interactions. 
Chapter 3 
 73
Chapter 3. Palladium(II) Complexes with the 1,3-Dibenzhydryl
-benzimidazolin-2-ylidene Ligand 
 
It has been reported previously by our group that the Ni(II) bis(carbene) complex with 
the very sterically demanding 1,3-dibenzhydrylbenzimidazolin-2-ylidene (Bh2-bimy) 
ligand shows high catalytic activity in the Ullman coupling reaction.66 In connection with 
that as well as our work presented in Chapter 2, it is of our interest to explore the 




Our investigation began with the attempt to synthesize a Pd(II) bis(carbene) complex 
by reacting Pd(OAc)2 with the sterically bulky 1,3-dibenzhydrylbenzimidazolium 
bromide (Bh2-bimyH+Br-, C) in DMSO at 75°C. Surprisingly, this reaction did not yield 
the desired product. Instead, an unexpected monocarbene Pd(II) complex (19) with a 
remarkably rearranged N-coordinated 1,2-disubstituted benzimidazole derivative 
[2-(1-benzhydrylbenzimidazol-2-yl)-benzophenone] was isolated in a good yield of 70% 
as a yellow solid (Scheme 3.1). Besides complex 19, this reaction also afforded a minor 
compound (X) tentatively assigned to the initially targeted bis(carbene) complex 
[PdBr2(Bh2-bimy)2], which is insoluble in DMSO and thus precipitated from the reaction 
























R = benzhydrylC 19  
 
Scheme 3.1. Synthesis of complex 19. 
 
The formation of complex 19 was supported by its positive mode ESI mass spectrum, 
which shows an isotopic pattern centered at m/z = 1101 corresponding to the [M-Br]+ 
fragment. In addition, the identity of complex 19 was further corroborated by 13C NMR 
spectroscopy. The signals for the CO carbon and the NCN carbon in the unusual 
1,2-disubstituted benzimidazole ligand arise at 195.3 and 172.4 ppm, respectively. The 
Ccarbene resonates at 153.7 ppm, which is comparable with the values for 
trans-dibromo-(benzimidazolin-2-ylidene) Pd(II) complexes with N-heterocyclic 
co-ligands (5a-d). 
Single crystals of complex 19 suitable for X-ray diffraction were obtained as solvate 
192(CH3)2CO by slow evaporation of a concentrated acetone solution. Its molecular 
structure is depicted in Figure 3.1. The palladium center in complex 19 is coordinated by 
two bromo ligands, one NHC ligand and the 1,2-disubstituted benzimidazole in a trans 
fashion. The deviation angle of the carbene ring from the PdBr2CN coordination plane is 
79.31°. Similarly, the N-bound benzimidazole plane is twisted from the coordination 
plane with a torsion angle of 68.02°. The Pd1-C1 and Pd1-N3 bonds amount to 1.9579(18) 





Figure 3.1. Molecular structure of complex 192Me2CO showing 50% probability 
ellipsoids; hydrogen atoms and solvent molecules are omitted for clarity. Selected bond 
lengths [Å] and angles [°]: Pd1-C1 1.9579(18), Pd1-Br1 2.4346(5), Pd1-Br2 2.4230(5), 
Pd1-N3 2.0909(15), C1-N1 1.353(2), C1-N2 1.351(2), N3-C34 1.321(2), N3-C35 
1.391(2), N4-C34 1.362(2); C1-Pd1-Br1 86.66(5), C1-Pd1-Br2 89.84(5), N3-Pd1-Br1 
91.35(5), N3-Pd1-Br2 92.18(5), N1-C1-N2 107.14(15), C34-N3-C35 106.17(14), 
N3-C34-N4 112.13(15). 
 
Notably, several examples of unusual NHC rearrangement/decomposition reactions 
have been reported in literature that generally lead to a C-N bond cleavage between the 
heterocylic ring and the N-alkyl or N-aryl substituents.75 However, the formation of the 
1,2-disubstituted benzimidazole ligand in complex 19 is still unique as it apparently 
requires at least three steps: (i) C-N cleavage between the N-heterocyclic ring and one 
benzhydryl substituent; (ii) ortho-C-H activation of the aromatic ring in this benzhydryl 
substituent and subsequent rearrangement to the 2-position of the heterocycle; 




At present, the mechanism for this unusual rearrangement and the formation of 
complex 19 is still unclear. However, it is believed that the presence of palladium, aerial 
oxygen and the use of relatively high temperature are crucial for this process. When the 
reaction was carried out either in the absence of palladium, under nitrogen atmosphere or 
at ambient temperature (ceteris paribus), no formation of complex 19 or 
2-(1-benzhydrylbenzimidazol-2-yl)-benzophenone was detected. Furthermore, it is 
anticipated that complex 19 may result from the decomposition of complex X. To 
investigate this possibility, complex X was heated in either DMSO at 75 °C or in 
refluxing acetonitrile overnight under air, but no reaction took place. Further heating in 
DMSO to 130 °C led to an intractable product mixture, from which complex 19 could not 
be identified. 
In the attempt to obtain the desired bis(carbene) complex [PdBr2(Bh2-bimy)2], the 
milder Ag-carbene-transfer method was explored.13 The silver monocarbene complex 
[AgBr(Bh2-bimy)] (20), which should subsequently serve as a carbene-transfer agent, 
was synthesized in an excellent yield of 93% by the reaction of Ag2O with 2 equiv of salt 
C in CH2Cl2 at ambient temperature (Scheme 3.2). The characteristic downfield signal 
for the NCHN proton in salt C is absent in the 1H NMR spectrum of complex 20, 
corroborating the formation of a carbene complex. Furthermore, the 13C NMR spectrum 
shows a downfield resonance at 192.1 ppm arising from the coordinated carbene carbon. 
This carbenoid signal is broad and does not show 13C-107,109Ag coupling, which is 
consistent with the labile nature of the Ag-Ccarbene bond. The ESI mass spectrum of 
complex 20 is dominated by an isotopic cluster centered at m/z = 1101 corresponding to 
the [AgL2]+ (L = Bh2-bimy) fragment in the positive mode and an isotopic envelope at 
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Scheme 3.2. Synthesis of complexes 20-22. 
 
Single crystals of complex 20 suitable for X-ray diffraction were obtained from a 
mixed CH2Cl2/Et2O solution upon standing. It may be worth noting that complex 20 
represents one of only few reported benzimidazolin-2-ylidene Ag(I) complexes, which 
have been crystallographically characterized,13, 76  as imidazolin-2-ylidenes have 
prevailed in the field of silver-NHC chemistry.77 As shown in Figure 3.2, complex 20 is a 
neutral monomer, in which the coordination geometry deviates from linearity with an 
C1-Ag1-Br2 angle amounting to 170.81(13)°. The Ag1-C1 bond length is 2.081(5) Å and 
similar to those reported for other benzimidazolin-2-ylidene Ag(I) complexes.13,76 
Different from other halo-benzimidazolin-2-ylidene Ag(I) complexes, complex 20 shows 
neither intermolecular AgAg nor AgBr interactions at all, presumably due to the 




Figure 3.2. Molecular structure of complex 20 showing 50% probability ellipsoids; 
hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and angles [°]: Ag1-C1 
2.081(5), Ag1-Br2 2.4253(6), C1-N1 1.363(6), C1-N2 1.340(6); C1-Ag1-Br2 170.81(13), 
N1-C1-N2 106.5(4). 
  
After having established the straightforward formation and identity of the silver 
carbene complex, the in-situ generated 20 was conveniently reacted with 
[PdBr2(CH3CN)2] in subsequent reactions. When this reaction was carried out in a L:Pd 
ratio of 2:1, formation of the dibromo-bis(carbene) complex [PdBr2(Bh2-bimy)2] was 
expected (Scheme 3.2). After filtration of the AgBr precipitate and drying of the filtrate 
under vacuo, a yellowish powder was obtained. This compound is only sparingly soluble 
in halogenated solvents and acetonitrile, but insoluble in more polar solvents such as 
DMSO and DMF. The 1H NMR spectrum of this compound in CDCl3 is identical to that 
of the minor complex X obtained by the reaction of Pd(OAc)2 and salt C in DMSO (vide 
supra), which shows only aromatic protons in the range of 6.82-7.36 ppm and a singlet at 
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8.69 ppm presumably arising from the CH protons of the benzhydryl substituents. Due to 
the poor solubility, its 13C NMR spectrum could not be obtained despite prolonged 
acquisition time. Attempts to confirm the identity of this compound by ESI or FAB MS 
were also unsuccessful as the mass spectra measured under various temperature and 
different voltages showed only one identifiable peak at m/z = 451 corresponding to the 
[HL]+ fragment of salt C. In addition, the C, H, N values found by elemental analysis (C, 
66.78; H, 4.95; N, 4.56%) deviate from the calculated values for target complex 
[PdBr2(Bh2-bimy)2] (C, 67.91; H, 4.49; N, 4.80%) despite many efforts of purification. 
Hence, the identity of complex X as [PdBr2(Bh2-bimy)2] remains uncertain. 
The attempt was then made to synthesize a monocarbene Pd(II) complex by reacting 
in-situ generated complex 20 with [PdBr2(CH3CN)2] in a L:Pd ratio of 1:1 in acetonitrile. 
Immediate precipitation of AgBr was observed, and as expected, the monocarbene 
complex trans-[PdBr2(CH3CN)(Bh2-bimy)] (21) was obtained as air-stable yellow 
crystals from the filtrate (Scheme 3.2). The 1H NMR spectrum of complex 21 in CD3CN 
is rather simple. The signal for the CH protons of the benzhydryl groups arises as a 
singlet at 8.54 ppm, which is shifted downfield by 0.79 ppm compared to the analogous 
resonance of salt C. The 1H NMR spectrum of the same product in CDCl3, on the other 
hand, is more complicated. It shows three singlets at 8.58, 8.70 and 8.76 ppm in an 
intensity ratio of approximately 1:0.5:2, which remains largely unchanged after 1 day.  
After comparison with 1H NMR spectra of isolated and authentic samples, we assigned 
the three resonances to the benzhydryl CH protons in complex 21 (8.58 ppm), complex X 




















































Scheme 3.3. Proposed dynamic processes of complex 21 in CDCl3. 
 
Apparently, the lability of the CH3CN ligand gives rise to two dynamic processes that 
can be observed when pure complex 21 was dissolved in CDCl3 (Scheme 3.3): (a) two 
molecules of complex 21 undergo ligand exchange to form complex X {tentatively 
[PdBr2(Bh2-bimy)2]} and [PdBr2(CH3CN)2]; (b) two molecules of complex 21 form the 
dimeric complex [PdBr2(Bh2-bimy)]2 (22) under CH3CN dissociation. A comparison of 
the integrals for the aforementioned resonances suggests that process (b) is kinetically 
more favored, which should allow for a selective preparation of complex 22 (Vide infra). 
It may be worth mentioning that the dynamic processes observed for complex 21 is 
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different from that for its iPr2-bimy analogue trans-[PdBr2(CH3CN)(iPr2-bimy)] (2) where 
only the formation of a dimer similar to process (b) was observed. 
 
(a) (b) 
Figure 3.3. Molecular structures of complexes 21 (a) and 222CHCl3 (b) showing 50% 
probability ellipsoids; hydrogen atoms and solvent molecules are omitted for clarity. 
Selected bond lengths [Å] and angles [°]: 21: Pd1-C1 1.938(4), Pd1-Br1 2.4075(6), 
Pd1-Br2 2.4279(6), Pd1-N3 2.077(4), C1-N1 1.349(4), C1-N2 1.351(4), N3-C34 1.111(5); 
C1-Pd1-Br1 87.92(11), C1-Pd1-Br2 89.08(11), N3-Pd1-Br1 88.41(10), N3-Pd1-Br2 
94.64(10), N1-C1-N2 107.6(3), Pd1-N3-C34 167.9(4). 222CHCl3: Pd1-C1 1.957(3), 
Pd1-Br1 2.4161(5), Pd1-Br2 2.4439(5), Pd1-Br4 2.5085(4), Pd2-C34 1.949(3), Pd2-Br2 
2.5225(4), Pd2-Br3 2.4038(5), Pd2-Br4 2.4454(5), C1-N1 1.350(4), C1-N2 1.346(4), 
C34-N3 1.344(4), C34-N4 1.346(4); C1-Pd1-Br1 89.69(10), C1-Pd1-Br2 90.09(10), 
Br2-Pd1-Br4 88.359(15), Br1-Pd1-Br4 92.515(16), C34-Pd2-Br3 86.24(10), 
C34-Pd2-Br4 91.86(10), Br2-Pd2-Br3 94.286(16), Br2-Pd2-Br4 88.007(15), N1-C1-N2 
108.2(3), N3-C34-N4 107.9(3). 
 
However, complex 21 is stable in CH3CN and thus single crystals suitable for X-ray 
diffraction were obtained by slow evaporation of a concentrated CH3CN solution. Its 
molecular structure depicted in Figure 3.3a shows a square planar geometry around the 
palladium center with a weakly bonded acetonitrile ligand in trans position to the NHC. 
The Pd1-C1 [1.938(4) Å] and Pd1-N3 [2.077(4) Å] bond lengths are comparable to the 
Chapter 3 
 82
corresponding bond parameters of the iPr2-bimy analogue (2). In addition, the 
Pd1-N3-C34 angle [167.9(4)°] is smaller than that for complex 2 [175.35(18)°]. 
As mentioned above, the lability of the acetonitrile ligand in complex 21 and the 
preference for process (b) (vide supra) should allow for a selective preparation of the 
dimeric complex 22. Indeed, it was found that upon washing of complex 21 with diethyl 
ether, dissociation of acetonitrile from the metal center readily occurred to yield the 
dimeric complex [PdBr2(Bh2-bimy)]2 (22) as an orange powder (Scheme 3.2). The 
formation of complex 22 was confirmed by 1H NMR spectroscopy, which shows the 
absence of the methyl signal from the acetonitrile ligand and a slight downfield shift for 
the benzhydryl CH proton. The other 1H and 13C chemical shifts for the NHC ligand 
remain largely unchanged upon dissociation of acetonitrile and formation of complex 22. 
Notably, our attempt to prepare complex 22 directly from salt C and Pd(OAc)2 in the 
presence of KBr in DMSO at 90°C failed and gave rise to an intractable product mixture, 
although the same synthetic route worked very well for the iPr2-bimy analogue 
[PdBr2(iPr2-bimy)]2 (1). The failure is presumably attributed to the decomposition of the 
carbene ligand under the relatively harsh reaction conditions. 
The molecular structure of solvate 222CHCl3 determined by X-ray diffraction analysis 
is illustrated in Figure 3.3b. Complex 22 contains two essentially square-planar Pd(II) 
centers coordinated by one carbene, one terminal bromo and two bridging bromo ligands 
with the carbene ligands oriented anti to each other. Different from the iPr2-bimy 
analogue (1) that has a planar [Pd2Br2] ring, the [Pd2Br2] ring in complex 22 is slightly 
bent with a hinge angle of ca. 165°. The two Pd-Ccarbene bond distances of 1.957(3) and 
1.949(3) Å have slightly elongated compared to that in the precursor complex 21, which 
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is in line with less Lewis acidic metal centers in complex 22. Furthermore, among the 
three types of Pd-Br bonds in this complex, the Pd-Br bonds trans to the carbene ligands 
are significantly longer than the other two types due to the strong trans influence of the 
NHC. This observation is similar to that found in complex 1. 
 
3.2 Catalytic studies in Suzuki-Miyaura coupling  
 
In Chapter 2, it has been shown that the dimeric complex [PdBr2(iPr2-bimy)]2 (1) 
bearing the bulky iPr2-bimy ligand serves as a very good precatalyst for aqueous 
Suzuki-Miyaura cross-coupling reactions. Herein, it is of our interest to compare its 
performance to that of complex 22 bearing the even bulkier Bh2-bimy ligand.  
 












Entry Solvent Yield [%]b 
1 H2O 100 
2 CH3CN/H2O (1:1 in volume) 97 
3 Toluene 97 
4 CH3CN 26 
a Reaction conditions: 1 mmol of 4-bromobenzaldehyde; 1.2 mmol of phenylboronic acid; 3 ml of 
solvent; 1.5 equivalents of K2CO3; 0.5 mol% of 22; under nitrogen atmosphere. b Yields were 
determined by 1H NMR spectroscopy for an average of two runs. 
 
The coupling of 4-bromobenzaldehyde with phenylboronic acid with 0.5 mol% of 
complex 22 and a reaction time of 6 h at ambient temperature was chosen as a standard 
test reaction to study the effects of various solvents. As shown in Table 3.1, the reaction 
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carried out in pure water as “green” solvent gave the highest yield of 100%, whereas that 
in CH3CN afforded the lowest yield of only 26%. Reactions in a CH3CN/H2O mixture or 
toluene gave near-quantitative yields. The same solvent trend was observed when 
complex 1 was employed as the precatalyst for the same reaction. 
Subsequently, the comparison of both catalyst precursors was extended to various 
substrates using water as the reaction media. The result is shown in Table 3.2. For the 
coupling of activated 4-bromoacetophenone, the two complexes gave the same yield of 
89% after 6 h (Entry 1). However, their activities were found to be very different in the 
coupling of deactivated aryl bromides. For instance, complex 22 gave generally higher 
yields in the coupling of electron-rich 4-bromotoluene or 4-bromoanisole (Entries 2/3). It 
was observed that in reactions with deactivated substrates the reaction mixture turned to 
black within a few minutes. Hence, it is likely that the real catalysts in these reactions are 
colloidal palladium(0) nanoparticles, which has been reported by other research groups 
when different catalyst precursors were used in Suzuki-Miyaura58a,78 or Mizoroki-Heck79 
reactions with less reactive substrates and at elevated temperatures. The difference in the 
catalytic activities of complexes 22 and 1 observed here may lead to the hypothesis that 
the two complexes with different N-substituents generate active palladium(0) colloids of 
different sizes, which exhibit different catalytic activities. Furthermore, the comparison 
between entries 2 and 4 suggests that the CH3CN/H2O mixture is a better solvent system 
than pure H2O for the coupling of deactivated 4-bromotoluene. On the other hand, pure 
H2O is the best choice of solvent for the activated 4-bromobenzaldehyde. A simple 




Table 3.2. Suzuki-Miyaura cross-coupling reactionsa 
 
XR + B(OH)2 R
R = COCH3, OCH3, CH3
1 mol% [Pd]










1 4-bromoacetophenone H2O 6 RT 89(89)c 
2 4-bromotoluene H2O 12 85 80(55)c 
3 4-bromoanisole H2O 12 85 80(28)c 
4 4-bromotoluene CH3CN/H2O (1:1 in volume) 1 85 100(100)c 
5 4-bromotoluene CH3CN/H2O (1:1 in volume) 2 RT 84(61)d 
6 4-bromotoluene CH3CN/H2O (1:1 in volume) 0.5 85 100d 
7 4-bromoanisole CH3CN/H2O (1:1 in volume) 2 RT 31d 
8 4-bromoanisole CH3CN/H2O (1:1 in volume) 2 85 100d 
9 4-chlorobenzaldehyde CH3CN/H2O (1:1 in volume) 5 85 8d 
10 4-chloroacetophenone CH3CN/H2O (1:1 in volume) 5 85 36d 
11 4-chlorobenzaldehyde CH3CN/H2O (1:1 in volume) 5 85 14d,e 
12 4-chloroacetophenone CH3CN/H2O (1:1 in volume) 5 85 32d,e 
13 4-bromotoluene CH3CN/H2O (1:1 in volume) 2 RT 0d,e 
14 4-bromoanisole CH3CN/H2O (1:1 in volume) 2 RT 0d,e 
a Reaction conditions: 1 mmol of aryl halide; 1.2 mmol of phenylboronic acid; 3 ml of solvent; 
1.5 equivalents of K2CO3; 0.5 mol% of 22 or [PdBr2(iPr2-bimy)]2 (1). b Yields were determined by 
1H NMR spectroscopy for an average of two runs; values in brackets are the yield for the 
reactions catalyzed by 1. c Reactions were carried out under nitrogen atmosphere. d Reactions 
were carried out under air. e With addition of 1.5 equivalents of [N(n-Bu)4]Br. 
 
It was also found that using the CH3CN/H2O mixture as solvent, the coupling of 
electron-rich 4-bromotoluene or 4-bromoanisole catalyzed by complex 22 could occur at 
ambient temperature, giving yields of 84% and 31%, respectively, after 2 h (Entries 5/7). 
These reactions could go to completion in a short time when the reaction temperature was 
raised to 85 °C (Entries 6/8). In an attempt to test the reusability of the active catalyst in 
the coupling of 4-bromotoluene (Entry 6), it was found that a second run still afforded a 
Chapter 3 
 86
good yield of 83% after 0.5 h (ceteris paribus). Furthermore, aerobic conditions did not 
cause loss of yield, which is evident when entries 4 and 6 are compared. However, the 
coupling of 4-chlorobenzaldehyde and 4-chloroacetophenone were more difficult and 
afforded only low yields of 8% and 36%, respectively, even at 85 °C (Entries 9/10). 
Surprisingly, addition of [N(n-Bu)4]Br (TBAB), which is commonly used as a 
phase-transfer catalyst and promoter did not lead to any significant improvements 
(Entries 11/12). In the case of 4-bromotoluene and 4-bromoanisole a TBAB-addition 
prevents the formation of active Pd(0) species at ambient temperature due to its 
stabilizing effect and thus no conversion was observed (Entries 13/14). 
An attempt to study the kinetics of the coupling reaction using 4-bromotoluene at 
ambient temperature was also made. To our surprise, after 12 min a high yield of 80% 
was already obtained, but longer reaction time did not improve the yield to a great extend. 
This observation corroborates the proposal that palladium(0) colloids are the real 
catalysts. It seems that after converting ~80% of the substrates the initially smaller 
colloids have substantially grown in size, which results in self-deactivation due to the 
resulting smaller active surface area. 
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Chapter 4. Palladium(II) Complexes with Pyrazole-based 
Remote N-heterocyclic Carbene Ligands 
 
Recent studies pioneered by Raubenheimer and coworkers have shown that complexes 
containing N-heterocyclic carbene ligands with remote heteroatoms (rNHC) exhibit 
better performance compared to their classical NHC analogues in certain C-C coupling 
catalysis.22a,23 The superiority of the former may stem from the stronger  donor ability 
of rNHC ligands as supported by computational studies.22 However, all reported rNHC 
complexes by then contain a six-membered ring derived from pyridine, quinoline or 
acridine. Hence, it is of our interest to extend the rNHC chemistry to pyrazole-based 
system which contains a five-membered carbene ring. 
 
4.1 Synthesis and catalytic studies of mononuclear Pd(II) complexes 




As shown in Chapters 2 and 3, general routes to palladium(II) NHC complexes include: 
a) in-situ deprotonation of azolium salts with Pd(OAc)2, and b) use of Ag-carbene transfer 
reagents. However, our initial attempts to synthesize a palladium(II) pyrazolin-4-ylidene 
complex from a 1,2,3,5-tetrasubstituted pyrazolium salt using these methods under 
various reaction conditions proved unsuccessful (Scheme 4.1). Apparently, the proton 
attached to C4 in these carbene precursors is less acidic than the C2 proton in 
conventional imidazolium or benzimidazolium salts. The former experiences 
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comparatively weaker inductive effects from the electron-withdrawing N atoms, which 










































R1 = R2 =Me, R3 = Bz, X = Br
R1 = R2 = Me, R3 = Ph, X = I R1 = R2 = R3 =Me, X = Iaor or
R1 = R2 = Me, R3 = Ph, X = I
a In this case, addition of 2 equiv of NaOH or KOtBu as an external base was also attempted to no avail.   





























23a R = Ph
23b R = Me
24a R = Ph
24b R = Me
25a R = Ph
25b R = Me
26a R = Ph









Scheme 4.2. Synthetic pathway to neutral Pd(II) rNHC complexes 26a/b. 
 
Due to the difficulty in deprotonating pyrazolium salts, the oxidative addition method 
using a low-valent metal precursor was explored.16 Suitable ligand precursors (25a/b) 
were readily prepared in moderate yields of 33-50% by heating 
1,3,5-trisubstituted-4-iodopyrazoles (24a/b) in neat iodoethane under reflux (Scheme 4.2). 
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The former were obtained by iodination of the corresponding 1,3,5-trisubstituted 
pyrazoles (23a/b), 81  which can be generated via condensation of diones with 
monosubstituted hydrazines if not commercially available. 82  This straightforward, 
modular synthetic protocol is highly desirable as ligands with a wide range of substitution 
pattern can be conveniently obtained through the condensation of readily available diones 
with substituted hydrazines, which in turn allows facile fine-tuning of steric and 
electronic properties of the resulting rNHC ligands.  
The formation of 25a/b was confirmed by a base peak in the positive ESI mass spectra 
at m/z = 327 (25a) and 265 (25b), respectively, corresponding to the [M-I]+ fragments. In 
addition, the C4 carbon atoms resonate at 72.6 ppm (25a, CDCl3) and 69.3 ppm (25b, 
d6-DMSO), which are shifted downfield upon N-ethylation as compared to the analogous 
carbon resonances for their precursors (24a/b) consistent with the formation of aromatic 
cations.  
Treatment of [Pd2(dba)3] with two equivalents of 25a/b and two equivalents of 
triphenylphosphine in refluxing dichloromethane leads to the formation of the neutral 
palladium(II) pyrazolin-4-ylidene complexes 26a/b. Slow evaporation of a concentrated 
CH2Cl2 solution gave analytically pure 26a/b as yellow crystals in yields of 70% and 
60%, respectively. It is worth mentioning that pre-mixing of [Pd2(dba)3] with PPh3 before 
the addition of the ligand precursors is important for obtaining good yields of the 
complexes. For instance, complex 26b was obtained in a yield of only 45% when 25b, 
[Pd2(dba)3] and PPh3 were added in a fast sequence. However, the yield could be 
increased to 60% when the ligand precursor 25b was added only after having mixed 
[Pd2(dba)3] and PPh3 in CH2Cl2 at ambient temperature for 10 min. Complexes 26a/b are 
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stable to air and moisture. They are both soluble in polar solvents such as 
dichloromethane, acetonitrile or DMSO, but insoluble in pentane, diethyl ether or THF. 
The formation of the complexes was confirmed by ESI mass spectrometry with 
positive mode spectra showing base peaks at m/z = 695 (26a) and 633 (26b) for the 
[M-I]+ fragments. The phosphine donors in both complexes resonate at similar positions 
in 31P NMR spectra with chemical shifts of 29.4 ppm (26a) and 29.3 ppm (26b), 
respectively. The 1H NMR spectrum of complex 26a shows two doublets of quartets for 
the two inequivalent CH2 protons of the ethyl substituent centered at 3.78 and 3.63 ppm 
with a geminal coupling constant of 2J(H,H) = 15.4 Hz. This can be attributed to a 
hindered rotation of the ethyl group in close proximity of the sterically bulky N-phenyl 
substituent as well as the non-symmetrical environment in a cis arranged complex. 
Correspondingly, the 13C NMR spectrum of complex 26a exhibits six distinct signals in 
the range of 132.3-127.7 ppm revealing a hindered rotation for the N-phenyl substituent 
as well. In contrast to 26a, the CH2 protons of the ethyl substituent in 26b appear as one 
quartet in the 1H NMR spectrum indicating a free rotation of the ethyl group neighboring 
to the less bulky methyl group. In addition, the carbon atoms C3 and C5 adjacent to the 
carbene carbon of both complexes resonate in the range of 145.4-147.2 ppm as doublets 
with coupling constants of 3J(C,P) = 2.7-4.6 Hz, respectively. The carbenoid signals, on 
the other hand, were not observed due to insufficient solubilities. However, the identity of 
the palladium(II) pyrazolin-4-ylidene complexes 26a/b was further confirmed by single 
crystal X-ray diffraction studies. Their molecular structures depicted in Figure 4.1, show 
the expected square planar arrangement around the palladium center with the rNHC and 
the phosphine cis to each other. The Pd-Ccarbene bond lengths of 2.012(8) Å in 26a and 
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1.996(7) Å in 26b are comparable with those reported for standard NHC complexes or 
other types of rNHC complexes. Furthermore, the Pd-I1 bonds trans to the rNHC 
[2.6691(10) Å in 26a and 2.6730(7) Å in 26b] are slightly longer than the Pd-I2 bonds 
trans to the phosphine (2.6564(10) Å in 26a and 2.6458(7) Å in 26b) confirming a 
slightly stronger trans influence of the rNHCs. The carbene ring plane of the rNHC is 
oriented almost perpendicular to the PdI2CP coordination plane with a torsion angle of 
89.40° (26a) or 85.98° (26b) to minimize interligand interactions. 
 
Figure 4.1. Molecular structures of complexes 26a0.5C6H5CH3 (left) and 26b0.5CH2Cl2 
(right) showing 50% probability ellipsoids; hydrogen atoms and solvent molecules are 
omitted for clarity. Selected bond lengths[Å] and angles [°]: 26a0.5C6H5CH3: Pd1-C1 
2.012(8), Pd1-P1 2.266(3), Pd1-I1 2.6691(10), Pd1-I2 2.6564(10), C1-C2 1.381(13), 
C1-C3 1.373(13), N1-C2 1.358(12), N2-C3 1.366(12), N1-N2 1.358(11); C1-Pd1-P1 
90.6(3), C1-Pd1-I2 86.1(3), P1-Pd1-I1 91.67(7), I2-Pd1-I1 91.69(3), C3-C1-C2 106.0(8). 
26b0.5CH2Cl2: Pd1-C1 1.996(7), Pd1-P1 2.2765(16), Pd1-I1 2.6730(7), Pd1-I2 
2.6458(7), C1-C2 1.377(9), C1-C3 1.388(9), N1-C2 1.330(9), N2-C3 1.348(9), N1-N2 
1.359(8); C1-Pd1-P1 89.79(19), C1-Pd1-I2 86.44(18), P1-Pd1-I1 90.69(4), I2-Pd1-I1 
93.35(2), C3-C1-C2 104.3(6). 
 
In order to improve the solubilities of the new palladium(II) pyrazolin-4-ylidene 
complexes, which would help in identifying the carbene signals by 13C NMR 
spectroscopy, we substituted the iodo ligands of complexes 26a/b by trifluoroacetato 
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ligands via a salt metathesis reaction (Scheme 4.3). The dicarboxylato complexes 27a/b 
were obtained as colorless crystals in yields of 70% and 68%, respectively, by slow 
evaporation of concentrated CH2Cl2/hexane solutions. They are well soluble in 
chlorinated solvents, acetonitrile, and DMSO, but insoluble in nonpolar solvents such as 
hexane, toluene and diethyl ether. Under aerobic conditions and upon prolonged standing, 
solutions of both complexes 27a/b slowly deposit palladium black. The decreased 
stability upon halo/trifluoroacetato exchange was also observed in other Pd(II) NHC 
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Scheme 4.3. Synthesis of complexes 27a/b. 
 
The 1H and 31P NMR spectra of complexes 27a/b show little changes in their chemical 
shifts compared to those for their precursor complexes 26a/b. However, 19F NMR 
spectroscopy on 27a/b reveals two singlets in a narrow range of 0.70 to -0.05 ppm, 
pointing to a cis arrangement of the carboxylato ligands in solution. In addition, the 13C 
carbene signals of 27a and 27b arise as doublets at 115.1 ppm with 2J(C,P) = 10.4 Hz and 
at 113.8 ppm with 2J(C,P) = 9.9 Hz, respectively. It is worth mentioning, that these 
carbene signals are significantly shifted to lower field by 42.5 and 44.5 ppm with 
reference to the analogous C4 carbon resonances in their ligand precursors 25a/b. Finally, 
two broad quartets are observed at 160.5 ppm with 2J(C,F) = 31.8 Hz and at 116.3 ppm 
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with 1J(C,F) = 273.9 Hz for the CO and CF3 carbon atoms of complex 27a, respectively. 
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Scheme 4.4. Synthesis of the ionic Pd(II) rNHC complexes 29a/b. 
 
  For the purpose of comparison, the mono-cationic Pd(II) rNHC complexes 29a/b were 
also prepared, according to Scheme 4.4. The 4-iodopyrazolium triflate salt-precursors 
28a/b were easily obtained in quantitative yields by reacting 25a/b with silver triflate. In 
a similar preparative manner to 26a/b, treatment of 28a/b with pre-mixed [Pd2(dba)3] and 
PPh3 in CH2Cl2 under reflux condition led to the formation of the mono-cationic 
bis(phosphine) complexes 29a/b in good yields of 80 and 73%, respectively. Complexes 
29a/b are also stable to air and moisture. They are generally more soluble than the neutral 
complexes 26a/b in most polar solvents such as CHCl3, CH2Cl2, CH3CN and DMSO. The 
improved solubilities of 29a/b allow for an identification of their carbene signals by 13C 
NMR spectroscopy (Vide infra). 
The formation of complexes 29a/b was confirmed by ESI mass spectrometry, which 
shows base peaks at m/z = 957 (29a) and 895 (29b) in their positive mode spectra, 
corresponding to the cationic complex [M-CF3SO3]+. In the 31P NMR spectra, the 
phosphine donors in both complexes give rise to very similar chemical shifts with values 
of 23.0 (29a) and 22.8 ppm (29b), respectively. The fact that only one 31P NMR signal 
was observed for each complex indicates two equivalent phosphine ligands and therefore 
Chapter 4 
 94
a trans configuration of the complex. The triflate 19F NMR resonances in 29a/b found in 
a narrow range of -2.2~-2.3 ppm remain largely unchanged compared to the ligand 
precursors 28a/b, which is in line with a non-coordinating triflate counter-anion. In 
general, the 1H NMR resonances of both complexes are shifted upfield with respect to the 
corresponding signals of their ligand precursors. More importantly, the 13C NMR signals 
for the carbenoid carbon atoms in the ionic complexes 29a/b are observed at 128.2 and 
127.8 ppm, respectively. Both signals appear as triplets due to heteronuclear coupling 
with constants of 2J(C,P) = 7.3 Hz, again corroborating the trans arrangement of the two 
phosphine ligands. Although these carbenoid resonances are more upfield than the values 
commonly observed for analogous Pd(II) complexes of other rNHCs83 or standard 
NHCs,22a, 84  they are still significantly downfield-shifted by  = 60.4 (29a) and 
61.0 ppm (29b), respectively, compared to the C4 carbon resonances in their ligand 
precursors. 
Single crystals of complexes 29a/b were obtained from concentrated CH2Cl2/Et2O 
solutions and analyzed by X-ray diffraction. The molecular structures of the 
complex-cations are depicted in Figure 4.2. As found by solution NMR studies, both 
complexes exhibit the expected trans configuration of the phosphine ligands. The carbene 
ring plane of the rNHC ligand in each complex is situated almost perpendicularly to the 
PdICP2 coordination plane with a torsion angle of 89.91 (29a) or 90.00 (29b) to relieve 
steric congestion. These angles are bigger than those in the less crowded complexes 
26a/b (89.40 and 85.98) for obvious reasons. The Pd-P bonds amounting to 
2.3270(13) Å, 2.3299(13) Å in 29a and 2.3375(15) Å in 29b are comparable with those 
in analogous complexes containing other rNHCs.83 Furthermore, both Pd-Ccarbene bond 
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lengths of 2.020(5) Å (29a) and 2.004(9) Å (29b) fall within the normal range with the 
former slightly longer than the latter. The same trend was also observed in the 
comparison of 26a [2.012(8) Å] with 26b [1.996(7) Å]. These observations suggest, that 
2-ethyl-3,5-dimethyl-1-phenylpyrazolin-4-ylidene in 29a and 26a is a weaker ligand than 
1-ethyl-2,3,5-trimethylpyrazolin-4-ylidene in 29b and 26b due to the less 
electron-donating N-phenyl substituent compared to N-methyl substituent as a 
consequence of different inductive effects. However, the existence of such substituent 
effects in pyrazole-based rNHCs remains to be investigated in more detail. 
 
Figure 4.2. Molecular structures of the complex-cations of 29aCH2Cl2H2O (left) and 
29bCH2Cl2 (right) showing 50% probability ellipsoids; OTf- counterion, hydrogen atoms 
and solvent molecules are omitted for clarity. Selected bond lengths[Å] and angles [°]: 
29aCH2Cl2H2O: Pd1-C1 2.020(5), Pd1-I1 2.6727(5), Pd1-P1 2.3270(13), Pd1-P2 
2.3299(13), C1-C2 1.391(7), C1-C3 1.396(6), C2-N1 1.351(6), C3-N2 1.357(6), N1-N2 
1.369(6); C1-Pd1-P1 88.72(13), C1-Pd1-P2 89.37(13), I1-Pd1-P1 90.46(3), I1-Pd1-P2 
91.27(3), C2-C1-C3 105.9(4). 29bCH2Cl2: Pd1-C1 2.004(9), Pd1-I1 2.6685(9), Pd1-P1 
2.3375(15), C1-C2 1.422(14), C1-C3 1.374(15), C2-N1 1.340(15), C3-N2 1.379(15), 




4.1.2 Catalytic studies in Suzuki-Miyaura coupling 
 
The catalytic activities of the neutral Pd(II) rNHC complexes (26a/b) and the ionic 
Pd(II) rNHC complexes (29a/b) were tested and compared in the Suzuki-Miyaura 
coupling reactions. The coupling of simple aryl bromides and chlorides with 
phenylboronic acid in water under aerobic conditions with 1 mol% catalyst loading was 
chosen as a standard test reaction, and the results are presented in Table 4.1. Water was 
selected to be the reaction media, because it is economical and is environmentally benign. 
In addition, it has been shown previously (see Sections 2.1.3 and 3.2) that water can be a 
good solvent for the Suzuki-Miyaura coupling reaction.58,59,60  
From entries 1-8 it can be seen, that all four complexes give rise to catalysts that are 
able to couple the activated substrates 4-bromobenzaldehyde and 4-bromoacetophenone 
at ambient temperature in moderate to very good yields. As for the non-activated 
substrate 4-bromoanisole, good conversions could only be obtained at elevated 
temperatures and with the addition of [N(n-Bu)4]Br (TBAB) (Entries 9-12). However, 
even under such conditions, the coupling of the more difficult substrate 
4-chlorobenzaldehyde afforded only low yields ranging from 14 to 39% (Entries 13-16). 
Overall, reactions using the ionic precatalysts 29a and 29b generally show remarkably 
better conversions than those of their corresponding neutral counterparts 26a and 26b. 
This finding is consistent with the result reported by Raubenheimer and coworkers, 
where the superiority of the simple cationic NHC complex 
trans-[PdCl(Me2-imy)(PPh3)2]+ over its corresponding neutral complex 
trans-[PdI2(Me2-imy)(PPh3)] was observed in both Mizoroki-Heck and Suzuki-Miyaura 
reactions.22a The catalyst derived from complex 29a exhibits the best catalytic activity in 
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the reactions with aryl bromides. However, in the coupling of 4-chlorobenzaldehyde, 29b 
performs slightly better. 
 







X = Br, Cl
R = COCH3, CHO, OCH3  
 
Entry Catalyst Aryl halide t [h] Temp [ºC] Yield [%]b 
 1 26a 4-bromobenzaldehyde 19 RT 80 
2 26b 4-bromobenzaldehyde 19 RT 82 
3 29a 4-bromobenzaldehyde 19 RT 93 
4 29b 4-bromobenzaldehyde 19 RT 92 
5 26a 4-bromoacetophenone 19 RT 80 
6 26b 4-bromoacetophenone 19 RT 67 
7 29a 4-bromoacetophenone 19 RT 95 
8 29b 4-bromoacetophenone 19 RT 91 
9 26a 4-bromoanisole 21 80 82c 
10 26b 4-bromoanisole 21 80 90c 
11 29a 4-bromoanisole 21 80 96c 
12 29b 4-bromoanisole 21 80 92c 
13 26a 4-chlorobenzaldehyde 21 80 20c 
14 26b 4-chlorobenzaldehyde 21 80 14c 
15 29a 4-chlorobenzaldehyde 21 80 37c 
16 29b 4-chlorobenzaldehyde 21 80 39c 
a Reaction conditions: 1 mmol of aryl halide; 1.2 mmol of phenylboronic acid; 3 ml of water; 1.5 
equivalents of K2CO3; 1 mol% of catalyst. b Yields were determined by 1H NMR spectroscopy for 
an average of two runs. c With addition of 1.5 equivalents of [N(n-Bu)4]Br. 
 





4.2.1 Synthesis of Pd(II) phosphine complexes with different pyrazolin-4-ylidenes 
 
Synthesis and characterization of 4-iodopyrazolium salts. In order to tune the 
sterics and electronics around the carbene center and to study the substituent-effects on 
the formation of pyrazolin-4-ylidene complexes, three 4-iodopyrazolium salt-precursors 
(32a-c) with different 3,5-substituents were synthesized in a similar sequence to 25a/b as 
depicted in Scheme 4.5. It may be worth noting that, the introduction of an 
iodo-substituent at the 4-position in the 2nd step deactivates the pyrazole for electrophilic 
attack, and thus relatively strong alkylating reagents such as alkyl iodides and 
Meerwein’s salts are required. Alkyl bromides generally afforded only negligible yields 
even under harsh reaction conditions and prolonged reaction time. When alkyl iodides are 
employed, the 4-iodopyrazole has to be heated under reflux either with a large excess or 
in neat alkylating agent in order to obtain reasonable yield (see synthesis of 25a/b in the 
Experimental section). However, when Meerwein’s stronger trimethyloxonium salt is 
used, the alkylation can proceed smoothly with stoichiometric amount of the reagent and 
under milder reaction conditions. Furthermore, it was found that the rate of alkylation is 
also affected by the 3,5-substituents. Correspondingly, the reaction of 31b and 31c 
bearing bulkier 3,5-diphenyl and 3,5-diisopropyl substituents, respectively, required 
heating under reflux for an additional day in order to obtain 32b and 32c in good yields. 
The formation of all three 4-iodopyrazolium salts was confirmed by a base peak in the 
positive ESI MS spectra at m/z = 313 (32a), 437 (32b) and 369 (32c), respectively, 
corresponding to the [M-BF4]+ fragment. Interestingly, the 13C NMR spectra revealed that 
the C-I carbon resonances decrease in the order 32b (68.5 ppm) > 32a (67.4 ppm) > 32c 
(60.7 ppm), in accordance with the electron-donating ability of the 3,5-substituents Ph 
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(32b) < Me (32a) < iPr (32c) and thus increased shielding effect. In addition, two singlets 
with an intensity ratio of ~1:4 are observed in the 19F NMR spectrum for the BF4- 
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Scheme 4.5. Synthetic pathway to 4-iodopyrazolium salts 32a-c. a Only for the synthesis 
of 32b and 32c. 
 
Synthesis and characterization of Pd(II) pyrazolin-4-ylidene-phosphine complexes. 
In an attempt to obtain cationic Pd(II) rNHC-phosphine complexes, [Pd2(dba)3] was 
treated with two equiv of 32a/b/c and four equiv of PPh3 in refluxing dichloromethane 
for 6 h, according to the procedure described in Section 4.1 (Scheme 4.6). Interestingly, 
these three reactions gave rise to products of different geometry or connectivity, 
indicating a dramatic influence of the 3,5-substituents in rNHC ligands on complexation. 
As shown in Scheme 4.6a, the reaction of 32a bearing the least bulky 3,5-dimethyl 
substituents afforded the cationic complex trans-33a in a quantitative yield.†† The trans 
configuration of 33a is indicated by its 31P NMR spectrum, which shows only one signal 
at 22.9 ppm suggesting two equivalent phosphine ligands. This chemical shift is very 
similar to those observed for complexes 29a/b. Furthermore, the 13C NMR signals for the 
carbenoid carbon and the two adjacent carbon atoms C3/C5 in complex 33a are observed 
at 128.3, 145.1 and 145.6 ppm, respectively. All these signals appear as triplets due to 
                                                        
†† Complex 33a and its ligand precursor 32a were prepared by an Honors student, Lee Li Juan, under my guidance.  
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heteronuclear coupling with constants of 2J(C,P) = 7.3 Hz and 3J(C,P) = 3.2 Hz, 

















































































Scheme 4.6. Synthesis of pyrazolin-4-ylidene-phosphine complexes 33a-c. 
 
Single crystals of complex 33a were obtained by slow evaporation of a concentrated 
acetone/hexane solution and analyzed by X-ray diffraction. Its molecular structure is 
depicted in Figure 4.3. As found in solution, complex 33a adopts the expected trans 
configuration of the phosphine ligands in an essentially square planar coordination 
geometry. The Pd-P bonds of 2.326(3) and 2.332(3) Å and Pd-Ccarbene bond of 2.006(8) Å 
fall in the range observed for pyrazolin-4-ylidene complexes (26a/b and 29a/b) discussed 




Figure 4.3. Molecular structure of the complex-cation of trans-33a·Me2CO showing 50% 
probability ellipsoids; BF4- counterion, solvent molecule and hydrogen atoms are omitted 
for clarity. Selected bond lengths [Å] and angles [°]: Pd1-C1 2.006(8), Pd1-I1 2.6717(13), 
Pd1-P1 2.326(3), Pd1-P2 2.332(3), C1-C2 1.415(13), C1-C3 1.392(12), N1-C2 1.318(12), 
N2-C3 1.355(12), N1-N2 1.360(11); C1-Pd1-P1 90.2(3), C1-Pd1-P2 89.0(3), P1-Pd1-I1 
90.75(7), P2-Pd1-I1 90.13(7), C2-C1-C3 103.8(8). 
 
In contrast to the formation of trans-33a, the reaction involving 32b bearing the 
bulkier 3,5-diphenyl substituents afforded a cis-configured complex cis-33b as the 
kinetically favored product, which slowly converts to the thermodynamically more stable 
trans-isomer upon standing in solution (Scheme 4.6b). Complex cis-33b was isolated in 
40% yield after recrystallization from a concentrated CH2Cl2/hexane solution. In 
literature, most complexes of the type [PdXL(PR3)2]+ (X = halide; L = NHC, rNHC or 
Fisher-carbene; R = aryl or alkyl) adopt a trans configuration with only two 
exceptions.17d,23a For example, Raubenheimer and co-workers reported that the complex 
cis-[PdCl(NHC)(PPh3)2]+BF4- derived from a quinolinium salt was observed only at low 
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temperatures of -20 °C or below, whereas at room temperature its trans-isomer was 
observed exclusively. In our case, the isomerization of cis-33b to trans-33b in 
dichloromethane at ambient temperature is slow enough to allow for the isolation of the 
former. The 31P NMR spectrum of cis-33b shows two doublets at 28.7 and 16.3 ppm with 
a coupling constant of 2J(P,P) = 24.8 Hz, pointing to two inequivalent phosphine ligands 
and thus a cis geometry. In the 13C NMR spectrum, two downfield doublets of doublets 
are observed at 150.5 and 148.5 ppm corresponding to the C3/C5 carbon atoms in the 
rNHC ring. In addition, the carbenoid carbon also appears as a doublet of doublet 
centered at 125.0 ppm with 2J(Ptrans,C) = 143.9 Hz  and 2J(Pcis,C) = 5.5 Hz, due to the 
coupling to two inequivalent phosphorus atoms.  
Upon standing in CD2Cl2, cis-33b slowly isomerizes to trans-33b as monitored by 31P 
NMR spectroscopy, which shows a gradual decrease of the two doublets for cis-33b 
accompanied by a slow increase of one singlet at 20.3 ppm for trans-33b. A comparison 
of their integrals reveals a conversion of ~9% after 28 d. However, this isomerization 
process is much faster in more polar solvents such as CH3CN and DMSO. For example, 
after standing in CD3CN for 2 d, cis-33b has completely converted to trans-33b. Such a 
solvent dependence of the cis-trans isomerization was also reported for a Pt(II) complex 
of the type [PtCl(rNHC)(PPh3)2]+BF4-, where the rNHC is a quinoline-4-ylidene 
ligand.83a The thermodynamic preference of trans-33b over cis-33b, again, could be due 
to the transphobia effect, similar to the isomerization of trans-4 to cis-4 (see Section 
2.1.2).38 
As expected, the 1H NMR spectrum of trans-33b shows a better-resolved pattern in the 
aromatic region compared to that of cis-33b. More importantly and different from the two 
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doublets of doublets observed for the C3/C5 carbon atoms in cis-33b, the analogous 
carbon resonances in trans-33b arise at 149.8 and 148.6 ppm as two triplets with a 
coupling constant of 3J(P,C) = 3.7 Hz. However, the carbene signal for trans-33b could 
not be clearly identified due to the interference of many aromatic signals in the same 






Figure 4.4. Molecular structures of the complex-cations of cis-33b·CH2Cl2 (left) and 
trans-33b·0.5CH3CN (right) showing 50% probability ellipsoids; BF4- counterion, solvent 
molecules, and hydrogen atoms are omitted for clarity. Selected bond lengths [Å] and 
angles [°]: cis-4b·CH2Cl2: Pd1-C1 2.038(4), Pd1-I1 2.6539(4), Pd1-P1 2.3861(12), 
Pd1-P2 2.2882(11), C1-C2 1.402(6), C1-C3 1.397(6), N1-C2 1.350(5), N2-C3 1.361(5), 
N1-N2 1.370(5); C1-Pd1-P2 89.81(12), P1-Pd1-I1 86.12(3), C1-Pd1-I1 86.95(11), 
P1-Pd1-P2 97.16(4), C2-C1-C3 104.4(4). trans-4b·0.5CH3CN: Pd1-C1 2.033(7), Pd1-I1 
2.6501(8), Pd1-P1 2.356(2), Pd1-P2 2.351(2), C1-C2 1.411(11), C1-C3 1.374(11), N1-C2 
1.354(11), N2-C3 1.370(10), N1-N2 1.352(11); C1-Pd1-P1 89.5(2), C1-Pd1-P2 90.6(2), 
P1-Pd1-I1 92.17(5), P2-Pd1-I1 87.92(5), C2-C1-C3 106.1(7). 
 
Single crystals were grown by slow evaporation of a concentrated CH2Cl2/hexane 
solution (cis-33b) or by diffusion of diethyl ether into a CH3CN solution (trans-33b) and 
subjected to X-ray diffraction analysis. Their molecular structures are shown in Figure 
4.4. The Pd-Ccarbene [2.038(4) Å] and Pd-I [2.6539(4) Å] bond lengths in cis-33b are very 
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similar to the corresponding parameters [Pd-Ccarbene = 2.033(7) Å; Pd-I = 2.6501(8) Å] in 
trans-33b. However, a comparison of the Pd-Ccarbene bonds in trans-33b and trans-33a 
[2.006(8) Å] revealed an elongation in the former. This may be attributed to the greater 
steric congestion and weaker donating ability resulting from the bulkier but less 
electron-donating Ph substituents in trans-33b compared to the Me groups in trans-33a. 
Finally, comparison of the Pd-P bonds in complex cis-33b revealed that the one trans to 
the rNHC ligand is significantly longer than that trans to the iodo ligand, which is 
consistent with a stronger trans influence of the rNHC ligand. 
The oxidative addition of the bulkiest and electron-richest salt 32c proved to be very 
difficult and again dramatically different from 32a and 32b affording a dinuclear, 
dicationic complex 33c in a low yield of 8% (Scheme 4.6c). Attempts to improve the 
yield of 33c by varying stoichiometry and reaction conditions were met with limited 
success. In all cases, the majority of 32c remained unreacted. Despite sufficient amount 
of phosphine, no mononuclear Pd(II) complex of the type [PdI(rNHC)(PPh3)2]+BF4- was 
isolated from these attempts. A CH2Cl2 solution subjected to ESI mass spectrometry 
confirmed the identity of 33c by a base peak at m/z = 738 corresponding to the 
[M-2BF4]2+ fragment. However, the 1H, 13C and 31P NMR spectra of 33c in CD2Cl2 are 
unexpectedly complicated. In the 1H NMR spectrum, numerous doublets of different 
intensities arise in the range of 0.46~1.48 ppm, which are assignable to the isopropyl-Me 
groups of 3,5-substituents. In addition, a few sets of overlapping septets and singlets are 
observed in the range of 3.27~3.72 ppm arising from the isopropyl-CH protons and the 
N-Me groups, respectively. Correspondingly, the 13C and 31P NMR spectra are also rather 
complicated, indicating the presence of an isomeric mixture in solution. In principle, four 
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isomers of 33c, namely trans-anti, trans-syn, cis-anti and cis-syn (trans/cis refers to the 
arrangement of the PPh3 ligands; anti/syn refers to the orientation of the unsymmetrical 





































































R = iPr, P = PPh3
2 BF4 2 BF4
2 BF4 2 BF4
 
Figure 4.5. Possible isomers of complex 33c. 
 
On the other hand, the respective NMR spectra of 33c measured in CD3CN are much 
simpler. In the 1H NMR spectrum, four well-resolved doublets of equal intensity are 
observed at 1.39, 1.11, 0.88 and 0.35 ppm, each integrating to 3 protons and thus 
assigned to the isopropyl-Me groups of 3,5-substituents. The isopropyl-CH protons of the 
same substituents resonate at 3.54 and 3.22 ppm as two septets. Correspondingly, the 13C 
NMR spectra show 4 singlets in the range of 19.6~21.0 ppm and another 2 singlets at 
30.8 and 31.2 ppm for the isopropyl substituents. The carbene carbon resonates as a 
singlet at 106.3 ppm. Finally, the 31P NMR spectrum shows only one singlet at 19.8 ppm 
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for the phosphine ligand. The simple NMR spectra suggest the presence of only one 
complex in solution. It was anticipated that upon dissolution in coordinating CD3CN, 33c 
is cleaved to form the mononuclear complex [PdI(CH3CN)(iPr2-rNHC)(PPh3)]+BF4- 
(iPr2-rNHC = 3,5-diisopropyl-2-methyl-1-phenylpyrazolin-4-ylidene). At the moment, the 
exact configuration of the four different ligands in this complex is still uncertain. 
However, it is expected that the iPr2-rNHC and PPh3 ligands are cis to each other in line 
with the transphobia effect. The cleavage of 33c by the solvent is also supported by the 
positive ESI mass spectrum measured of a CH3CN solution, which shows a base peak at 
m/z = 778 corresponding to the [PdI(CH3CN)(iPr2-rNHC)(PPh3)]+ cation and a smaller 
peak at m/z = 737 corresponding to the [PdI(iPr2-rNHC)(PPh3)]+ fragment. 
X-ray diffraction analysis on single crystals of 33c obtained by diffusion of diethyl 
ether into a concentrated CH3CN solution of 33c revealed an iodo-bridged dinuclear 
structure (Figure 4.6). The reversible de-coordination of CH3CN and formation of 
dimeric species under influence of diethyl ether was also observed previously for 
complex [PdBr2(CH3CN)(Bh2-bimy)] (21) (see Section 3.1). The molecular structure 
shows two essentially square-planar Pd(II) centers each coordinated by one phosphine 
and one rNHC ligands and bridged by two iodo ligands. The two iPr2-rNHC ligands are 
oriented in a trans-syn fashion to each other. The [Pd2I2] rhombus in 33c is slightly bent 
with a hinge angle of ca.153°. Furthermore, the two Pd-I bonds trans to the rNHC ligand 
are notably longer than those trans to the PPh3 ligand, confirming a stronger trans 
influence of the former. Efforts to obtain single crystals of the mononuclear complex 





Figure 4.6. Molecular structure of complex 33c showing 50% probability ellipsoids 
(upper: top view; lower: side view); BF4- counterion, hydrogen atoms and all phenyl 
substituents are omitted for clarity. Selected bond lengths [Å] and angles [°]: Pd(1)-C(1) 
2.023(16), Pd(1)-P(1) 2.267(5), Pd(1)-I(1) 2.6534(17), Pd(1)-I(2) 2.6783(17), Pd(2)-C(17) 
1.998(17), Pd(2)-P(2) 2.283(5), Pd(2)-I(2) 2.6304(17), Pd(2)-I(1) 2.6825(17), C(1)-C(2) 
1.36(2), C(1)-C(3) 1.35(2), N(1)-C(2) 1.36(2), N(2)-C(3) 1.351(17), N(1)-N(2) 1.323(18), 
C(17)-C(18) 1.43(2), C(17)-C(19) 1.41(2), N(3)-C(18) 1.307(19), N(4)-C(19) 1.41(2), 
N(3)-N(4) 1.378(19); C(1)-Pd(1)-P(1) 93.7(5), C(1)-Pd(1)-I(1) 88.3(4), P(1)-Pd(1)-I(2) 
93.52(12), I(1)-Pd(1)-I(2) 84.56(5), C(17)-Pd(2)-P(2) 91.4(5), C(17)-Pd(2)-I(2) 88.6(5), 
P(2)-Pd(2)-I(1) 95.08(13), I(2)-Pd(2)-I(1) 84.92(5), C(3)-C(1)-C(2) 106.0(15), 
C(19)-C(17)-C(18) 104.5(15). 
 
The preferable formation of dinuclear 33c over the hypothetical mononuclear 
[PdI(iPr2-rNHC)(PPh3)2]+BF4- complex could be explained by the strong 





4.2.2 Synthesis of Pd(II) pyridine complexes with different pyrazolin-4-ylidenes 
 
To date, all known rNHC complexes contain PPh3 as a co-ligand due to the ready 
availability of low valent [M(PPh3)4] (M = Ni, Pd and Pt) as metal precursors. In an 
attempt to extend the scope of rNHC complexes, the feasibility of incorporating other 
donors such as pyridine was studied. Hence, two equiv of pyrazolium precursors 32a/b/c 
were reacted with [Pd2(dba)3] and four equiv of pyridine in order to obtain cationic mixed 
rNHC-pyridine complexes of the type [PdI(rNHC)(pyridine)2]+BF4-. Surprisingly, these 
reactions afforded neutral diiodo complexes of the type [PdI2(rNHC)(pyridine)] (34a-c) 
in low yields of 48%, 66% and 4%,‡‡ respectively, and no cationic complex could be 
detected (Scheme 4.7). In this series, the bulkiest and most electron-rich precursor 32c 
gave rise to a rather sluggish reaction again highlighting the influence of 3,5-substituents 































32a R = Me
32b R = Ph
32c R = iPr
34a R = Me
34b R = Ph







Scheme 4.7. Synthesis of pyrazolin-4-ylidene-pyridine complexes 34a-c. 
 
                                                        




Since no additional iodide source was added, the formation of the neutral diiodo 
complexes 34a-c required the sacrifice of 1 equiv of salt-precursor 32a-c, which explains 
their generally low yields. It was anticipated that the use of 4-iodopyrazolium iodides 
instead of the BF4- salts should lead to an improvement. Hence, 
4-iodo-2,3,5-trimethyl-1-phenylpyrazolium iodide (32a’) was prepared by refluxing 24a 
in iodomethane to test this possibility. Indeed, by oxidative addition of two equiv of 32a’ 
to [Pd2(dba)3] in the presence of pyridine the yield of complex 34a could be increased 
























24a 32a' 34a  
Scheme 4.8. Improved synthesis of complex 34a. 
 
 
Positive mode ESI MS spectra of complexes 34a-c revealed isotopic clusters centered 
at m/z = 498 (34a), 622 (34b), 553 (34c), respectively, corresponding to the [M-I]+ 
fragment. Their 1H NMR spectra corroborate the presence of the coordinated pyridine 
with the 2,6-py-H resonance shifted downfield by ~0.5 ppm compared to the analogous 
signal for free pyridine. More importantly, the 13C NMR signal of the carbenoid carbon is 
observed at 99.3 (34a), 104.5 (34b) and 95.0 (34c) ppm, respectively. These chemical 
shifts decrease in the order 34b > 34a > 34c, which correlates to the electron-donating 
ability of the R substituents Ph (34b) < Me (34a) < iPr (34c). The same trend was also 
observed when comparing the chemical shifts of the CI carbon atoms in their ligand 
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precursors 32a-c (vide supra).  
 
 
Figure 4.7. Molecular structure of complex 34c·0.5H2O showing 50% probability 
ellipsoids; the other molecule, hydrogen atoms and solvent molecules are omitted for 
clarity. Selected bond lengths [Å] and angles [°]: Pd(1)-C(1) 1.983(5), Pd(1)-N(3) 
2.116(4), Pd(1)-I(1) 2.6303(6), Pd(1)-I(2) 2.6268(6), C(1)-C(2) 1.405(7), C(1)-C(3) 
1.390(7), N(1)-C(2) 1.346(6), N(2)-C(3) 1.355(6), N(1)-N(2) 1.358(6); C(1)-Pd(1)-I(2) 
88.78(13), N(3)-Pd(1)-I(2) 89.10(12), C(1)-Pd(1)-I(1) 90.27(13), N(3)-Pd(1)-I(1) 
91.86(12), C(3)-C(1)-C(2) 104.5(4). 
 
Single-crystal X-ray diffraction analysis revealed that complexes 34a-c all adopt a 
trans arrangement around the palladium center. Two molecules were found in the unit 
cell of 34c and one of them is depicted in Figure 4.7 as a representative. The carbene ring 
planes of all complexes are oriented almost perpendicularly to the PdCNI2 coordination 
plane with dihedral angles ranging from 73.36 to 87.32. On the other hand, the pyridine 
ring planes in 34a and 34b deviate from the perpendicular orientation with respect to the 
PdCNI2 coordination plane with torsion angles of 66.75 for 34a and 64.34 for 34b. As 
an exception, that in 34c adopts a nearly right angle (88.92 and 89.22) to the 
coordination plane. The Pd-Ccarbene bonds of 34a-c fall in a narrow range of 
1.981(7)-1.987(4) Å, and the Pd-N bonds amounting to 2.121(6) (34a), 2.119(4) (34b), 
Chapter 4 
 111
2.116 (4) and 2.117(4) Å (34c), respectively, are comparable to those observed for 
analogues containing benzimidazolin-2-ylidene (5a) or imidazolin-2-ylidene ligands.85 
 
4.3 Synthesis of dinuclear or multinuclear Pd(II) complexes with 
pyrazolin-4-ylidenes 
 
4.3.1 Synthesis of iodo-bridged dinuclear Pd(II) complexes 
 
  It was anticipated that a mono(pyrazolin-4-ylidene) dinuclear complex analogous to 
[PdBr2(iPr2-bimy)]2 (1) should offer a convenient entry to a wide range of 
pyrazolin-4-ylidene complexes for different purposes by tuning the co-ligands. Therefore, 
the feasibility to synthesize a dinuclear complex of the type [PdI2(pyrazolin-4-ylidene)]2 
by oxidative addition of 4-iodopyrazolium iodides (25a/b) to [Pd2(dba)3] was tested, as 
shown in Scheme 4.9. These reactions proved to be very straightforward and yielded the 











25a R = Ph











35a R = Ph
35b R = Me  
Scheme 4.9. Synthesis of complexes 35a/b. 
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  Complexes 35a/b are stable to air and moisture. Their identities were supported by the 
positive ESI MS spectra which show isotopic envelopes centered at m/z = 995 (35a) and 
871 (35b), respectively, corresponding to the [M-I]+ fragment. Their 1H NMR spectra 
show little change as compared to that of the respective precursor salt (25a/b). In the 13C 
NMR of complex 35a, the carbenoid signal was found at 112.7 ppm, which is more 
upfield than those of complexes [Pd(O2CCF3)2(rNHC)(PPh3)] (27a) and 
[PdI(rNHC)(PPh3)2]+OTf- (29a) with the same pyrazolin-4-ylidene but still significantly 
more downfield by 40.1 ppm compared to the analogous resonance of the precursor-salt 
25a, suggesting the successful coordination of the pyrazolin-4-ylidene. On the other hand, 
the 13C carbene signal for complex 35b was not resolved due to its poor solubility.  
 
 
Figure 4.8. Molecular structure of complex 35b·4CH2Cl2 showing 50% probability 
ellipsoids; hydrogen atoms and solvent molecules are omitted for clarity. Selected bond 
lengths [Å] and angles [º]: Pd1-C1 1.980(6), Pd1-I1 2.5719(15), Pd1-I2 2.5572(15), 
Pd1-I1A 2.6774(17), C1-C2 1.354(9), C1-C3 1.374(9), C3-N2 1.334(8), C2-N1 1.321(8), 
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N1-N2 1.361(8); C1-Pd1-I1 89.25(19), C1-Pd1-I2 89.10(19), I1-Pd1-I1A 87.76(5), 
I2-Pd1-I1A 93.90(5), C2-C1-C3 106.0(6). 
 
  However, the identity of 35b could be further confirmed by X-ray diffraction analysis 
on single crystals obtained by slow evaporation of a CH2Cl2 solution. As depicted in 
Figure 4.8, each of the two Pd centers is coordinated by one rNHC ligand, one terminal 
iodo and two bridging iodo ligands in a square planar fashion. The rNHC ligands are 
oriented almost perpendicular to the coordination plane in a dihedral angle of 77.45°. The 
Pd-Ccarbene bond length amounting to 1.980(6) Å is shorter than those found in the 
mononuclear phosphine complexes [PdI2(rNHC)(PPh3)] (26b) [1.996(7) Å] and 
[PdI(rNHC)(PPh3)2]+OTf- (29b) [2.004 (9) Å] with the same rNHC ligand, in line with a 
more Lewis acidic metal center in complex 35b. Furthermore, among the three different 
types of Pd-I bonds, the one trans to the rNHC ligand is significantly longer than the 
other two due to the strong trans influence of the rNHC ligand. 
 
4.3.2 Synthesis of di(pyrazolin-4-ylidene)-bridged dinuclear or multinuclear Pd(II) 
complexes 
 
  All rNHC complexes reported thus far contain monodentate rNHC ligands. To date, 
there are no bidentate or multidentate rNHC ligands known. The rather limited structural 
scope of rNHC complexes is in big contrast to the versatility of normal NHC complexes, 
but on the other hand, leaves room for further development in the area of rNHC 
chemistry. In an attempt to broaden the structural scope of rNHC complexes efforts were 
made to synthesize di(pyrazolin-4-ylidene)-bridged Pd(II) complexes. 
Synthesis and characterization of di(pyrazolium) salts. As shown in Scheme 4.10, 
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the alkyl-bridged 4,4’-diiododipyrazole (36a-c) were synthesized in a short reaction 
sequence according to a literature procedure.86 Upon alkylation of 36a-c with Me3OBF4, 
the suitable ligand precursors with the alkyl bridge of different lengths (37a-c) were 
obtained as white solids in moderate to high yields of 86%, 93% and 62%, respectively.§§ 
37a-c show poorer solubility compared to mono(pyrazolium) salts with the former being 
only soluble in polar solvents such as CH3CN, DMSO, MeOH and H2O but insoluble in 



























reflux, 1d 2 BF4
36a: n = 1
36b: n = 2
36c: n = 3
37a: n = 1
37b: n = 2
37c: n = 3   
Scheme 4.10. Synthesis of di(pyrazolium) salts 37a-c. 
 
The formation of 37a-c was confirmed by ESI MS spectrometry with the positive 
mode spectra showing isotopic patterns centered at m/z = 243, 250 and 257, respectively, 
corresponding to the dicationic [M-2BF4]2+ fragments. In addition, the spectra of 37a/c 
also show another peak at m/z = 573 and 601, respectively, due to the monocationic 
[M-BF4]+ fragment. The 1H NMR spectra of 37a-c display downfield shift of all protons 
except the middle CH2 protons of the propylene bridge, compared to the corresponding 
resonances in their precursors (36a-c). This general downfield shift is in line with the 
                                                        
§§ The dipyrazolium salts 37a/c and their corresponding complexes 38/39 were prepared by an Honors student, Lee Li 
Juan, under my guidance. 
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formation of aromatic cations upon N-alkylation. In the 13C NMR spectra of 37a-c, it was 
found that the C-I resonances decrease in the order 37a (71.2 ppm) > 37b (68.8 ppm) > 
37c (67.7 ppm) as the alkyl chain length increases. 
Synthesis and characterization of di(pyrazolin-4-ylidene)-bridged Pd(II) 
complexes. In an attempt to prepare a dinuclear Pd(II) complex with a bidentate 
pyrazoline-4-ylidene ligand, the methylene-bridged dipyrazolium salt 37a was reacted 
with a pre-mixed [Pd2(dba)3]/PPh3 (in a 1:4 ratio) solution in CH2Cl2 (Scheme 4.11). 
Given the insolubility of 37a in CH2Cl2 and the difficulty of two oxidative additions in 
one molecule, the reaction time was prolonged from 4-6 h which is the common reaction 
time for the formation of Pd(II) complexes with monodentate pyrazolin-4-ylidene ligands, 














































Scheme 4.11. Synthesis of di(pyrazolin-4-ylidene)-bridged tetranuclear Pd(II) complex 
38. 
 
However, this reaction did not proceed smoothly and significant amount of palladium 
black was observed during the course of the reaction and upon work-up. ~70% of 
precursor salt 37a was recovered and no expected dicationic 1,1’-methylene-dipyrazolin- 
4,4’-diylidene complex (“Y”) was detected from this reaction. On the other hand, a small 
Chapter 4 
 116
amount of a yellowish compound was crystallized from the crude product by slow 
evaporation of a CH2Cl2/hexane solution. It was found that once formed, these crystals 
are not very soluble in CH2Cl2 anymore. 
 
Figure 4.9. Molecular structure of the complex-cation of 38·2C6H5CH3 showing 50% 
probability ellipsoids; the BF4- counterions, partial chloro atoms at I2/I2A, hydrogen 
atoms and solvent molecules are omitted for clarity. Selected bond lengths [Å] and angles 
[º]: Pd1-C1 1.976(7), Pd1-I1 2.6504(8), Pd1-I2 2.617(6), Pd1-P2 2.273(2), Pd2-C8 
1.970(7), Pd2-I1 2.6520(8), Pd2-I2 2.687(6), Pd2-P1 2.244(2), C1-C2 1.379(11), C1-C3 
1.383(10), C3-N2 1.362(10), C2-N1 1.348(10), N1-N2 1.362(9), C8-C9 1.365(11), 
C8-C10 1.385(10), C9-N3 1.374(10), C10-N4 1.332(10), N3-N4 1.367(9); C1-Pd1-I1 
86.8(2), C1-Pd1-P2 88.2(2), I1-Pd1-I2 93.36(14), I2-Pd1-P2 92.60(16), C8-Pd2-I1 
87.9(2), C8-Pd2-P1 89.8(2), I2-Pd2-P1 90.64(14), I2-Pd2-I1 91.73(14), C2-C1-C3 
105.5(7), C9-C8-C10 105.2(6). 
  
X-ray diffraction analysis on single crystals of the yellowish compound, obtained by 
layering a concentrated CH3CN solution with toluene at ca. 8°C, revealed an interesting 
tetranuclear Pd(II) complex 38 (Figure 4.9). This complex crystallized as toluene solvate 
382C6H5CH3 in the space group of P-1. Two of the bridging anions (I2 and I2A) are 
found to be partially replaced by Cl from the solvent with refined occupancy ratio of 
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30:70 (I:Cl), but only I atoms are shown in Figure 4.8 for clarity. Complex 38 consists of 
a tetranuclear cation and four BF4- counteranions. The four Pd centers and the bridging 
iodo ligands form two rhombuses which are linked by two bidentate rNHC ligands to 
form a rectangular macrocyclic structure with dimensions of 7.051  8.338 Å. The two 
carbene ring planes in one rNHC ligand are almost perpendicular to each other with a 
hinge angle of 88.37°. They are also almost perpendicular to their respective coordination 
planes with dihedral angles of 87.74 and 81.74°, respectively. In addition, the Pd-Ccarbene 
bonds of 1.976(7) and 1.970(7) Å in complex 38 are slightly shorter than that in the 
mononuclear complex 33a [2.006(8) Å] with a monodentate pyrazolin-4-ylidene ligand, 
in line with a more Lewis acidic metal center in the former. 
  This tetranuclear rectangular structure of complex 38 is retained in CH2Cl2 solution as 
evidenced by its positive mode ESI MS spectra which shows the isotopic patterns 
corresponding to the tetranuclear cations with different bridging anions plus one or two 
BF4- counteranions (Figure 4.10). However, the solubility of 38 in CD2Cl2 is insufficient 
for NMR measurement. Therefore, its NMR analysis was recorded in CD3CN. It should 
be noted that upon dissolution in CD3CN, complex 38 may be cleaved by the solvent to 
form the CD3CN-coordinated dinuclear complex, similar to that observed for complex 
33c (see Section 4.2.1). The 1H NMR of 38 in CD3CN shows two singlets at 3.33 and 
3.24 ppm, indicating two inequivalent N-Me groups. The methylene protons resonate at 
6.12 ppm as a broad doublet with geminal coupling constant of 2J(H,H) = 24 Hz, 
suggesting restricted rotation about the N-CH2 bond. Three singlets at 21.7, 25.5 and 
27.4 ppm with the first one being the major signal are observed in the 31P NMR spectrum, 
probably due to the iodo-chloro scrambling. Furthermore, the 13C NMR spectrum 
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displays three singlets at 152.5, 148.7 and 148.3 ppm, tentatively assigned to the carbon 
atoms adjacent to the carbene center. The observation of more than expected signals for 
these carbons is again, plausibly attributed to the iodo-chloro scrambling. However, the 




































F1 F2  
  m/z = 1264.4 [F1+2BF4]2+ 
 
    m/z = 814.2 [F1+BF4]3+ 
 
  m/z = 1218.4 [F2+2BF4]2+ 
 
     m/z = 783.6 [F2+BF4]3+ 
 
Figure 4.10. Tetranuclear species observed in the positive ESI MS spectrum mearsured 
of a CH2Cl2 solution of complex 38.  
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  Efforts to avoid the iodo-chloro scrambling were made by carrying out the reaction in 
non-chlorinated solvents such as CH3CN, THF and toluene. However, these attempts led 
to either almost full decomposition to Pd black (in CH3CN) or an intractable product 
mixture from which the isolation of complex 38 was not achieved (in THF and toluene).   
It was proposed that the steric congestion between the bulky PPh3 ligands on the two 
Pd centers may have disfavored the formation of the hypothetical dinuclear Pd(II) 
complex “Y”. The methylene bridge between the two five-membered rings of the rNHC 
ligand is too short and hence the bulky PPh3 ligands on one Pd center is too close to the 
nearby PPh3 ligands on the other Pd center, which results in significant steric repulsion 



































Scheme 4.12. Synthesis of di(pyrazolin-4-ylidene)-bridged dinuclear Pd(II) complex 39. 
 
This rationale was supported by the ready formation of the dinuclear Pd(II) complex 
with a longer propylene bridge (39), which was prepared via oxidative addition of 
propylene-bridged dipyrazolium salt 37c to [Pd2(dba)3]/PPh3 as shown in Scheme 4.12. 
Complex 39 was obtained as yellow crystals in a yield of 36%. Its relatively low yield 
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may be attributed to the formation of the mononuclear species (Z) with only one C-I 
bond of the propylene-bridged dipyrazolium salt oxidatively added to Pd(0) as the 
byproduct. The isolation of complex Z was not successful, but its formation is evident by 
the ESI MS spectrum of the crude product, which shows a peak at m/z = 572, 
corresponding to the mononuclear species, [Z-2BF4-]2+.  
The formation of the dinuclear Pd(II) complex 39 was corroborated by its positive ESI 
MS spectrum, which is dominated by an isotopic envelope centered at m/z = 888, due to 
the dicationic [M-2BF4]2+ fragment. All the signals in the 1H NMR spectrum of 
complexes 39 show upfield shift with respect to the corresponding signals of its ligand 
precursor (37c). The NCH2 and CH2 protons of the propylene bridge resonate at 3.76 and 
1.53 ppm as a triplet and a quintet, respectively, which implies that the propylene bridge 
can rotate freely even in the close proximity of the sterically bulky PPh3 ligands on Pd 
centers. In the 13C NMR spectrum, the carbenoid signal appears at 128.7 ppm as a triplet 
with the coupling constant of 2J(C,P) = 7.3 Hz, suggesting a trans arrangement of the two 
PPh3 ligands on each Pd center. Correspondingly, only one singlet was observed at 
22.7 ppm in the 31P NMR spectrum. These carbenoid and phosphine chemical shifts are 
very similar to the corresponding value observed for the mononuclear complex 33a (see 
Section 4.2.1). 
The structural identity of complex 39 was unambiguously confirmed by X-ray 
diffraction analysis on single crystals obtained by slow evaporation of a CH2Cl2/hexane 
solution. The molecular structure depicted in Figure 4.11 shows the expected trans 
configuration as found in solution by NMR spectroscopy. The two Pd(II) centers are 
linked by the propylene-bridged bidentate rNHC ligand with each adopting a nearly 
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perfect square planar geometry. The two carbene ring planes are oriented almost 
perpendicular to the respective PdICP2 coordination plane with dihedral angles of 85.02 
and 81.85º to relieve steric congestion. The Pd-Ccarbene bond lengths of 2.011(9) and 
2.013(8) Å are comparable to that in the mononuclear complex 33a [2.006(8) Å]. Other 
bond lengths around the Pd centers fall within the normal ranges observed for 
pyrazolin-4-ylidene complexes and therefore no further comments are necessary. 
 
 
Figure 4.11. Molecular structure of the complex-cation of 39·2CH2Cl2 showing 50% 
probability ellipsoids; the BF4- counterions, hydrogen atoms and solvent molecules are 
omitted for clarity. Selected bond lengths [Å] and angles [º]: Pd1-C1 2.011(9), Pd1-I1 
2.6524(10), Pd1-P1 2.310(2), Pd1-P2 2.335(2), Pd2-C7 2.013(8), Pd2-I2 2.6734(10), 
Pd2-P3 2.326(2), Pd2-P4 2.331(2), C1-C2 1.378(12), C1-C3 1.387(13), N1-C2 1.318(12), 
N2-C3 1.355(12), N1-N2 1.370(10), C7-C8 1.389(12), C7-C9 1.414(13), N3-C8 
1.352(12), N4-C9 1.355(12), N3-N4 1.346(11); C1-Pd1-P1 89.0(2), C1-Pd1-P2 90.3(2),  
P1-Pd1-I1 90.35(7), P2-Pd1-I1 90.38(7), C7-Pd2-P3 89.7(2), C7-Pd2-P4 90.12, 
P3-Pd2-I2 90.06(7), P4-Pd2-I2 90.97, C2-C1-C3 104.5(9), C8-C7-C9 105.5(8).  
 
It was also attempted to synthesize tetranuclear (in analogy to 38) or dinuclear (in 
analogy to 39) Pd(II) complexes containing the ethylene-bridged rNHC ligand by 
reacting salt 37b with equimolar [Pd2(dba)3] in the presence of two or four equivalents of 
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PPh3 under the same reaction conditions employed in the synthesis of 38/39. However, 
both these trials led to a rather complex product mixture, from which no Pd rNHC 
complexes could be isolated. 
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Chapter 5. Conclusions 
 
  The synthesis, reactivity and catalytic activity of group 10 transition metal complexes 
with 1,3-diisopropylbenzimidazolin-2-ylidene (iPr2-bimy), 1,3-dibenzhydrylbenzimidazo-
lin-2-ylidene (Bh2-bimy) or pyrazolin-4-ylidene ligands were investigated in this work. 
 The reaction of Pd(OAc)2 with the sterically bulky 1,3-diisopropylbenzimidazolium 
bromide A in DMSO at 90°C yielded the monocarbene dimeric complex 
[PdBr2(iPr2-bimy)]2 (1). It was found that complex 1 can be readily cleaved by a wide 
range of donors to form monocarbene Pd(II) complexes with different co-ligands. For 
instance, cleavage of complex 1 with CH3CN, salt A and triphenylphosphine afforded 
complexes [PdBr2(CH3CN)(iPr2-bimy)] (2), (iPr2-bimyH)[PdBr3(iPr2-bimy)] (3), 
trans-/cis-[PdBr2(iPr2-bimy)(Ph3P)] (trans-/cis-4), respectively. The trans-cis 
isomerization of the mixed NHC-phosphine complexes 4 monitored by 1H NMR 
spectroscopy, demonstrates that this isomerization process is solvent-dependent and a cis 
arrangement in such complexes is thermodynamically favored in line with the 
transphobia effect. A series of linear dinuclear Pd(II) complexes 5b-d containing 
bis(4-pyridyl) linkers and the bulky iPr2-bimy as the supporting ligand were prepared by 
reacting complex 1 with the respective bridging ligand. Their mononuclear counterpart 
[PdBr2(iPr2-bimy)(pyridine)] (5a) was also synthesized. UV-vis and CV analyses revealed 
that the electrochemical behavior of the dinuclear complexes 5b-d is similar to that of the 
mononuclear species 5a. Furthermore, cleavage of 1 with various isocyanides afforded a 
series of mixed NHC-isocyanide complexes [PdBr2(iPr2-bimy)(CN-R)] (R = Cy, 6a; R = 
nBu, 6b; R = Xyl, 6c) as a mixture of trans- and cis- isomers. Complex 6c was used as a 
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metal template to prepare a mixed NHC-ADC complex 7. In addition, the reaction of 
trans-/cis-6c with AgO2CCF3 yielded a mixed NHC-isocyanide-carboxylato complex 
[Pd(O2CCF3)2(iPr2-bimy)(CN-Xyl)] (cis-10) in quantitative yield. Interestingly, a close 
investigation on the 13C NMR spectra of complexes of the type 
trans-[PdBr2(iPr2-bimy)L]n- {L = CH3CN, n = 0 (2); L = Br-, n = 1 (3); L = “Py”, n = 0 
(5a-d); L = isocyanide, n = 0 (6a-c)} revealed that the carbenoid resonance decreases as 
the donor ability of the transoid ligand L decreases. Based on this correlation, a new 
method was developed to evaluate the donor ability of different NHC ligands by 
comparing the carbene carbon resonances of the constant iPr2-bimy ligand in complexes 
of the type trans-[PdBr2(iPr2-bimy)(NHC)] (11a-i). This new method has advantages 
over the conventional carbonyl method in that the former doesn’t require the use of 
air-sensitive starting materials and highly toxic CO gas.  
  The bis(carbene) complexes trans-[PdX2(iPr2-bimy)2] (X = Br, trans-12; X = I, 
trans-13) were obtained through the reaction of Pd(OAc)2 and the corresponding 
1,3-diisopropylbenzimidazolium salts A or B in DMSO at 120°C. Salt metathesis of 
trans-12 or trans-13 with AgO2CCF3 afforded the mixed NHC-carboxylato complex 
cis-[Pd(O2CCF3)2(iPr2-bimy)2] (cis-14). The formation of cis-14 from trans-12 or 
trans-13, together with the above-mentioned transformation of trans-/cis-6c to cis-10, 
suggests that the halo/trifluoroacetato exchange may be regarded as a selective method 
towards cis arranged NHC complexes. The catalytic activities of complexes cis-4 and 
12-14 are tested in the Mizoroki-Heck coupling of aryl bromides and chlorides and the 
results revealed that the steric bulk of the iPr2-bimy ligand results in a slower conversion 
in comparison with the reactions catalyzed by the analogous complex with less bulky 
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Me2-bimy ligand.  
  The platinum chemistry of the iPr2-bimy ligand was also studied. The reaction of PtBr2 
with NaOAc and salt A in DMSO afforded the monocarbene complex 
cis-[PtBr2(iPr2-bimy)(DMSO)] (cis-15) and the bis(carbene) complex 
trans-[PtBr2(iPr2-bimy)2] (trans-16). Substitution of DMSO in cis-15 with 
triphenylphosphine and pyridine afforded complexes trans-/cis-[PtBr2(iPr2-bimy)(PPh3)] 
(trans-/cis-17) and trans-[PtBr2(iPr2-bimy)(pyridine)] (trans-18), respectively. The 
trans/cis isomerization in the former reaction was found to be much slower than that 
observed for the Pd(II) analogues trans-/cis-4.  
  X-ray diffraction analysis revealed that all complexes with the iPr2-bimy ligand 
synthesized in this work show a fixed orientation of the N-isopropyl substituents with the 
C-H protons pointing to the metal center, suggesting intramolecular C-HM anagostic 
interactions. These interactions are also retained in solution as indicated by the downfield 
shift of the isopropyl C-H protons of the complexes in their 1H NMR spectra compared to 
that in the precursor-salt A.  
  A series of the Pd(II) complexes with the even bulkier Bh2-bimy ligand were also 
synthesized and studied. An unexpected monocarbene Pd(II) complex (19) with a 
N-bound 1,2-disubstituted benzimidazole derivative was obtained when 
1,3-dibenzhydrylbenzimidazolium bromide (C) was reacted with Pd(OAc)2 in DMSO at 
75 °C, involving an unique NHC rearrangement reaction. On the other hand, this 
rearrangement reaction was not observed in the preparation of the Ag(I) carbene complex 
[AgBr(Bh2-bimy)] (20) under milder reaction conditions. A transmetallation protocol 
using complex 20 successfully afforded the acetonitrile complex 
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trans-[PdBr2(CH3CN)(Bh2-bimy)] (21), which was found to undergo two dynamic 
processes in deutero-chloroform solution. Dissociation of acetonitrile in complex 21 
allowed for an easy synthesis of the dimeric complex [PdBr2(Bh2-bimy)]2 (22) in a 
quantitative yield. The catalytic activity of complex 22 was tested in Suzuki-Miyaura 
coupling reactions and compared with that of the analogue 1. The results show that water 
is a good solvent for the activated aryl bromides, whereas a H2O/CH3CN (1:1 in volume) 
mixture is a better choice for deactivated substrates. Furthermore, it was found that 
complex 22 exhibits superior activity for deactivated aryl bromides over complex 1. 
  A preparative protocol towards Pd(II) complexes with unprecedented pyrazole-based 
rNHC ligands was established in Chapter 4. The suitable ligand precursors 
4-iodopyrazolium salts (25a/b and 28a/b) were synthesized through a modular approach, 
which allows for facile tuning of steric and electronic properties of the resulting rNHC 
ligands. Oxidative addition of 25a/b to [Pd2(dba)3]/PPh3 gave rise to neutral 
pyrazolin-4-ylidene complexes cis-[PdI2(rNHC)(PPh3)] (26a/b) while the similar 
reactions with 28a/b afforded the ionic complexes trans-[PdI(rNHC)(PPh3)2]+OTf- 
(29a/b). The catalytic activity of complexes 26a/b and 29a/b are compared in aqueous 
Suzuki-Miyaura coupling reactions and the results show that the cationic complexes 
29a/b are generally more active than their neutral counterparts 26a/b. In order to study 
the substituent-effects on the formation of pyrazolin-4-ylidene complexes, three 
4-iodopyrazolium salts (32a-c) with different 3.5-substituents and their corresponding 
complexes supported by phosphine (33a-c) or pyridine (34a-c) were synthesized. It was 
found that these 3,5-substituents have dramatic influence on the geometry and 
connectivity of the resulting complexes as well as on product yields. The iodo-bridged 
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dinuclear Pd(II) complexes [PdI2(rNHC)]2 (35a/b) with pyrazolin-4-ylidene ligands were 
also synthesized. In addition, the structural scope of pyrazolin-4-ylidene complexes could 
be successfully extended to dinuclear or tetranuclear complexes (38 and 39) containing 
bidentate rNHC ligands. 
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Chapter 6. Experimental Section 
 
General Considerations  
Unless otherwise noted all operations were performed without taking precautions to 
exclude air and moisture. All solvents and chemicals were used as received without any 
further treatment if not noted otherwise. THF and CH2Cl2 were dried over 
sodium/benzophenone or calcium hydride, respectively, and distilled under nitrogen prior 
to use. 1H, 13C, 31P NMR and 19F spectra were recorded on a Bruker ACF 300 or AMX 
500 spectrometer and the chemical shifts () were internally referenced by the residual 
solvent signals relative to tetramethylsilane (1H, 13C) or externally to 85% H3PO4 (31P) 
and CF3CO2H (19F). Mass spectra were measured using a Finnigan MAT LCQ (ESI) or 
Finnigan MAT 95XL-T (FAB) spectrometer. Cyclic voltammograms were measured on 
an ECO/Metrohm, PGSTAT 30 potentiostat/galvanostat. UV/Vis spectra were obtained 
using a Hewlett-Packard HP8452A diode array spectrophotometer. Infrared spectra were 
recorded with a Varian 3100 FT-IR spectrometer. Elemental analyses were performed on 
a Perkin-Elmer PE 2400 elemental analyzer at the Department of Chemistry, National 
University of Singapore. 1,3-dibenzhydrylbenzimidazolium bromide (C),66 
3-benzyl-1-mesitylimidazolium bromide (VH+Br-),87 1,3-dimesitylimidazolium bromide 
(IMesH+Br-),53b 1,3-dimesitylimidazolinium bromide (SIMesH+Br-),53b 1,3-bis(2,6- 
diisopropylphenyl)imidazolium bromide (IPrH+Br-),53b 1,3-bis(2,6-diisopropylphenyl)- 
imidazolinium bomide (SIPrH+Br-),53b 3,5-dimethyl-1-phenylpyrazole (23a)82 and the 
alkyl-bridged 4,4’-dipyrazole (36a-c)86 were synthesized according to existing or 
slightly-modified literature procedures. 
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1,3-diisopropylbenzimidazolium bromide (A) 
A mixture of benzimidazole (591 mg, 5 mmol) and K2CO3 (760 mg, 
5.5 mmol) was suspended in CH3CN (3 mL) and stirred at ambient 
temperature for 1 h. To the suspension was added isopropyl bromide 
(1.40 mL, 15 mmol). The reaction mixture was stirred under reflux conditions for 24 h 
followed by a second addition of isopropyl bromide (1.40 mL, 15 mmol). Stirring under 
reflux continued for additional 72 h. After removing the volatiles in vacuo, CH2Cl2 
(50 mL) was added to the residue and the resulting suspension was filtered over celite. 
The remaining solid was washed with CH2Cl2 (520 mL) and the solvent of the filtrate 
was removed in vacuo to give a spongy solid, which upon washing with ethyl acetate 
afforded the product as a white powder. Yield: 1.190 g, 4.2 mmol, 84%. 1H NMR 
(300 MHz, CDCl3): δ 11.45 (s, 1 H, NCHN), 7.80 (dd, 2 H, Ar-H), 7.65 (dd, 2 H, Ar-H), 
5.21 (m, 3J(H,H) = 6.7 Hz, 2 H, NCH(CH3)2), 1.88 (d, 3J(H,H) = 6.7 Hz, 12 H, CH3). 
13C{1H} NMR (75.47 MHz, CDCl3): 140.7 (s, NCHN), 131.0, 127.0, 114.0 (s, Ar-C), 
52.5 (s, NCH(CH3)2), 22.3 (s, CH3). Anal. Calc. for C13H19BrN2H2O: C, 51.84; H, 7.03; 
N, 9.30. Found: C, 51.98; H, 7.00; N, 9.38%. MS (ESI): m/z = 203 [M-Br]+. 
 
1,3-diisopropylbenzimidazolium iodide (B) 
B was prepared in analogy to A from benzimidazole (354 mg, 3 mmol), 
K2CO3 (456 mg, 3.3 mmol) and isopropyl iodide (1.8 ml, 18 mmol). Yield: 
894 mg, 2.7 mmol, 90%. 1H NMR (300 MHz, CDCl3): δ 10.79 (s, 1 H, 
NCHN), 7.83 (dd, 2 H, Ar-H), 7.64 (dd, 2 H, Ar-H), 5.21 (m, 3J(H,H) = 6.7 Hz, 2 H, 









139.5 (s, NCHN), 130.9, 127.2, 114.1 (s, Ar-C), 52.5 (s, NCH(CH3)2), 22.3 (s, CH3). Anal. 
Calc. for C13H19IN2: C, 47.29; H, 5.80; N, 8.48. Found: C, 47.46; H, 6.02; N, 8.49%. MS 




A mixture of salt A (85 mg, 0.3 mmol), Pd(OAc)2 (67 mg, 
0.3 mmol) and NaBr (124 mg, 1.2 mmol) in DMSO (7 mL) 
was stirred at 90 °C for 24 h. The reaction mixture was 
filtered over celite and the solvent of the filtrate was 
removed by vacuum distillation. The resulting residue was suspended in CH2Cl2 (30 mL) 
and then extracted with H2O (4×20 mL). Drying of the organic phase over MgSO4 
followed by removal of the solvent in vacuo afforded the product as an orange solid. 
Yield: 131 mg, 0.14 mmol, 93%. 1H NMR (300 MHz, CDCl3):  7.61 (dd, 4 H, Ar-H), 
7.26 (dd, 4 H, Ar-H), 6.54 (m, 3J(H,H) = 7.1 Hz, 4 H, NCH(CH3)2), 1.82 (d, 3J(H,H) = 
7.1 Hz, 24 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 133.5, 123.0, 113.0 (s, Ar-C), 
55.0 (s, NCH(CH3)2), 21.0 (s, CH3), carbene signal not detected. However, by labeling 
the carbene carbon with 13C, the carbenoid signal for complex 1 was easily resolved and 
found to be at 157.1 ppm. Anal. Calc. for C26H36Br4N4Pd2: C, 33.33; H, 3.87; N, 5.98. 

















A suspension of complex 1 (47 mg, 0.05 mmol) in CH3CN (5 mL) 
was stirred at ambient temperature for 6 h and then refluxed for 
2 h. The reaction mixture was filtered over celite. Removal of the 
solvent in vacuo afforded the product as yellow powder. Yield: 44 mg, 0.09 mmol, 90%. 
1H NMR (300 MHz, CD3CN):  7.73 (dd, 2 H, Ar-H), 7.29 (dd, 2 H, Ar-H), 6.14 (m, 
3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 1.96 (s, CH3CN, correct integration is not possible 
due to ligand exchange with the solvent), 1.70 (d, 3J(H,H) = 7.1 Hz, 12 H, CH3). 13C{1H} 
NMR (75.47 MHz, CD3CN): 158.4 (s, NCN), 133.8, 123.9 (s, Ar-C), 118.3 (s, CN), 113.9 
(s, Ar-C), 55.8 (s, NCH(CH3)2), 20.5 (s, CH3), 1.32 (m, CH3CN, assignment is tentative 
due to overlap with solvent signals). Anal. Calc. for C15H21Br2N3Pd: C, 35.36; H, 4.15; N, 




A mixture of complex 1 (94 mg, 0.1 mmol) and salt 
A (57 mg, 0.2 mmol) was stirred in refluxing CHCl3 
(6 mL) for 2 h. The reaction mixture was filtered 
over celite. Slow evaporation of CHCl3 afforded the 
product as orange crystalline plates. Yield: 143 mg, 0.19 mmol, 95%. 1H NMR (300 MHz, 
CDCl3, signals arising from the counter-cation are indicated with an asterisk*):  11.04 (s, 

















(dd, 2 H, Ar-H), 6.60 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 5.28 (m, 3J(H,H) = 6.9 Hz, 
2 H, NCH*(CH3)2), 1.90 (d, 3J(H,H) = 6.9 Hz, 12 H, CH*3), 1.75 (d, 3J(H,H) = 7.1 Hz, 
12 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 165.6 (s, NCN), 141.9 (s, NC*HN), 
134.3, 122.4, 113.1 (s, Ar-C), 131.5, 127.2, 114.7 (s, Ar-C*), 54.7 (s, NCH(CH3)2), 53.2 
(s, NC*H(CH3)2), 22.8 (s, C*H3), 21.2 (s, CH3).  Anal. Calc. for C26H37Br3N4Pd: C, 
41.54; H, 4.96; N, 7.45. Found: C, 41.42; H, 4.98; N, 7.38%. MS (ESI): 498 




A mixture of complex 1 (140 mg, 0.15 mmol) and 
triphenylphosphine (81 mg, 0.31 mmol) in CH2Cl2 (8 mL) was 
stirred at ambient temperature for 10 min. Removal of the solvent 
in vacuo afforded the product as spectroscopically pure orange powder in quantitative 
yield. Further purification proves difficult due to trans-cis isomerization. 1H NMR 
(300 MHz, CDCl3):  7.73 (m, 6 H, Ar-H), 7.56 (dd, 2 H, Ar-H), 7.43 (br, 9 H, Ar-H), 
7.20 (dd, 2 H, Ar-H), 6.03 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH(CH3)2), 1.76 (d, 3J(H,H) = 
7.0 Hz, 12 H, CH3). 31P{1H} NMR (121.49 MHz, CDCl3): 18.0 (s, 1 P, PPh3). No 13C 














A mixture of complex 1 (234 mg, 0.25 mmol) and triphenylphosphine 
(144 mg, 0.55 mmol) in CH2Cl2 (5 mL) was stirred under reflux 
conditions overnight. Slow evaporation of a dichloromethane/toluene 
mixture afforded the product as yellow crystals. Yield: 333 mg, 0.46 mmol, 92%. 1H 
NMR (300 MHz, CDCl3):  7.47 (dd, 2 H, Ar-H), 7.40 (br, 15 H, Ar-H), 7.22 (dd, 2 H, 
Ar-H), 5.84 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 1.66 (d, 3J(H,H) = 6.9 Hz, 6 H, 
CH3), 0.87 (d, 3J(H,H) = 7.1 Hz, 6 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 134.5 
(br, Ar-C), 133.8 (s, Ar-C), 131.3 (br, Ar-C), 128.8, 128.6, 122.9, 113.0 (s, Ar-C), 54.9 (s, 
NCH(CH3)2), 21.1, 19.4 (s, CH3), the carbene signal could not be detected. 31P{1H} NMR 
(121.49 MHz, CDCl3): 26.6 (s, 1 P, PPh3). Anal. Calc. for C31H33Br2N2PPd: C, 50.95; H, 




Complex 1 (47 mg, 0.05 mmol) was dissolved in pyridine (3 mL) 
and stirred at ambient temperature overnight. The reaction 
mixture was filtered over celite. The celite was repeatedly 
washed with CH2Cl2 until it is white. All volatiles of the filtrate were removed in vacuo 
to give the product as yellow powder. Yield: 45 mg, 0.082 mmol, 82%. 1H NMR 
(300 MHz, CDCl3):  9.13 (m, 2 H, 2,6-py-H), 7.78 (m, 1 H, 4-py-H), 7.59 (dd, 2 H, 















NCH(CH3)2), 1.79 (d, 3J(H,H) = 7.1 Hz, 12 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 
160.0 (s, NCN), 153.4, 138.6, 134.2, 125.2, 122.9, 113.3 (s, Ar-C), 55.2 (s, NCH(CH3)2), 
21.3 (s, CH3). Anal. Calc. for C18H23N3Br2Pd: C, 39.48; H, 4.23; N, 7.67. Found: C, 




A mixture of complex 1 (94 mg, 0.10 
mmol) and 4,4’-bipyridine (16 mg, 0.10 
mmol) was dissolved in CH2Cl2 (5 mL) 
and stirred at ambient temperature overnight. The reaction mixture was filtered over 
celite. Slow evaporation at ambient temperature of a CH2Cl2 solution afforded the 
product as yellow crystals. Yield: 93 mg, 0.085 mmol, 85%. 1H NMR (300 MHz, CDCl3): 
 9.32 (d, 3J(H,H) = 6.7 Hz, 4 H, 2,6-bpy-H), 7.61-7.58 (m, 8 H, 3,5-bpy-H and Ar-H), 
7.24 (dd, 4 H, Ar-H), 6.33 (m, 3J(H,H) = 7.1 Hz, 4 H, NCH(CH3)2), 1.81 (d, 3J(H,H) = 
7.1 Hz, 24 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 159.4 (s, NCN), 154.4, 147.1, 
134.2, 123.0, 122.9, 113.4 (s, bpy-C and Ar-C), 55.3 (s, NCH(CH3)2), 21.3 (s, CH3). Anal. 
Calc. for C36H44N6Br4Pd2: C, 39.55; H, 4.06; N, 7.69. Found: C, 39.94; H, 4.56; N, 7.36. 




















Complex 5c was prepared in 
analogy to 5b from complex 1 
(94 mg, 0.10 mmol) and 
4,4’-bipyridylethane (18 mg, 0.10 mmol). Crystallization from a CH2Cl2/Et2O mixture 
afforded the product as yellow crystals. Yield: 99 mg, 0.088 mmol, 88%. 1H NMR 
(300 MHz, CDCl3):  9.04 (d, 3J(H,H) = 6.6 Hz, 4 H, 2,6-py-H), 7.59 (dd, 4 H, Ar-H), 
7.22 (dd, 4 H, Ar-H), 7.18 (d, 3J(H,H) = 6.6 Hz, 4 H, 3,5-py-H), 6.33 (m, 3J(H,H) = 
7.1 Hz, 4 H, NCH(CH3)2), 2.95 (s, 4 H, CH2), 1.79 (d, 3J(H,H) = 7.1 Hz, 24 H, CH3). 
13C{1H} NMR (75.47 MHz, CDCl3): 160.0 (s, NCN), 153.3, 152.2, 134.2, 125.1, 122.9, 
113.3 (s, py-C and Ar-C), 55.2 (s, NCH(CH3)2), 35.9 (s, CH2), 21.3 (s, CH3). Anal. Calc. 
for C38H48Br4N6Pd2: C, 40.70; H, 4.31; N, 7.49. Found: C, 40.60; H, 4.44; N, 7.40%. MS 




Complex 5d was prepared in 
analogy to 5b from complex 1 
(94 mg, 0.10 mmol) and 
4,4’-bipyridylethylene (18 mg, 
0.10 mmol). Slow evaporation at ambient temperature of a concentrated CH2Cl2 solution 

























(300 MHz, CD2Cl2):  9.16 (d, 3J(H,H) = 6.7 Hz, 4 H, 2,6-py-H), 7.66 (dd, 4 H, Ar-H), 
7.56 (d, 3J(H,H) = 6.7 Hz, 4 H, 3,5-py-H), 7.37 (s, 2 H, CH=CH), 7.29 (dd, 4 H, Ar-H), 
6.36 (m, 3J(H,H) = 7.1 Hz, 4 H, NCH(CH3)2), 1.82 (d, 3J(H,H) = 7.1 Hz, 24 H, CH3). 
13C{1H} NMR (75.47 MHz, CD2Cl2): 159.6 (s, NCN), 152.8, 144.9, 133.3 (s, py-C and 
Ar-C), 131.2 (s, CH=CH), 122.2, 121.9, 112.5 (s, py-C and Ar-C), 54.5 (s, NCH(CH3)2), 
20.2 (s, CH3). Anal. Calc. for C38H46Br4N6Pd2: C, 40.78; H, 4.14; N, 7.51. Found: C, 




Complex 1 (94 mg, 0.10 mmol) and 
cyclohexyl isocyanide (25 l, 
0.2 mmol) were dissolved in dry THF 
(10 ml) and stirred at ambient 
temperature for 5 h under nitrogen. 
The volatiles were removed under reduced pressure. The residue was washed with hexane 
(15 ml  3) and dried in vacuo. Crystallization by diffusion of pentane into a concentrated 
CHCl3 solution afforded the product as yellow crystals. Total yield: 98 mg, 0.17 mmol, 
85%. trans-6a: 1H NMR (300 MHz, CDCl3):  7.57-7.54 (dd, 2 H, Ar-H), 7.22-7.19 (dd, 
2 H, Ar-H), 5.98 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.88 (m, 1 H, CNCH), 
1.89-1.77 (m, 6 H, CH2), 1.72 (d, 3J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2), 1.43-1.32 (m, 
4 H, CH2). 13C{1H} NMR (75.47 MHz, CDCl3): 169.1 (s, Ccarbene), 133.9 (s, Ar-C), 130.3 


















(s, CH2), 21.3 (s, NCH(CH3)2). cis-6a: 1H NMR (300 MHz, CDCl3):  7.64-7.61 (dd, 2 H, 
Ar-H), 7.31-7.28 (dd, 2 H, Ar-H), 5.92 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.80 (m, 
1 H, CNCH), 1.89-1.77 (m, 6 H, CH2), 1.73 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2), 
1.67 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2), 1.43-1.32 (m, 4 H, CH2). 13C{1H} NMR 
(75.47 MHz, CDCl3): 165.2 (s, Ccarbene), 134.0 (s, Ar-C), 123.8, 113.6 (s, Ar-C), 55.1 (s, 
NCH(CH3)2), 53.0 (s, CNC), 32.5, 25.1, 23.1 (s, CH2), 21.7, 21.0 (s, NCH(CH3)2). The 
CN signal could not be detected. trans-6a and cis-6a: IR (KBr pellet) ~ = 2234 (s, 
CN) cm-1. Anal. Calc. for C20H29N3Br2Pd: C, 41.58; H, 5.06; N, 7.27. Found: C, 41.94; 




6b was prepared in analogy to 6a from 
complex 1 (94 mg, 0.10 mmol) and 
n-butyl isocyanide (21 l, 0.2 mmol). 
Total yield: 105 mg, 0.19 mmol, 95%. 
trans-6b: 1H NMR (300 MHz, CDCl3):  7.57-7.54 (dd, 2 H, Ar-H), 7.22-7.19 (dd, 2 H, 
Ar-H), 5.97 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.64 (t, 2 H, CNCH2), 1.74-1.65 
(m, 2 H, CH2), 1.72 (d, 3J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2), 1.55-1.45 (m, 2 H, CH2),  
0.95 (t, 3 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 168.8 (s, Ccarbene), 133.9, 123.1, 
113.5 (s, Ar-C), 55.0 (s, NCH(CH3)2), 44.4 (br, CNC), 31.1 (s, CH2), 21.4 (s, 
NCH(CH3)2), 20.1 (s, CH2), 13.8 (s, CH3). The CN signal could not be detected. cis-6b: 




















5.91 (m, 3J(H,H) = 7.1 Hz, 2 H, NCH(CH3)2), 3.59 (t, 2 H, CNCH2), 1.74-1.65 (m, 2 H, 
CH2), 1.73 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2), 1.67 (d, 3J(H,H) = 7.1 Hz, 6 H, 
NCH(CH3)2), 1.32-1.23 (m, 2 H, CH2), 0.81 (t, 3 H, CH3). 13C{1H} NMR (75.47 MHz, 
CDCl3): 164.9 (s, Ccarbene), 134.0, 123.9, 113.7 (s, Ar-C), 55.1 (s, NCH(CH3)2), 45.2 (br, 
CNC), 30.9 (s, CH2), 21.7, 21.1 (s, NCH(CH3)2), 20.0 (s, CH2), 13.5 (s, CH3). The CN 
signal could not be detected. trans-6b and cis-6b: IR (KBr pellet) ~= 2229 (s, CN) cm-1. 
Anal. Calc. for C18H27N3Br2Pd: C, 39.19; H, 4.93; N, 7.62. Found: C, 38.98; H, 4.75; N, 
7.50%. MS (FAB): m/z = 472 [M-Br]+, 555 [M-Br+C5NH9]+. 
 
Dibromo(1,3-diisopropylbenzimidazolin-2-ylidene)(2,6-dimethylphenylisocyanide)- 
palladium(II) (6c)  
6c was prepared in analogy to 6a from 
complex 1 (281 mg, 0.30 mmol) and 
2,6-dimethylphenyl isocyanide (79 mg, 
0.60 mmol). Total yield: 335 mg, 0.56 
mmol, 93%. trans-6c: 1H NMR (300 MHz, CDCl3):  7.63-7.58 (dd, 2 H, Ar-H), 
7.26-7.21 (m, 3 H, Ar-H), 7.12-7.10 (d, 2 H, Ar-H), 6.05 (m, 3J(H,H) = 7.1 Hz, 2 H, 
NCH(CH3)2), 2.52 (s, 6 H, CH3), 1.77 (d, 3J(H,H) = 7.1 Hz, 12 H, NCH(CH3)2). 13C{1H} 
NMR (75.47 MHz, CDCl3): 168.8 (s, Ccarbene), 136.8, 133.8, 130.6, 128.5, 123.1, 113.5 (s, 
Ar-C), 55.0 (s, NCH(CH3)2), 21.3 (s, NCH(CH3)2), 19.3 (s, CH3). The CN and Ar-CN 
signals could not be detected. cis-6c: 1H NMR (300 MHz, CDCl3):  7.68-7.65 (dd, 2 H, 
Ar-H), 7.34-7.31 (dd, 2 H, Ar-H), 7.25-7.21 (t, 1 H, Ar-H), 7.08-7.05 (d, 2 H, Ar-H), 6.05 




















6 H, NCH(CH3)2), 1.72 (d, 3J(H,H) = 7.1 Hz, 6 H, NCH(CH3)2). 13C{1H} NMR 
(75.47 MHz, CDCl3): 164.5 (s, Ccarbene), 136.2, 133.8, 131.0, 128.8, 123.9, 113.6 (s, Ar-C), 
55.0 (s, NCH(CH3)2), 21.7, 21.0 (s, NCH(CH3)2), 19.1 (s, CH3). The CN and Ar-CN 
signals could not be detected. trans-6c and cis-6c: IR (KBr pellet) ~ = 2194 (s, CN) 
cm-1. Anal. Calc. for C22H27N3Br2Pd: C, 44.06; H, 4.54; N, 7.01. Found: C, 44.03; H, 




Complex 6c (90 mg, 0.15 mmol) and hydrazine 
monohydrate (3.6 l, 0.075 mmol) were dissolved 
in CH2Cl2 (5 ml) and stirred at ambient temperature 
overnight. The resulting mixture was filtered over celite and the solvent was removed 
under reduced pressure. Upon adding CHCl3 (2 ml) to the residue, yellow precipitates 
were formed and collected by filtration. Reducing the solvent of the filtrate to 1 ml 
followed by prolonged stirring (3 h) afforded a second crop of a yellow precipitate. The 
yellow precipitate was combined and dried in vacuo to give the product. Yield: 33 mg, 
0.034 mmol, 45%. 1H NMR (500 MHz, CD2Cl2):  7.61-7.59 (m, 4 H, Ar-H), 7.25-7.23 
(m, 4 H, Ar-H), 6.21 (m, 3J(H,H) = 6.9 Hz, 4 H, NCH(CH3)2), 4.72 (s, 4 H, NH2), 1.73 (d, 
3J(H,H) = 6.9 Hz, 24 H, NCH(CH3)2). 13C{1H} NMR (125.76 MHz, CD2Cl2): 159.9 (s, 
Ccarbene), 133.7, 122.8, 113.0 (s, Ar-C), 54.9 (s, NCH(CH3)2), 20.7 (s, NCH(CH3)2). IR 
(KBr pellet) ~ = 3233, 3143 (m, NH) cm-1. Anal. Calc. for C26H40N6Br4Pd2: C, 32.22; H, 






















A mixture of complex 6c (120 mg, 0.20 mmol) and AgO2CCF3 
(93 mg, 0.42 mmol) was suspended in acetonitrile (10 ml) and 
stirred at ambient temperature overnight shielded from light. 
The reaction mixture was filtered over celite and the solvent of 
the filtrate was removed under reduced pressure. To the residue 
was added CHCl3 (15 ml) and the resulting mixture was filtered over celite. Removing 
the solvent of the filtrate in vacuo afforded the product as white powder. Yield: 126 mg, 
0.19 mmol, 95%. 1H NMR (500 MHz, CDCl3):  7.69-7.67 (m, 2 H, Ar-H), 7.37-7.35 (m, 
2 H, Ar-H), 7.23 (t, 1 H, Ar-H), 7.06 (d, 2 H, Ar-H), 6.14 (m, 3J(H,H) = 6.9 Hz, 2 H, 
NCH(CH3)2), 2.17 (s, 6 H, CH3), 1.82 (d, 3J(H,H) = 6.9 Hz, 6 H, NCH(CH3)2), 1.75 (d, 
3J(H,H) = 6.9 Hz, 6 H, NCH(CH3)2). 13C{1H} NMR (125.76 MHz, CDCl3): 162.4 (q, 
2J(C,F) = 37.6 Hz, O2CCF3), 161.6 (q, 2J(C,F) = 38.5 Hz, O2CCF3), 155.9 (s, Ccarbene), 
136.0, 133.2, 131.1, 128.6 (s, Ar-C), 127.9, 125.1 (br, Ar-CN and CN), 124.0 (s, Ar-C), 
116.0 (q, 1J(C,F) = 290.0 Hz, CF3), 115.5 (q, 1J(C,F) = 290.5 Hz, CF3), 113.4 (s, Ar-C), 
55.2 (s, NCH(CH3)2), 21.5, 21.2 (s, NCH(CH3)2), 18.3 (s, CH3). 19F{1H} NMR 
(282.4 MHz, CDCl3): 2.0 (s, 6 F, CF3). IR (KBr pellet) ~ = 2214 (s, CN) cm-1. Anal. 
Calc. for C26H27F6N3O4Pd·CH2Cl2: C, 43.19; H, 3.89; N, 5.60. Found: C, 43.70; H, 3.68; 











V·H+Br- (71 mg, 0.20 mmol), Ag2O (24 mg, 0.10 mmol) and 1 
(94 mg, 0.10 mmol) were suspended in DCM (15 mL) and 
stirred at ambient temperature overnight shielded from light. 
The resulting suspension was filtered over celite and the filtrate 
was dried in vacuo to give the product as a yellow solid. Yield: 
146 mg, 0.19 mmol, 95%. 1H NMR (500 MHz, CDCl3): δ 7.64 
(d, 2 H, Ar-H), 7.49-7.37 (m, 5 H, Ar-H), 7.12-7.11 (m, 2 H, 
Ar-H), 7.07 (s, 2 H, Ar-H), 6.87-6.86 (m, 2 H, CH), 5.88 (m, 3J(H,H) = 6.95 Hz, 1 H, 
CH(CH3)2), 5.87 (s, 2 H, CH2), 5.58 (m, 3J(H,H) = 6.95 Hz, 1 H, CH(CH3)2), 2.43 (s, 3 H, 
p-CH3), 2.34 (s, 6 H, o-CH3), 1.70 (d, 3J(H,H) = 6.95 Hz, 6 H, CH(CH3)2), 1.45 (d, 
3J(H,H) = 6.95 Hz, 6 H, CH(CH3)2). 13C{1H} NMR (125.76 MHz, CDCl3): 178.3 (s, 
NCN-iPr2-bimy), 173.4 (s, NCN-V), 139.1, 137.4, 137.0, 136.5, 134.2, 134.1, 129.7, 
129.6, 129.4, 128.9, 123.9, 122.33, 122.30, 121.2, 113.1, 112.9 (s, Ar-C & CH), 55.6 (s, 
CH2), 54.3, 53.9 (s, CH(CH3)2), 21.8 (s, p-CH3), 21.7, 21.1 (s, CH(CH3)2), 20.3 (s, 
o-CH3). Anal. Calc. for C32H38Br2N4Pd: C, 51.60; H, 5.14; N, 7.52. Found: C, 51.58; H, 




11f was prepared in analogy to 11e from IMes·H+Br- (193 mg, 
0.50 mmol), Ag2O (58 mg, 0.25 mmol) and 1 (234 mg, 0.25 
mmol). Yield: 382 mg, 0.49 mmol, 98%. 1H NMR (500 MHz, 
CDCl3): δ 7.38-7.36 (dd, 2 H, Ar-H), 7.09-7.07 (m, 8 H, Ar-H & 
CH), 5.43 (m, 3J(H,H) = 6.95 Hz, 2 H, CH(CH3)2), 2.44 (s, 6 H, 
p-CH3), 2.42 (s, 12 H, o-CH3), 1.47 (d, 3J(H,H) = 6.95 Hz, 12 H, 
CH(CH3)2). 13C{1H} NMR (125.76 MHz, CDCl3): 177.2 (s, 
NCN-iPr2-bimy), 175.5 (s, NCN-IMes), 139.1, 137.2, 136.5, 134.3, 129.3, 123.6, 122.1, 
112.6 (s, Ar-C & CH), 53.8 (s, CH(CH3)2), 21.8 (s, p-CH3), 21.3 (s, CH(CH3)2), 20.4 (s, 



















11g was prepared in analogy to 11e from SIMes·H+Br- (155 mg, 
0.40 mmol), Ag2O (46 mg, 0.20 mmol) and 1 (187 mg, 0.20 
mmol). Yield: 304 mg, 0.39 mmol, 98%. 1H NMR (500 MHz, 
CDCl3): δ 7.35-7.33 (dd, 2 H, Ar-H), 7.07-7.06 (dd, 2 H, Ar-H), 
7.04 (s, 4 H, Ar-H), 5.25 (m, 3J(H,H) = 6.95 Hz, 2 H, CH(CH3)2), 
4.02 (s, 4 H, CH2), 2.62 (s, 12 H, o-CH3), 2.39 (s, 6 H, p-CH3), 
1.40 (d, 3J(H,H) = 6.95 Hz, 12 H, CH(CH3)2). 13C{1H} NMR 
(125.76 MHz, CDCl3): 204.0 (s, NCN-SIMes), 177.6 (s, NCN-iPr2-bimy), 138.3, 136.4, 
134.2, 129.5, 122.1, 112.6 (s, Ar-C), 53.7 (s, CH(CH3)2), 51.6 (s, CH2), 21.7 (s, p-CH3), 
21.2 (s, CH(CH3)2), 20.6 (s, o-CH3). Anal. Calc. for C34H44Br2N4Pd: C, 52.69; H, 5.72; N, 




IPr·H+Br- (94 mg, 0.20 mmol), Ag2O (24 mg, 0.10 mmol) 
and 1 (94 mg, 0.10 mmol) were suspended in DCM (15 mL) 
and stirred at ambient temperature overnight shielded from 
light. The resulting suspension was filtered over celite and 
the solvent of the filtrate was removed in vacuo. The residue 
was subjected to column chromatography (SiO2, diethyl 
ether:hexane = 4:1). The first band (Rf = 0.9) was collected and dried under vacuum to 
afford the product as a yellow solid. Yield: 127 mg, 0.15 mmol, 75%. 1H NMR (500 MHz, 
CDCl3): δ 7.52 (t, 2 H, Ar-H), 7.39 (d, 4 H, Ar-H), 7.35-7.33 (dd, 2 H, Ar-H), 7.16 (s, 2 H, 
CH), 7.05-7.03 (dd, 2 H, Ar-H), 5.34 (m, 3J(H,H) = 6.90 Hz, 2 H, NCH(CH3)2), 3.30 (m, 
3J(H,H) = 6.90 Hz, 4 H, CH(CH3)2), 1.45 (d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2), 1.38 
(d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2), 1.11 (d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2). 
















147.8, 136.7, 134.2, 130.3, 124.9, 124.1, 122.0, 112.8 (s, Ar-C & CH), 53.7 (s, 
NCH(CH3)2), 29.5 (s, CH(CH3)2), 27.3, 23.6, 21.2 (s, CH(CH3)2). Anal. Calc. for 
C40H54Br2N4Pd: C, 56.05; H, 6.35; N, 6.54. Found: C, 56.19; H, 6.29; N, 6.22%. MS 




SIPr·H+Br- (94 mg, 0.20 mmol), Ag2O (24 mg, 0.10 mmol) 
and 1 (94 mg, 0.10 mmol) were suspended in DCM (15 mL) 
and stirred at ambient temperature for 3 days shielded from 
light. The resulting suspension was filtered over celite and 
the solvent of the filtrate was removed in vacuo. The 
residue was subjected to column chromatography (SiO2, 
ethyl acetate:hexane = 3:7). The first band (Rf = 0.88) was collected and dried under 
vacuum to afford the product as a yellow solid. Yield: 73 mg, 0.085 mmol, 43%. 1H 
NMR (500 MHz, CDCl3): δ 7.44 (t, 2 H, Ar-H), 7.35-7.32 (m, 6 H, Ar-H), 7.04-7.01 (m, 
2 H, Ar-H), 5.20 (m, 3J(H,H) = 6.90 Hz, 2 H, NCH(CH3)2), 4.15 (s, 4 H, CH2), 3.73 (m, 
3J(H,H) = 6.90 Hz, 4 H, CH(CH3)2), 1.53 (d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2), 1.33 
(d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2), 1.24 (d, 3J(H,H) = 6.90 Hz, 12 H, CH(CH3)2). 
13C{1H} NMR (125.76 MHz, CDCl3): 206.3 (s, NCN-SIPr), 177.6 (s, NCN-iPr2-bimy), 
149.0, 136.9, 134.1, 129.5, 124.5, 121.9, 112.9 (s, Ar-C), 54.3 (s, CH2), 53.6 (s, 
NCH(CH3)2), 29.6 (s, CH(CH3)2), 27.8, 24.4, 21.2 (s, CH(CH3)2). Anal. Calc. for 
C40H56Br2N4Pd: C, 55.92; H, 6.57; N, 6.52. Found: C, 56.18; H, 6.56; N, 6.30%. MS 
(ESI): m/z = 881 [M+Na]+. 
 
trans-Dibromo-bis(1,3-diisopropylbenzimidazolin-2-ylidene)palladium(II) (trans-12) 
A mixture of A (283 mg, 1 mmol) and Pd(OAc)2 (112 mg, 0.5 
mmol) was dissolved in wet DMSO (6 ml) and stirred at 
















precipitate obtained was filtered off and washed with small portions of DMSO and 
diethyl ether. It was then dried in vacuo to give the product as a yellow powder. Upon 
stirring the DMSO-filtrate at 100 °C overnight a second crop of the product can be 
obtained giving an overall yield of 60% (200 mg, 0.30 mmol). 1H NMR (300 MHz, 
CDCl3):  7.59 (dd, 4 H, Ar-H), 7.22 (dd, 4 H, Ar-H), 6.25 (m, 3J(H,H) = 7.1 Hz, 4 H, 
NCH(CH3)2), 1.87 (d, 3J(H,H) = 7.1 Hz, 24 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 
180.6 (s, NCN), 134.3, 122.7, 113.3 (s, Ar-C), 54.6 (s, NCH(CH3)2), 21.8 (s, CH3). Anal. 
Calc. for C26H36Br2N4Pd: C, 46.55; H, 5.41; N, 8.35. Found: C, 46.63; H, 5.59; N, 8.32%. 
MS (ESI): m/z = 591 [M-Br]+. 
 
trans-Diiodo-bis(1,3-diisopropylbenzimidazolin-2-ylidene)palladium(II) (trans-13)  
Complex trans-13 was prepared in analogy to trans-12 from 
B (528 mg, 1.6 mmol) and Pd(OAc)2 (180 mg, 0.8 mmol). 
Yield: 390 mg, 0.51 mmol, 64%. 1H NMR (300 MHz, CDCl3): 
 7.57 (dd, 4 H, Ar-H), 7.20 (dd, 4 H, Ar-H), 6.00 (m, 3J(H,H) = 7.1 Hz, 4 H, 
NCH(CH3)2), 1.80 (d, 3J(H,H) = 7.1 Hz, 24 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 
177.9 (s, NCN), 134.0, 122.0, 112.8 (s, Ar-C), 54.0 (s, NCH(CH3)2), 20.6 (s, CH3). Anal. 
Calc. for C26H36I2N4Pd: C, 40.83; H, 4.74; N, 7.33. Found: C, 40.74; H, 4.63; N, 7.20%. 















A mixture of complex trans-12 (112 mg, 0.17 mmol) and 
AgO2CCF3 (81 mg, 0.37 mmol) was suspended in acetonitrile 
(15 ml) and stirred overnight at ambient temperature shielded from 
light. The resulting suspension was filtered over celite and the 
solvent was removed in vacuo to give the crude product as 
yellowish powder. Slow evaporation at ambient temperature of a concentrated acetonitrile 
solution afforded the product as colorless crystals. Yield: 94 mg, 0.128 mmol, 75%. 1H 
NMR (300 MHz, CDCl3):  7.61 (dd, 4 H, Ar-H), 7.28 (dd, 4 H, Ar-H), 5.97 (m, 3J(H,H) 
= 7.0 Hz, 4 H, NCH(CH3)2), 1.72 (d, 3J(H,H) = 7.0 Hz, 12 H, CH3), 1.33 (d, 3J(H,H) = 
7.0 Hz, 12 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3,): 164.8 (s, NCN), 162.3 (q, 
2J(C,F) = 36.0 Hz, CF3CO), 132.8, 123.5 (s, Ar-C), 116.0 (q, 1J(C,F) = 289.1 Hz, CF3), 
113.5 (s, Ar-C), 54.6 (s, NCH(CH3)2), 21.4, 20.3 (s, CH3). 19F{1H} NMR (282.38 MHz, 
CDCl3): 1.83 (s, CF3). Anal. Calc. for C30H36F6N4O4Pd: C, 48.89; H, 4.92; N, 7.60. 
Found: C, 48.57; H, 5.16; N, 7.31%. MS (ESI): m/z = 623 [M-O2CCF3]+. 
 
cis-Dibromo(1,3-diisopropylbenzimidazolin-2-ylidene)(dimethylsulfoxide)platinum 
(II) (cis-15) and trans-Dibromo-bis(1,3-diisopropylbenzimidazolin-2-ylidene)plati- 
num(II) (trans-16) 
A mixture of salt A (170 mg, 0.6 mmol), 
PtBr2 (106 mg, 0.3 mmol) and 























DMSO (5 mL) was stirred at 90 °C for 10 h. The initially orange reaction mixture turned 
to a yellow solution. Further heating at 140 °C for 20 h afforded some yellow precipitate, 
which was filtered off and washed with small portions of DMSO and diethyl ether. It was 
then dried in vacuo to give trans-16 as a yellow powder (6 mg, 0.008 mmol, 3%). 
Removal of the solvent from the filtrate via vacuum distillation and subsequent washing 
of the resulting residue with H2O (4×30 mL) afforded crude cis-15, which after drying in 
vacuo was isolated as an off-white solid. Slow evaporation of a concentrated CHCl3 
solution of the crude product afforded cis-15 as white crystals (102 mg, 0.16 mmol, 55%). 
cis-15: 1H NMR (500 MHz, CDCl3):  7.63 (dd, 2 H, Ar-H), 7.28 (dd, 2 H, Ar-H), 6.27 
(m, 3J(H,H) = 7.0 Hz, 2 H, NCH(CH3)2), 3.61 (s, 3J(Pt,H) = 21.5 Hz, 6 H, (CH3)2SO), 
1.75 (d, 3J(H,H) = 7.0 Hz, 6 H, CH3), 1.74 (d, 3J(H,H) = 7.0 Hz, 6 H, CH3). 13C{1H} 
NMR (125.8 MHz, CDCl3): 153.6 (s, NCN), 132.8, 123.2, 113.5 (s, Ar-C), 54.3 (3J(Pt,C) 
= 31.2 Hz, NCH(CH3)2), 47.1 (s, 2J(Pt,C) = 70.6 Hz, (CH3)2SO), 20.6, 20.4 (s, CH3). IR 
(KBr pellet) ~  = 1134 (s, S=O) cm-1. Anal. Calc. for C15H24Br2N2OPtS: C, 28.36; H, 
3.81; N, 4.41. Found: C, 28.33; H, 3.49; N, 4.57%. MS (ESI): m/z = 1191 [2M-Br]+. 
trans-16: 1H NMR (500 MHz, CDCl3):  7.60 (dd, 4 H, Ar-H), 7.21 (dd, 4 H, Ar-H), 6.52 
(m, 3J(H,H) = 7.0 Hz, 4 H, NCH(CH3)2), 1.81 (d, 3J(H,H) = 7.0 Hz, 24 H, CH3). 13C{1H} 
NMR (125.8 MHz, CDCl3): 176.5 (s, NCN), 133.6, 122.1, 112.9 (s, Ar-C), 53.1 (s, 
NCH(CH3)2), 21.1 (s, CH3). Anal. Calc. for C26H36Br2N4Pt: C, 41.12; H, 4.78; N, 7.38. 







(II) (cis-17)  
A mixture of complex cis-15 (64 mg, 0.1 mmol) and 
triphenylphosphine (26 mg, 0.1 mmol) in CH2Cl2 (5 mL) was stirred 
at ambient temperature for 6 h and then refluxed for 15 h. After 
removing the solvent in vacuo, 3 ml of THF was added to the residue. The precipitate 
obtained was filtered off and washed with another 3 ml of THF. It was then dried in 
vacuo to give the product as white powder. Yield: 29 mg, 0.035 mmol, 35%. 1H NMR 
(500 MHz, CDCl3):  7.46 (dd, 2 H, Ar-H), 7.38 (br, 15 H, Ar-H), 7.20 (dd, 2 H, Ar-H), 
6.09 (m, 3J(H,H) = 7.0 Hz, 2 H, NCH(CH3)2), 1.63 (d, 3J(H,H) = 7.0 Hz, 6 H, CH3), 0.86 
(d, 3J(H,H) = 7.0 Hz, 6 H, CH3). 13C{1H} NMR (125.8 MHz, CDCl3): 161.0 (d, 2J(P,C) = 
5.5 Hz, NCN), 134.9 (br, Ar-C), 133.8, 131.8, 129.1, 129.0, 123.4, 113.5 (s, Ar-C), 54.6 
(s, NCH(CH3)2), 21.4, 19.7 (s, CH3). 31P{1H} NMR (202.4 MHz, CDCl3): 10.0 (2J(Pt,P) 
= 3848 Hz, 1 P, PPh3). Anal. Calc. for C31H33Br2N2PPt: C, 45.44; H, 4.06; N, 3.42. Found: 




Complex cis-15 (64 mg, 0.1 mmol) was dissolved in pyridine 
(1 mL) and stirred at ambient temperature for 6 h. All volatiles 
were removed in vacuo to give a yellow solid. Crystallization 
from a CH2Cl2/Hexane solution of this solid afforded the product as yellow crystals. 















7.78 (m, 1 H, 4-py-H), 7.59 (dd, 2 H, Ar-H), 7.36 (m, 2 H, 3,5-py-H), 7.19 (dd, 2 H, 
Ar-H), 6.59 (m, 3J(H,H) = 6.9 Hz, 2 H, NCH(CH3)2), 1.77 (d, 3J(H,H) = 6.9 Hz, 12 H, 
CH3). 13C{1H} NMR (125.8 MHz, CDCl3): 153.4 (s, Ar-C), 149.7 (s, NCN), 138.4, 133.8, 
125.6, 122.8, 113.3 (s, Ar-C), 54.3 (s, NCH(CH3)2), 21.3 (s, CH3). Anal. Calc. for 
C18H23N3Br2Pt: C, 33.98; H, 3.64; N, 6.60. Found: C, 33.75; H, 3.95; N, 6.76%. MS 
(FAB): m/z = 637 [M]+. 
 
trans-Dibromo(1,3-dibenzhydrylbenzimidazolin-2-ylidene)(2-(1-benzhydrylbenzimi-
dazol-2-yl)-benzophenone)palladium(II) (19)  
A mixture of Pd(OAc)2 (67 mg, 0.3 mmol) and salt C 
(318 mg, 0.6 mmol) was dissolved in DMSO (8 ml) 
and stirred at 75 °C overnight. The resulting 
suspension was filtered through a sintered funnel. The 
solvent of the filtrate was removed by vacuum 
distillation and the residue was subjected to column chromatography (SiO2, ethyl acetate: 
hexane = 1:4). The 4th band (Rf = 0.45) was collected and dried under reduced pressure 
to give the product as a yellow solid. Yield: 248 mg, 0.21 mmol, 70%. 1H NMR 
(300 MHz, CDCl3):  9.10 (s, 1 H, CH), 8.32 (d, 3J(H,H) = 8.1 Hz, 1 H, Ar-H), 8.11 (s, 
1 H, CH), 7.76-6.72 (m, 43 H, Ar-H & CH), 6.32 (d, 3J(H,H) = 8.4 Hz, 1 H, Ar-H). 
13C{1H} NMR (75.47 MHz, CDCl3): 195.8 (s, CO), 172.9 (s, NCN), 154.2 (s, Ccarbene), 
141.4, 139.3, 138.4, 138.3, 138.2, 138.1, 137.6, 137.3, 135.6, 135.5, 134.6, 134.5, 132.7, 
132.0, 131.9, 131.4, 130.9, 130.5, 130.4, 130.1, 129.9, 129.8, 129.7, 129.4, 129.1, 129.05, 
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(s, Ar-C), 68.7, 68.2, 65.5 (s, CH). IR (KBr pellet) ~ = 1660 cm-1 (s, C=O). Anal. Calc. 
for C66H50Br2N4OPd: C, 67.10; H, 4.27; N, 4.74. Found: C, 67.14; H, 4.42; N, 4.59%. 
MS (ESI): m/z = 1101 [M-Br]+. 
 
1,3-Dibenzhydrylbenzimidazolin-2-ylidene silver(I) bromide (20) 
A mixture of Ag2O (23 mg, 0.1 mmol) and salt C (106 mg, 0.2 mmol) 
was suspended in CH2Cl2 (15 ml) and stirred at ambient temperature 
for 7 h shielded from light. The reaction mixture was filtered through 
celite and the solvent of the filtrate was removed in vacuo to give the 
crude product as a white solid. Crystallization from a concentrated CH2Cl2/Et2O solution 
afforded the product as colorless crystals. Yield: 119 mg, 0.093 mmol, 93%. 1H NMR 
(500 MHz, CDCl3):  7.35-7.15 (m, Ar-H & CH). 13C{1H} NMR (125.76 MHz, CDCl3): 
192.1 (br, Ccarbene), 137.2, 134.2, 129.1, 128.6, 128.2, 124.1, 113.4 (s, Ar-C), 68.1 (s, CH). 
Anal. Calc. for C33H26AgBrN2: C, 62.09; H, 4.11; N, 4.39. Found: C, 61.79; H, 4.11; N, 




A mixture of Ag2O (23 mg, 0.1 mmol) and salt C (106 mg, 
0.2 mmol) was suspended in CH2Cl2 (10 ml) and stirred at 
ambient temperature for 7 h shielded from light. The resulting 
mixture was directly filtered into a solution of [PdBr2(CH3CN)2], which in turn was 



















conditions for 6 h. The reaction mixture was stirred at ambient temperature for 24 h and 
gradually lightened up from initially red to yellow. The resulting suspension was filtered 
through a sintered funnel and the residue was washed by CH3CN repeatedly until the 
filtrate is colorless. The solvent of the filtrate was removed under vacuum to give an 
orange residue. Washing the residue with small portions of ice-cold CH3CN followed by 
drying in vacuo afforded the pure product as a yellow powder. Yield: 82 mg, 0.11 mmol, 
54%. 1H NMR (500 MHz, CD3CN):  8.54 (s, 2 H, CH), 7.43-7.35 (m, 20 H, Ar-H), 6.91 
(m, 2 H, Ar-H), 6.83 (m, 2 H, Ar-H), 1.96 (s, CH3CN, correct integration is not possible 
due to ligand exchange with the solvent). 13C{1H} NMR (125.76 MHz, CD3CN): 165.7 (s, 
Ccarbene), 138.2, 135.1, 130.0, 129.4, 129.2, 124.0 (s, Ar-C), 118.3 (s, CN), 114.8 (s, Ar-C), 
69.2 (s, CH), 1.32 (m, CH3CN, assignment is tentative due to overlap with solvent 
signals). Anal. Calc. for C35H29Br2N3Pd: C, 55.47; H, 3.86; N, 5.54. Found: C, 55.81; H, 




Complex 21 (76 mg, 0.1 mmol) was suspended in Et2O 
(20 ml) and stirred at ambient temperature overnight. The 
resulting mixture was filtered through a sintered funnel 
and the residue was washed by Et2O again (10 ml  3). 
Drying the residue in vacuo afforded the product as an orange powder. Yield: 71 mg, 
0.049 mmol, 99%. 1H NMR (500 MHz, CDCl3):  8.76 (s, 4 H, CH), 7.44-7.31 (m, 40 H, 





















165.2 (s, Ccarbene), 137.5, 135.1, 129.8, 129.4, 129.0, 123.6, 114.5 (s, Ar-C), 69.4 (s, CH). 
Anal. Calc. for C66H52Br4N4Pd2: C, 55.29; H, 3.66; N, 3.91. Found: C, 55.00; H, 3.73; N, 
3.81%. MS (ESI): m/z = 1353 [M-Br]+. 
 
4-Iodo-3,5-dimethyl-1-phenylpyrazole (24a) 
An aqueous solution of KI3 {prepared by dissolving I2 (1505 mg, 
5.95 mmol) and KI (2955 mg, 17.8 mmol) in H2O (20 ml)} was added 
dropwise to a solution of 3,5-dimethyl-1-phenylpyrazole (520 mg, 3 mmol) 
and NaOAc (535 mg, 5.65 mmol) in H2O (12 ml) under reflux. The resulting dark brown 
solution was kept under reflux for another 7 h and then cooled to ambient temperature. 
Subsequently, an aqueous solution of Na2S2O3 was added dropwise until the reaction 
mixture was decolored. The product was extracted with diethyl ether (4  30 ml). The 
combined organic layer was washed with NaHCO3 (2  40 ml) and brine (2  40 ml). 
Drying over MgSO4 followed by removal of the solvent in vacuo afforded the product as 
a brown oil. Yield: 827 mg, 2.8 mmol, 93%. 1H NMR (300 MHz, CDCl3):  7.48-7.33 (m, 
5 H, Ar-H), 2.32 (s, 3 H, CH3), 2.30 (s, 3 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 
150.8 (s, CCH3), 140.9, 140.0 (s, CCH3/Ar-C), 129.2, 128.0, 124.9 (s, Ar-C), 65.4 (s, CI), 
14.2, 13.5 (s, CH3). Anal. Calc. for C11H11IN2: C, 44.32; H, 3.72; N, 9.40. Found: C, 
44.78; H, 3.78; N, 9.45%. MS (ESI): m/z = 299 [M+H]+. 
 
4-Iodo-1,3,5-trimethylpyrazole (24b) 
24b was prepared in analogy to 24a from 1,3,5-trimethylpyrazole (441 mg, 










diethyl ether. Yield: 637 mg, 2.7 mmol, 67%. 1H NMR (300 MHz, CDCl3):  3.77 (s, 3 H, 
NCH3), 2.24 (s, 3 H, CH3), 2.19 (s, 3 H, CH3). 13C{1H} NMR (75.47 MHz, CDCl3): 
149.0 (s, CCH3), 140.7 (s, CCH3), 62.2 (s, CI), 37.1 (s, NCH3), 14.0, 12.0 (s, CH3). Anal. 
Calc. for C6H9IN2: C, 30.53; H, 3.84; N, 11.87. Found: C, 30.89; H, 3.76; N, 11.60%. MS 
(ESI): m/z = 237 [M+H]+. 
 
2-Ethyl-4-iodo-3,5-dimethyl-1-phenylpyrazolium iodide (25a) 
24a (713 mg, 2.4 mmol) was dissolved in iodoethane (2 ml) and heated 
under reflux for 2 days shielded from light. The reaction mixture was 
cooled to ambient temperature and all volatiles were removed under 
reduced pressure. The residue was washed with diethyl ether and dried in vacuo to give 
the product as an off-white powder. Yield: 545 mg, 1.2 mmol, 50%. 1H NMR (300 MHz, 
CDCl3):  7.81-7.65 (m, 5 H, Ar-H), 4.39 (m, 3J(H,H) = 7.3 Hz, 2 H, CH2), 2.70 (s, 3 H, 
CH3), 2.25 (s, 3 H, CH3), 1.22 (t, 3J(H,H) = 7.3 Hz, 3 H, CH2CH3). 13C{1H} NMR 
(75.47 MHz, CDCl3): 149.9, 149.8 (s, CCH3), 133.6, 131.8, 131.6, 129.8 (s, Ar-C), 72.6 
(s, CI), 46.7 (s, CH2), 15.4 (s, CCH3), 15.0 (s, CH2CH3). Anal. Calc. for C13H16I2N2: C, 
34.39; H, 3.55; N, 6.17. Found: C, 34.78; H, 3.45; N, 6.19%. MS (ESI): m/z = 327 
[M-I]+. 
 
1-Ethyl-4-iodo-2,3,5-trimethylpyrazolium iodide (25b) 
25b was prepared in analogy to 25a from 24b (283 mg, 1.2 mmol). Yield: 
153 mg, 0.39 mmol, 33%. 1H NMR (300 MHz, d6-DMSO):  4.54 (m, 












2.45 (s, 3 H, CH3), 1.30 (t, 3J(H,H) = 7.2 Hz, 3 H, CH2CH3). 13C{1H} NMR (75.47 MHz, 
d6-DMSO): 147.9, 146.8 (s, CCH3), 69.3 (s, CI), 43.2 (s, CH2), 35.1 (s, NCH3), 13.7, 13.2, 
12.8 (s, CH3). Anal. Calc. for C8H14I2N2: C, 24.51; H, 3.60; N, 7.15. Found: C, 24.76; H, 




Tris(dibenzylideneacetone)dipalladium(0) (229 mg, 0.25 mmol) and 
triphenylphosphine (131 mg, 0.50 mmol) were dissolved in dry 
CH2Cl2 (30 ml) and stirred at ambient temperature for 10 min under 
nitrogen. The resulting dark red solution was transferred to a suspension of 25a (227 mg, 
0.5 mmol) in dry CH2Cl2 (20 ml) via cannula. The reaction mixture was heated under 
reflux for 4 h in an inert nitrogen atmosphere and then cooled to ambient temperature. 
The resulting mixture was filtered through celite, and the filtrate was extracted with H2O 
(4  30 ml). The CH2Cl2 layer was dried over MgSO4 and the solvent was removed under 
reduced pressure. The residue was washed with diethyl ether (2  30 ml) and dried in 
vacuo to give the crude product as a yellow powder. Slow evaporation of a concentrated 
CH2Cl2 solution at ambient temperature afforded the pure product as yellow crystals. 
Yield: 290 mg, 0.35 mmol, 70%. 1H NMR (300 MHz, CD2Cl2):  7.78-6.87 (m, 20 H, 
Ar-H), 3.78 (m, 2J(H,H) = 15.4 Hz, 3J(H,H) = 7.2 Hz, 1 H, CH2), 3.63 (m, 2J(H,H) = 15.4 
Hz, 3J(H,H) = 7.2 Hz, 1 H, CH2), 2.36 (s, 3 H, CH3), 1.99 (s, 3 H, CH3), 0.95 (m, 3J(H,H) 
= 7.2 Hz, 3 H, CH2CH3). 31P{1H} NMR (121 MHz, CD2Cl2): 29.4 (s, 1 P, PPh3). 13C{1H} 










2.7 Hz, CCH3), 134.9 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 132.9 (d, 1J(P,C) = 48.3 Hz, Ar-C), 
132.3, 131.6, 130.5 (s, Ar-C), 130.2 (d, 4J(P,C) = 2.2 Hz, Ar-C), 130.1, 128.7, 127.8 (s, 
Ar-C), 127.7 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 41.9 (s, CH2), 15.3, 15.1, 14.7(s, CH3), 
carbene signal could not be detected. Anal. Calc. for C31H31I2N2PPd: C, 45.25; H, 3.80; N, 




26b was prepared in analogy to 26a from 25b (196 mg, 0.5 mmol), 
tris(dibenzylideneacetone)dipalladium(0) (229 mg, 0.25 mmol) and 
triphenylphosphine (131 mg, 0.50 mmol). Yield: 228 mg, 0.30 mmol, 
60%. 1H NMR (500 MHz, CD2Cl2):  7.67-7.31 (m, 15 H, Ar-H), 3.86 (m, 3J(H,H) = 
7.3 Hz, 2 H, CH2), 3.43 (s, 3 H, NCH3), 2.21 (s, 3 H, CH3), 2.13 (s, 3 H, CH3), 1.15 (m, 
3J(H,H) = 7.3 Hz, 3 H, CH2CH3). 31P{1H} NMR (202 MHz, CD2Cl2): 29.3 (s, 1 P, PPh3). 
13C{1H} NMR (125.76 MHz, CD2Cl2): 145.9 (d, 3J(P,C) = 4.6 Hz, CCH3), 145.4 (d, 
3J(P,C) = 3.7 Hz, CCH3), 135.0 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 132.7 (d, 1J(P,C) = 48.6 Hz, 
Ar-C), 130.2 (d, 4J(P,C) = 1.8 Hz, Ar-C), 127.7 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 41.6 (s, 
CH2), 33.2 (s, NCH3), 15.0, (s, CH3), 14.9 (s, CH3), 14.7 (s, CH3), carbene signal could 
not be detected. Anal. Calc. for C26H29I2N2PPdCH2Cl2: C, 38.35; H, 3.69; N, 3.31. 














A mixture of complex 26a (82 mg, 0.10 mmol) and AgO2CCF3 
(44 mg, 0.20 mmol) was suspended in acetonitrile (10 ml) and 
stirred for 3 h at ambient temperature shielded from light. The 
resulting suspension was filtered over celite and the solvent was removed in vacuo. The 
residue was washed with ether (10 ml  3). Slow evaporation at ambient temperature of a 
concentrated CH2Cl2/Hexane solution afforded the product as colorless crystals. Yield: 
52 mg, 0.07 mmol, 70%. 1H NMR (300 MHz, CD2Cl2):  7.74-6.94 (m, 20 H, Ar-H), 
3.82 (m, 2J(H,H) = 15.0 Hz, 3J(H,H) = 7.2 Hz, 1 H, CH2), 3.69 (m, 2J(H,H) = 15.0 Hz, 
3J(H,H) = 7.2 Hz, 1 H, CH2), 2.42 (s, 3 H, CH3), 2.04 (s, 3 H, CH3), 0.95 (m, 3J(H,H) = 
7.2 Hz, 3 H, CH2CH3). 31P NMR (121 MHz, CD2Cl2): 29.8 (s, 1 P, PPh3). 19F NMR 
(282 MHz, CD2Cl2): 0.58, -0.04 (s, CF3). 13C{1H} NMR (75.47 MHz, CD2Cl2): 160.5 (m, 
3J(F,C) = 31.8 Hz, CO), 148.9 (d, 3J(P,C) = 2.7 Hz, CCH3), 148.4 (d, 3J(P,C) = 2.7 Hz, 
CCH3), 134.3 (d, 2/3J(P,C) = 11.5 Hz, Ar-C), 132.0, 131.9 (s, Ar-C), 131.1 (d, 4J(P,C) = 
2.7 Hz, Ar-C), 130.7, 130.3 (s, Ar-C), 129.1 (d, 1J(P,C) = 55.4 Hz, Ar-C), 128.4 (s, Ar-C), 
128.3 (d, 2/3J(P,C) = 11.5 Hz, Ar-C), 127.7 (s, Ar-C), 116.3 (m, 1J(F,C) = 273.9 Hz, CF3), 
115.1 (d, 2J(P,C) = 10.4 Hz, Ccarbene), 42.0 (s, CH2), 14.4, 14.2 (s, CCH3), 13.9 (s, 
CH2CH3). Anal. Calc. for C35H31F6N2O4PPd: C, 52.88; H, 3.93; N, 3.52. Found: C, 52.43; 














-phine)palladium(II) (27b)  
27b was prepared in analogy to 27a from 26b (76 mg, 
0.10 mmol) and AgO2CCF3 (44 mg, 0.20 mmol). Slow 
evaporation at ambient temperature of a concentrated 
CH2Cl2/THF solution afforded the product as colorless crystals. Yield: 50 mg, 0.068 
mmol, 68%. 1H NMR (300 MHz, CD2Cl2):  7.66-7.38 (m, 15 H, Ar-H), 3.99 (m, 3J(H,H) 
= 7.2 Hz, 2 H, CH2), 3.55 (s, 3 H, NCH3), 2.27 (s, 3 H, CH3), 2.22 (s, 3 H, CH3), 1.17 (m, 
3J(H,H) = 7.2 Hz, 3 H, CH2CH3). 31P NMR (121 MHz, CD2Cl2): 29.4 (s, 1 P, PPh3). 19F 
NMR (282 MHz, CD2Cl2): 0.65, -0.04 (s, CF3). 13C{1H} NMR (75.47 MHz, CD2Cl2): 
160.4 (m, 3J(F,C) = 34.4 Hz, CO), 147.7 (d, 3J(P,C) = 3.3 Hz, CCH3), 146.8 (d, 3J(P,C) = 
2.7 Hz, CCH3), 134.3 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 131.0 (d, 4J(P,C) = 2.2 Hz, Ar-C), 
128.9 (d, 1J(P,C) = 54.9 Hz, Ar-C), 128.1 (d, 2/3J(P,C) = 11.0 Hz, Ar-C), 116.3 (m, 1J(F,C) 
= 290.9 Hz, CF3), 113.8 (d, 2J(P,C) = 9.9 Hz, Ccarbene), 41.5 (s, CH2), 33.1 (s, NCH3), 14.2, 
13.9 (s, CCH3), 13.6 (s, CH2CH3). Anal. Calc. for C30H29F6N2O4PPd: C, 49.16; H, 3.99; 
N, 3.82. Found: C, 49.05; H, 4.26; N, 3.86%. MS (ESI): m/z = 619 [M-O2CCF3]+. 
 
2-Ethyl-4-iodo-3,5-dimethyl-1-phenylpyrazolium triflate (28a) 
25a (197 mg, 0.43 mmol) and silver triflate (118 mg, 0.46 mmol) were 
suspended in CH3CN (5 ml) and stirred at ambient temperature for 
30 min shielded from light. The reaction mixture was filtered through 
celite and the solvent of the filtrate was evaporated off. To the residue was added CH2Cl2 














vacuo afforded the product as an off-white powder. Yield: 201 mg, 0.42 mmol, 98%. 1H 
NMR (300 MHz, CDCl3):  7.74-7.62 (m, 5 H, Ar-H), 4.29 (m, 3J(H,H) = 7.3 Hz, 2 H, 
CH2), 2.62 (s, 3 H, CH3), 2.24 (s, 3 H, CH3), 1.20 (t, 3J(H,H) = 7.3 Hz, 3 H, CH2CH3). 
19F{1H} (282 MHz, CDCl3): -2.3 (s, 3 F, CF3). 13C{1H} NMR (75.47 MHz, CDCl3): 
149.6, 149.5 (s, CCH3), 133.2, 131.5, 131.2, 129.0 (s, Ar-C), 120.8 (m, 1J(C,F) = 320.7 
Hz, CF3), 67.8 (s, CI), 44.9 (s, CH2), 14.5, 14.2, 13.9 (s, CH3). Anal. Calc. for 
C14H16F3IN2O3S: C, 35.31; H, 3.39; N, 5.88. Found: C, 35.16; H, 3.13; N, 5.71%. MS 
(ESI): m/z = 327 [M-CF3SO3]+. 
 
1-Ethyl-4-iodo-2,3,5-trimethylpyrazolium triflate (28b) 
28b was prepared in analogy to 28a from 25b (169 mg, 0.43 mmol) 
and silver triflate (118 mg, 0.46 mmol). Yield: 174 mg, 0.42 mmol, 
98%. 1H NMR (300 MHz, CDCl3):  4.54 (m, 3J(H,H) = 7.3 Hz, 2 H, 
CH2), 4.09 (s, 3 H, NCH3), 2.50 (s, 3 H, CH3), 2.49 (s, 3 H, CH3), 1.42 (t, 3J(H,H) = 
7.3 Hz, 3 H, CH2CH3). 19F{1H} (282 MHz, CDCl3): -2.5 (s, 3 F, CF3). 13C{1H} NMR 
(75.47 MHz, CDCl3): 148.7, 147.5 (s, CCH3), 120.7 (m, 1J(C,F) = 320.2 Hz, CF3), 66.8 (s, 
CI), 44.4 (s, CH2), 35.7 (s, NCH3), 14.3 (s, CH3), 13.8 (s, CH3), 13.5 (s, CH3). Anal. Calc. 
for C9H14F3IN2O3S: C, 26.10; H, 3.41; N, 6.76. Found: C, 26.08; H, 2.94; N, 6.62%. MS 












phine)palladium(II) triflate (29a) 
Tris(dibenzylideneacetone)dipalladium(0) (92 mg, 0.10 
mmol) and triphenylphosphine (105 mg, 0.40 mmol) were 
dissolved in dry CH2Cl2 (20 ml) and stirred at ambient 
temperature for 10 min under nitrogen. The resulting dark red solution was transferred to 
a solution of 28a (83 mg, 0.20 mmol) in dry CH2Cl2 (10 ml) via cannula. The reaction 
mixture was heated under reflux for 4 h in an inert nitrogen atmosphere and then cooled 
to ambient temperature. The resulting mixture was filtered through celite, and the filtrate 
was extracted with H2O (4  30 ml). The CH2Cl2 layer was dried over MgSO4 and the 
solvent was reduced under vacuum to 1 ml. Adding diethyl ether to the concentrated 
solution resulted in off-white precipitate, which was collected and washed with diethyl 
ether again (2  30 ml) to give the product as a light yellow powder. Yield: 177 mg, 
0.16 mmol, 80%. 1H NMR (500 MHz, CDCl3):  7.62-7.41 (m, 33 H, Ar-H), 6.76-6.75 
(m, 2 H, Ar-H), 3.62 (m, 3J(H,H) = 7.3 Hz, 2 H, CH2), 2.07 (s, 3 H, CH3), 1.68 (s, 3 H, 
CH3), 0.76 (m, 3J(H,H) = 7.3 Hz, 3 H, CH2CH3). 31P{1H} NMR (202 MHz, CDCl3): 23.0 
(s, 2 P, PPh3). 19F{1H} NMR (282 MHz, CDCl3): -2.2 (s, 3 F, CF3). 13C{1H} NMR 
(125.76 MHz, CDCl3): 146.4 (t, 3J(P,C) = 3.2 Hz, CCH3), 145.1 (t, 3J(P,C) = 3.2 Hz, 
CCH3), 134.8 (t, 2/3J(P,C) = 6.0 Hz, Ar-C), 132.3 (s, Ar-C), 131.7 (t, 1J(P,C) = 24.7 Hz, 
Ar-C), 131.3, 131.2, 130.8 (s, Ar-C), 128.6 (t, 2/3J(P,C) = 5.5 Hz, Ar-C), 128.2 (t, 2J(P,C) 
= 7.3 Hz, Ccarbene), 127.9 (s, Ar-C), 121.0 (m, 1J(F,C) = 320.8 Hz, CF3), 42.8 (s, CH2), 
14.8, 14.7, 14.6 (s, CH3). Anal. Calc. for C50H46F3IN2O3P2PdS: C, 54.24; H, 4.19; N, 2.53. 












palladium(II) triflate (29b) 
29b was prepared in analogy to 29a from 28b (62 mg, 
0.15 mmol), tris(dibenzylideneacetone)dipalladium(0) (69 
mg, 0.075 mmol) and triphenylphosphine (79 mg, 
0.30 mmol). Yield: 115 mg, 0.11 mmol, 73%. 1H NMR (500 MHz, CDCl3):  7.55-7.36 
(m, 30 H, Ar-H), 3.80 (m, 3J(H,H) = 7.3 Hz, 2 H, CH2), 3.40 (s, 3 H, NCH3), 1.77 (s, 3 H, 
CH3), 1.73 (s, 3 H, CH3), 1.03 (t, 3J(H,H) = 7.3 Hz, 3 H, CH2CH3). 31P{1H} NMR 
(202 MHz, CDCl3): 22.8 (s, 2 P, PPh3). 19F{1H} NMR (282 MHz, CDCl3): -2.3 (s, 3 F, 
CF3). 13C{1H} NMR (125.76 MHz, CDCl3): 144.7 (t, 3J(P,C) = 3.2 Hz, CCH3), 143.9 (t, 
3J(P,C) = 3.7 Hz, CCH3), 134.7 (t, 2/3J(P,C) = 6.4 Hz, Ar-C), 131.2 (t, 1J(P,C) = 24.3 Hz, 
Ar-C), 131.1 (s, Ar-C), 128.4 (t, 2/3J(P,C) = 5.1 Hz, Ar-C), 127.8 (t, 2J(P,C) = 7.3 Hz, 
Ccarbene), 121.0 (m, 1J(F,C) = 320.8 Hz, CF3), 42.2 (s, CH2), 34.2 (s, NCH3), 14.9, 14.4, 
14.0 (s, CCH3/CH2CH3). Anal. Calc. for C45H44IN2P2PdO3SF3: C, 50.25; H, 4.17; N, 2.58. 
Found: C, 50.28; H, 4.07; N, 2.56%. MS (ESI): m/z = 895 [M- CF3SO3]+. 
 
1,3,5-Triphenylpyrazole (30b) 
30b was prepared in analogy to 23a from dibenzoylmethane (2.242 g, 
10.0 mmol) and phenylhydrazinium chloride (1446 mg, 10.0 mmol). Yield: 
2.542 g, 8.58 mmol, 86%. The purity of 30b was verified by spectroscopic 


















30c was prepared in analogy to 23a from 
2,2,6,6-tetramethyl-3,5-heptanedione (1.716 mL, 10.0 mmol) and 
phenylhydrazinium chloride (1.446 g, 10.0 mmol). Yield: 1.864 g, 
8.16 mmol, 82%. 1H NMR (300 MHz, CDCl3):  7.47-7.33 (m, 5 H, Ar-H), 6.03 (s, 1 H, 
CH), 3.01 (m, 3J(H,H) = 6.9 Hz, 2 H, CH(CH3)2), 1.30 (d, 3J(H,H) = 6.9 Hz, 6 H, 
CH(CH3)2), 1.17 (d, 3J(H,H) = 6.9 Hz, 6 H, CH(CH3)2). 13C{1H} NMR (75.47 MHz, 
CDCl3): 159.9, 151.5 (s, CN), 140.8, 129.7, 128.4, 126.7 (s, Ar-C), 100.2 (s, CH), 28.6, 
26.2 (s, CH(CH3)2), 23.7, 23.6 (s, CH(CH3)2). Anal. Calc. for C15H20N2: C, 78.90; H, 8.83; 
N, 12.27. Found: C, 78.10; H, 8.39; N, 12.05%. MS (ESI): m/z = 229 [M+H]+. 
 
4-Iodo-1,3,5-triphenylpyrazole (31b) 
31b was prepared in analogy to 24a from 30b (2.345 g, 7.91 mmol). Slow 
evaporation of a diethyl ether solution of the crude product afforded the 
pure product as colorless crystals. Yield: 1.455 g, 3.45 mmol, 43%. 1H 
NMR (300 MHz, CDCl3):  8.02-7.30 (m, 15 H, Ar-H). 13C{1H} NMR (75.47 MHz, 
CDCl3): 153.7, 146.1 (s, CN), 140.6, 133.5, 131.2, 130.9, 129.7, 129.5, 129.3, 129.2, 
129.1, 128.9, 128.2, 125.5 (s, Ar-C), 64.3 (s, CI). Anal. Calc. for C21H15IN2: C, 59.73; H, 
3.58; N, 6.63. Found: C, 59.56; H, 3.63; N, 6.65%. MS (ESI): m/z = 423 [M+H]+. 
 
4-Iodo-3,5-diisopropyl-1-phenylpyrazole (31c) 
31c was prepared in analogy to 24a from 30c (1.864 g, 8.16 mmol). Yield: 
















Ar-H), 3.10 (m, 3J(H,H) = 6.9 Hz, 1 H, CH(CH3)2), 3.04 (m, 3J(H,H) = 6.9 Hz, 1 H, 
CH(CH3)2), 1.32 (d, 3J(H,H) = 6.9 Hz, 6 H, CH(CH3)2), 1.31 (d, 3J(H,H) = 6.9 Hz, 6 H, 
CH(CH3)2). 13C{1H} NMR (75.47 MHz, CDCl3): 159.6, 148.0 (s, CN), 140.9, 129.8, 
129.2, 127.4 (s, Ar-C), 59.2 (s, CI), 28.7, 27.3 (s, CH(CH3)2), 22.5, 21.4 (s, CH(CH3)2). 
Anal. Calc. for C15H19IN2: C, 50.86; H, 5.41; N, 7.91. Found: C, 51.02; H, 5.24; N, 
7.91%. MS (ESI): m/z = 355 [M+H]+. 
 
4-Iodo-2,3,5-trimethyl-1-phenylpyrazolium tetrafluoroborate (32a) 
24a (597 mg, 2.0 mmol) was dissolved in dry CH2Cl2 (10 mL) and 
the resulting solution was transferred to a suspension of 
trimethyloxonium tetrafluoroborate (355 mg, 2.4 mmol) in dry 
CH2Cl2 (10 mL) via cannula. The reaction mixture was stirred at ambient temperature 
overnight under nitrogen. All volatiles were removed under reduced pressure and the 
off-white solid was washed with diethyl ether (3  20 mL). The residue was dried in 
vacuo to give the product as a white powder. Yield: 761 mg, 1.9 mmol, 95%. 1H NMR 
(300 MHz, CDCl3):  7.61-7.75 (m, 5 H, Ar-H), 3.79 (s, 3 H, NCH3), 2.63 (s, 3 H, CH3), 
2.29 (s, 3 H, CH3). 13C{1H} NMR (75.48 MHz, CDCl3): 150.8, 149.4 (s, CCH3), 133.6, 
132.0, 131.7, 129.4 (s, Ar-C), 67.4 (s, CI), 36.8 (s, NCH3), 14.7, 14.4 (s, CCH3). 19F{1H} 
NMR (282 MHz, CDCl3): -77.94, -77.89 (s, 4 F, BF4). Anal. Calc. for C12H14BF4IN2: C, 











4-Iodo-2,3,5-trimethyl-1-phenylpyrazolium iodide (32a’) 
24a (1.475 g, 4.95 mmol) was dissolved in iodomethane (2 ml) and 
heated under reflux for 2 days shielded from light. The reaction mixture 
was cooled to ambient temperature and all volatiles were removed under 
reduced pressure. The residue was washed with diethyl ether and dried in vacuo to give 
the product as an off-white powder. Yield: 1.097 g, 2.49 mmol, 50%). 1H NMR (500 
MHz, d6-DMSO):  7.81-7.70 (m, 5 H, Ar-H), 3.69 (s, 3 H, NCH3), 2.56 (s, 3 H, CH3), 
2.21 (s, 3 H, CH3). 13C{1H} NMR (125.76 MHz, d6-DMSO): 148.8, 148.2 (s, CCH3), 
132.5, 131.4, 130.5, 128.7 (s, Ar-C), 70.2 (s, CI), 36.0 (s, NCH3), 13.7, 13.4 (s, CCH3). 
Anal. Calc. for C12H14I2N2: C, 32.75; H, 3.21; N, 6.37. Found: C, 32.71; H, 3.25; N, 
6.25%. MS (ESI): m/z = 313 [M-I]+. 
 
4-Iodo-2-methyl-1,3,5-triphenylpyrazolium tetrafluoroborate (32b) 
31b (718 mg, 1.7 mmol) was dissolved in dry CH2Cl2 (10 mL) and 
the resulting solution was transferred to a suspension of 
trimethyloxonium tetrafluoroborate (281 mg, 1.9 mmol) in dry 
CH2Cl2 (10 mL) via cannula. The reaction mixture was stirred at ambient temperature for 
a day and then under reflux for another day under an inert nitrogen atmosphere. After 
cooling to ambient temperature, all volatiles were removed in vacuo. The residue was 
washed with diethyl ether (3  20 mL) and dried under vacuum to afford the product as a 
white powder. Yield: 873 mg, 1.66 mmol, 98%. 1H NMR (300 MHz, CDCl3):  7.79-7.24 
(m, 15 H, Ar-H), 3.72 (s, 3 H, NCH3). 13C{1H} NMR (75.48 MHz, CDCl3): 152.6, 151.9 














Ar-C), 68.5 (s, CI), 38.0 (s, NCH3). 19F{1H} NMR (282 MHz, CDCl3): -77.09, -77.14 (s, 
4 F, BF4). Anal. Calc. for C22H18BF4IN2: C, 50.42; H, 3.46; N, 5.35. Found: C, 50.41; H, 
3.53; N, 5.34%. MS (ESI): m/z = 437 [M-BF4]+. 
 
4-Iodo-3,5-diisopropyl-2-methyl-1-phenylpyrazolium tetrafluoroborate (32c) 
32c was prepared from 31c (1.806 g, 5.1 mmol) in analogy to 32b 
except that the residue was washed with ethyl acetate (4  20 mL) 
instead of diethyl ether (3  20 mL). Yield: 1.768 g, 3.88 mmol, 76%. 
1H NMR (300 MHz, CDCl3):  7.71-7.61 (m, 5 H, Ar-H), 3.70 (s, 3 H, NCH3), 3.44 (m, 
3J(H,H) = 7.1 Hz, 1 H, CH(CH3)2), 2.96 (m, 3J(H,H) = 7.1 Hz, 1 H, CH(CH3)2), 1.51 (d, 
3J(H,H) = 7.1 Hz, 6 H, CH(CH3)2), 1.25 (d, 3J(H,H) = 7.1 Hz, 6 H, CH(CH3)2). 13C{1H} 
NMR (75.47 MHz, CDCl3): 155.8, 155.3 (s, CN), 133.7, 132.0, 131.5, 130.1 (s, Ar-C), 
60.7 (s, CI), 36.4 (s, NCH3), 29.2, 29.0 (s, CH(CH3)2), 20.0, 19.7 (s, CH(CH3)2). 19F{1H} 
NMR (282 MHz, CDCl3): -77.32, -77.38 (s, 4 F, BF4). Anal. Calc. for C16H22BF4IN2: C, 




palladium(II) tetrafluoroborate (33a) 
Tris(dibenzylideneacetone)dipalladium(0) (92 mg, 0.1 mmol) 
and triphenylphosphine (105 mg, 0.4 mmol) were dissolved in 
dry CH2Cl2 (20 mL) and stirred at ambient temperature for 
















(80 mg, 0.2 mmol) in dry CH2Cl2 (10 mL) via cannula. The reaction mixture was heated 
under reflux for 6 h in an inert nitrogen atmosphere and then cooled to ambient 
temperature. The resulting mixture was filtered through celite, and the filtrate was 
extracted with H2O (4  30 mL). The CH2Cl2 layer was dried over Na2SO4 and the 
solvent was reduced under vacuum to 1 mL. Adding diethyl ether to the concentrated 
solution resulted in an off-white precipitate, which was collected and washed with diethyl 
ether again (4  30 mL) to give the product as a light yellow powder. Yield: 204 mg, 
0.2 mmol, 99%. 1H NMR (500 MHz, CD2Cl2):  7.63-7.44 (m, 33 H, Ar-H), 6.77-6.76 (m, 
2 H, Ar-H), 3.07 (s, 3 H, NCH3), 2.00 (s, 3 H, CH3), 1.73 (s, 3 H, CH3). 31P{1H} NMR 
(202.45 MHz, CD2Cl2): 22.9 (s, 2 P, PPh3). 19F{1H} NMR (282 MHz, CD2Cl2): -77.44, 
-77.38 (s, 4 F, BF4). 13C{1H} NMR (125.77 MHz, CD2Cl2): 145.6 (t, 3J(P,C) = 3.2 Hz, 
CN), 145.1 (t, 3J(P,C) = 3.2 Hz, CN), 135.0 (t, 2/3J(P,C) = 6.0 Hz, Ar-C), 132.3 (s, Ar-C), 
131.7 (t, 1J(P,C) = 24.7 Hz, Ar-C), 131.5, 131.1, 130.8 (s, Ar-C), 128.6 (t, 2/3J(P,C)= 5.0 
Hz, Ar-C), 128.3 (t, 2J(P,C) = 7.3 Hz, Ccarbene), 127.7 (s, Ar-C), 34.9 (s, NCH3), 14.8, 14.8 
(s, CH3). Anal. Calc. for C48H44BF4IN2P2Pd: C, 55.92; H, 4.30; N, 2.72%. Found: C, 
57.03; H, 4.61; N, 2.97% (Better values could not be obtained although the 1H and 13C 
NMR spectra don’t show any impurities). MS (ESI): m/z = 943 [M-BF4]+.  
  
cis-Iodo(2-methyl-1,3,5-triphenylpyrazolin-4-ylidene)-bis(triphenylphosphine)palla-
dium(II) tetrafluoroborate (cis-33b) 
Tris(dibenzylideneacetone)dipalladium(0) (92 mg, 
0.1 mmol) and triphenylphosphine (105 mg, 0.4 mmol) 













ambient temperature for 10 min under nitrogen. To the resulting dark red solution was 
added a solution of 32b (105 mg, 0.2 mmol) in dry CH2Cl2 (10 mL) via cannula. The 
reaction mixture was heated under reflux for 6 h in an inert nitrogen atmosphere and then 
cooled to ambient temperature. The resulting mixture was filtered through celite, and the 
solvent of the filtrate was removed in vacuo. The residue was washed with diethyl ether 
(4  30 mL) and then recrystallized by slow evaporation of a concentrated 
CH2Cl2/hexane solution. The resultant yellow crystals were collected by filtration and 
washed with small portions of acetone to afford the analytically pure product. Yield: 
95 mg, 0.08 mmol, 40%. 1H NMR (500 MHz, CD2Cl2):  8.24-6.94 (m, 45 H, Ar-H), 
3.50 (s, 3 H, NCH3). 13C{1H} NMR (125.76 MHz, CD2Cl2): 150.5, 148.5 (dd, 3J(P,C) = 
7.3 Hz, 3J(P,C) = 3.7 Hz, CN), 135.5, 134.0, 133.1, 132.3, 132.0, 131.9, 131.8, 131.7, 
131.2, 130.8, 130.5, 130.3, 130.1, 130.0, 129.0, 128.8, 128.6, 128.5, 128.4, 128.3, 128.2, 
128.1, 128.0 (Ar-C, coupling to phosphorus is not considered), 125.0 (dd, 2J(P,C)trans = 
143.9 Hz, 2J(P,C)cis = 5.5 Hz, Ccarbene), 37.5 (s, NCH3). 31P{1H} NMR (202.45 MHz, 
CD2Cl2): 28.7 (d, 2J(P,P) = 24.8 Hz, 1 P, PPh3), 16.3 (d, 2J(P,P) = 24.8 Hz, 1 P, PPh3). 
19F{1H} NMR (282 MHz, CD2Cl2): -77.65, -77.70 (s, 4 F, BF4). Anal. Calc. for 
C58H48BF4IN2P2Pd: C, 60.31; H, 4.19; N, 2.43. Found: C, 60.04; H, 4.22; N, 2.49%. MS 
(ESI): m/z = 1067 [M-BF4]+. 
   
trans-Iodo(2-methyl-1,3,5-triphenylpyrazolin-4-ylidene)-bis(triphenylphosphine)- 
palladium(II) tetrafluoroborate (trans-33b) 
Cis-33b (58 mg, 0.05 mmol) was dissolved in acetonitrile (5 mL) 












temperature, the product was obtained as yellow crystals in a quantitative yield. 1H NMR 
(500 MHz, d6-DMSO):  7.71-6.52 (m, 45 H, Ar-H), 3.50 (s, 3 H, NCH3). 13C{1H} NMR 
(125.76 MHz, d6-DMSO): 149.8 (t, 3J(P,C) = 3.7 Hz, CN), 148.6 (t, 3J(P,C) = 3.7 Hz, 
CN), 135.5, 133.1, 132.3, 132.0, 131.5, 131.4, 131.2, 131.1, 131.0, 130.5, 130.3, 130.0, 
129.9, 128.8, 128.7, 128.6, 128.5, 128.4, 128.3, 128.2, 1281.1, 128.0, 127.8 (Ar-C & 
Ccarbene, coupling to phosphorus is not considered), 36.8 (s, NCH3). 31P{1H} NMR 
(202.45 MHz, d6-DMSO): 20.6 (s, 2 P, PPh3). 19F{1H} NMR (282 MHz, d6-DMSO): 
-72.30, -72.35 (s, 4 F, BF4). Anal. Calc. for C58H48BF4IN2P2Pd: C, 60.31; H, 4.19; N, 2.43. 
Found: C, 60.25; H, 4.35; N, 2.39%. MS (ESI): m/z = 1067 [M-BF4]+. 
 
Di--iodo-bis(3,5-diisopropyl-2-methyl-1-phenylpyrazolin-4-ylidene)-bis(triphenyl- 
phosphine)dipalladium(II) bis(tetrafluoroborate) (33c) 
Tris(dibenzylideneacetone)dipalladium(0) (137 
mg, 0.15 mmol) and triphenylphosphine 
(79 mg, 0.3 mmol) were dissolved in dry 
CH2Cl2 (20 mL) and stirred at ambient 
temperature for 10 min under nitrogen. To the resulting dark red solution was added a 
solution of 3c (137 mg, 0.3 mmol) in dry CH2Cl2 (15 mL) via cannula. The reaction 
mixture was heated under reflux for 6 h in an inert nitrogen atmosphere and then cooled 
to ambient temperature. The resulting mixture was filtered through celite, and the solvent 
of the filtrate was removed in vacuo. The residue was washed with diethyl ether (4  
30 mL) and then recrystallized by slow evaporation of a concentrated methanol solution. 

















The remaining crystals were recrystallized twice by diffusing diethyl ether into a 
concentrated acetonitrile solution to afford the analytically pure product. Yield: 20 mg, 
0.012 mmol, 8%. 1H NMR (500 MHz, CD2Cl2):  7.71-7.01 (m, 40 H, Ar-H), 3.72-3.63 
(m, 2 H, CH(CH3)2), 3.45-3.41 (m, 6 H, NCH3), 3.38-3.26 (m, 2 H, CH(CH3)2), 1.48-1.38 
(m, 6 H, CH(CH3)2), 1.19-1.11 (m, 6 H, CH(CH3)2), 1.05-0.97 (m, 6 H, CH(CH3)2), 
0.53-0.46 (m, 6 H, CH(CH3)2). 31P{1H} NMR (202.45 MHz, CD2Cl2): 27.4, 27.3, 24.0, 
23.9 (s, PPh3). 19F{1H} NMR (282 MHz, CD2Cl2): -77.45, -77.50 (s, 4 F, BF4). 13C{1H} 
NMR (125.77 MHz, CD2Cl2): 155.2-154.8 (m, CN), 135.0, 133.1, 133.0, 132.3, 132.2, 
131.05, 131.01, 130.99, 130.8, 129.7, 129.50, 129.47, 129.27, 129.23, 129.19, 129.15, 
129.09, 129.06 (Ar-C), 118.8 (d, 2J(P,C) = 8.2 Hz, Ccarbene), 35.5, 35.4 (s, NCH3), 30.81, 
30.80, 30.78, 30.49, 30.46, 30.41 (s, CH(CH3)2), 21.7, 21.60, 21.57, 20.68, 20.66, 20.61, 
20.56, 20.55, 20.06, 20.00, 19.94, 19.92 (s, CH(CH3)2). Anal. Calc. for 
C68H74B2F8I2N4P2Pd2: C, 49.51; H, 4.52; N, 3.40%. Found: C, 49.17; H, 4.70; N, 3.33%. 




Method A: tris(dibenzylideneacetone)dipalladium(0) (247 mg, 
0.27 mmol) and pyridine (88 L, 1.09 mmol) were dissolved in 
dry CH2Cl2 (20 mL) and stirred at ambient temperature for 10 min 
under nitrogen. To the resulting dark red solution was added a solution of 32a (216 mg, 
0.54 mmol) in dry CH2Cl2 (10 mL) via cannula. The reaction mixture was heated under 










The resulting mixture was filtered through celite, and the filtrate was extracted with H2O 
(4  30 mL). The CH2Cl2 layer was dried over Na2SO4 and the solvent was removed 
under vacuum. The residue was washed with hexane (4  30 mL) and then recrystallized 
by slow evaporation of a concentrated acetone solution to afford the product as orange 
crystals. Yield: 84 mg, 0.13 mmol, 48%. Method B: The procedure is similar to that of 
method A except that in method B tris(dibenzylideneacetone) dipalladium(0) (183 mg, 
0.2 mmol), pyridine (32 L, 0.4 mmol) and 32a’ (176 mg, 0.4 mmol) were used. Yield: 
189 mg, 0.3 mmol, 75%. 1H NMR (500 MHz, CD2Cl2):  9.06-9.05 (m, 2 H, Ar-H), 
7.73-7.69 (m, 1 H, Ar-H), 7.65-7.61 (m, 3 H, Ar-H), 7.33-7.28 (m, 4 H, Ar-H), 3.47 (s, 
3 H, NCH3), 2.66 (s, 3 H, CH3), 2.37 (s, 3 H, CH3). 13C{1H} NMR (125.76 MHz, 
CD2Cl2): 153.9 (s, Ar-C), 149.3, 148.7 (s, CCH3), 137.3, 133.4, 131.8, 130.7, 128.7, 
124.2 (s, Ar-C), 99.3 (s, Ccarbene), 34.4 (s, NCH3), 16.9, 16.8 (s, CCH3). Anal. Calc. for 
C17H19I2N3Pd: C, 32.64; H, 3.06; N, 6.72. Found: C, 32.20; H, 3.04; N, 6.36%. MS (ESI): 




Tris(dibenzylideneacetone) dipalladium(0) (183 mg, 0.2 mmol) 
and pyridine (65 L, 0.8 mmol) were dissolved in dry CH2Cl2 
(20 mL) and stirred at ambient temperature for 10 min under 
nitrogen. To the resulting dark red solution was added a solution of 32b (210 mg, 0.4 
mmol) in dry CH2Cl2 (10 mL) via cannula. The reaction mixture was heated under reflux 












resulting mixture was filtered through celite, and the solvent of the filtrate was removed 
under vacuum. The residue was washed with hexane (4  30 mL) and then recrystallized 
by slow evaporation of a concentrated CH2Cl2 solution. The resultant orange crystals 
were collected and dissolved in minimal amount of CH2Cl2. Passing the CH2Cl2 solution 
through a short plug of silica gel followed by removal of the solvent in vacuo afforded 
the product as an orange solid. Yield: 95 mg, 0.13 mmol, 66%. 1H NMR (500 MHz, 
CD2Cl2):  8.79-8.77 (m, 2 H, Ar-H), 8.20-8.19 (m, 2 H, Ar-H), 8.03 -8.00 (m, 2 H, Ar-H), 
7.66-7.33 (m, 12 H, Ar-H), 7.20-7.17 (m, 2 H, Ar-H), 3.59 (s, 3 H, NCH3). 13C{1H} NMR 
(125.76 MHz, CD2Cl2): 153.8 (s, Ar-C), 152.4, 151.1 (s, CN), 137.2, 134.5, 131.9, 131.7, 
131.6, 131.2, 130.5, 130.1, 129.4, 129.3, 128.6, 128.0, 124.2 (s, Ar-C), 104.5 (s, Ccarbene), 
36.4 (s, NCH3). Anal. Calc. for C27H23I2N3Pd: C, 43.25; H, 3.09; N, 5.60. Found: C, 




Tris(dibenzylideneacetone)dipalladium(0) (183 mg, 0.2 mmol) 
and pyridine (65 L, 0.8 mmol) were dissolved in dry CH2Cl2 
(20 mL) and stirred at ambient temperature for 10 min under 
nitrogen. To the resulting dark red solution was added a solution of 32c (182 mg, 
0.4 mmol) in dry CH2Cl2 (10 mL) via cannula. The reaction mixture was heated under 
reflux for 6 h in an inert nitrogen atmosphere and then cooled to ambient temperature. 
The resulting mixture was filtered through celite, and the solvent of the filtrate was 










subjected to column chromatography (SiO2, diethyl ether). The 3rd band (Rf = 0.5) was 
collected and dried in vacuo to give an orange solid, which was recrystallized by 
diffusing pentane into a concentrated CH2Cl2 solution to afford the product as orange 
crystals. Yield: 6 mg, 0.01 mmol, 4%. 1H NMR (500 MHz, CD2Cl2):  9.07-9.06 (m, 2 H, 
Ar-H), 7.72-7.60 (m, 4 H, Ar-H), 7.38-7.37 (m, 2 H, Ar-H), 7.31-7.28 (m, 2 H, Ar-H), 
3.91 (m, 3J(H,H) = 6.9 Hz, 1 H, CH(CH3)2), 3.44 (s, 3 H, NCH3), 3.44 (m, 3J(H,H) = 
6.9 Hz, 1 H, CH(CH3)2), 1.70 (d, 3J(H,H) = 6.9 Hz, 6 H, CH(CH3)2), 1.45 (d, 3J(H,H) = 
6.9 Hz, 6 H, CH(CH3)2). 13C{1H} NMR (125.76 MHz, CD2Cl2): 155.5, 155.3 (s, CN), 
154.1 (s, Ar-C), 137.2, 133.8, 132.1, 130.5, 129.8, 124.3 (s, Ar-C), 95.0 (s, Ccarbene), 34.5 
(s, NCH3), 30.2, 29.8 (s, CH(CH3)2), 22.2, 21.0 (s, CH(CH3)2). Elemental analysis could 




Tris(dibenzylideneacetone)dipalladium(0) (92 mg, 
0.1 mmol) and 25a (91 mg, 0.2 mmol) were dissolved in 
dry CH2Cl2 (30 ml) and heated under reflux for 4 h in an 
inert nitrogen atmosphere. After cooling to ambient 
temperature, the resulting mixture was filtered through 
celite, and the filtrate was extracted with H2O (4  30 ml). The CH2Cl2 layer was dried 
over MgSO4 and the solvent was removed under reduced pressure. The residue was 
washed with pentane (3  30 ml) and dried in vacuo to give the crude product as a 













the pure product as reddish brown solid. Yield: 97 mg, 0.086 mmol, 86%. 1H NMR 
(500 MHz, CDCl3):  7.64-6.62 (m, 6 H, Ar-H), 7.31-7.30 (d, 4 H, Ar-H), 3.91 (m, 
3J(H,H) = 7.2 Hz, 4 H, CH2), 2.71 (s, 6 H, CH3), 2.37 (s, 6 H, CH3), 1.11 (t, 3J(H,H) = 7.2 
Hz, 6 H, CH2CH3). 13C{1H} NMR (125.76 MHz, CDCl3): 150.1, 149.6 (s, CCH3), 133.7, 
132.4, 131.2, 129.1 (s, Ar-C), 112.7 (s, Ccarbene), 43.1 (s, CH2), 17.2, 17.0, 15.5(s, CH3). 
Anal. Calc. for C26H32I4N4Pd2: C, 27.86; H, 2.88; N, 5.00. Found: C, 27.32; H, 2.80; N, 




35b was prepared in analogy to 35a from 
tris(dibenzylideneacetone)dipalladium(0) (92 mg, 0.1 mmol) 
and 25b (78 mg, 0.2 mmol). Yield: 75 mg, 0.075 mmol, 75%. 
1H NMR (500 MHz, CD2Cl2): 4.11 (m, 3J(H,H) = 7.2 Hz, 
4 H, CH2), 3.70 (s, 6 H, NCH3), 2.59 (s, 6 H, CH3), 2.58 (s, 6 H, CH3), 1.30 (t, 3J(H,H) = 
7.2 Hz, 6 H, CH2CH3). 13C{1H} NMR (125.76 MHz, CD2Cl2): 147.7, 146.9 (s, CCH3),  
42.2 (s, CH2), 33.6 (s, NCH3), 16.3, 16.0, 14.7(s, CH3). Anal. Calc. for C16H28I4N4Pd2: C, 




















Bis(4-iodo-3,5-dimethyl-pyrazol-1-yl)methane (2.685 g, 
5.9 mmol) was dissolved in dry CH2Cl2 (20 mL) and the 
resulting solution was transferred to a suspension of 
trimethyloxonium tetrafluoroborate (1.917 g, 12.9 mmol) in dry CH2Cl2 (20 mL). The 
reaction mixture was stirred at ambient temperature for a day and then heated under 
reflux for another day under nitrogen. After cooling to ambient temperature, the resulting 
mixture was filtered and the residue was washed with CH2Cl2 (3  20 mL) and THF (3  
20mL). Crystallization from acetonitrile afforded the product as colorless crystals. Yield:  
3.362 mg, 5.09 mmol, 86%. 1H NMR (300 MHz, CD3CN):  6.72 (s, 2 H, CH2), 3.84 (s, 
6 H, NCH3), 2.52 (s, 6 H, CH3), 2.50 (s, 6 H, CH3). 13C{1H} NMR (75.48 MHz, CD3CN): 
155.0, 152.3 (s, CCH3), 71.2 (s, CI), 59.7 (s, CH2), 37.5 (s, NCH3), 15.1, 14.9 (s, CCH3). 
19F{1H} NMR (282 MHz, CD3CN): -75.53, -75.59 (s, BF4). Anal. Calc. for 
C13H20B2F8I2N4: C, 23.65; H, 3.05; N, 8.49. Found: C, 23.39; H, 2.66; N, 8.27%. MS 




37b was prepared in analogy to 37a from 
1,2-bis(4-iodo-3,5-dimethylpyrazol-1-yl)ethane (1.307 g, 
2.78 mmol) and trimethyloxonium tetrafluoroborate 













4.79 (s, 4 H, CH2), 3.98 (s, 6 H, NCH3), 2.53 (s, 6 H, CH3), 2.34 (s, 6 H, CH3). 13C{1H} 
NMR (125.76 MHz, CD3CN): 152.2, 150.4 (s, CCH3), 68.8 (s, CI), 46.3 (s, NCH2), 36.7 
(s, NCH3), 14.5, 14.1 (s, CCH3). 19F{1H} NMR (282 MHz, CD3CN): -75.50, -75.55 (s, 
BF4-). Anal. Calc. for C14H22B2F8I2N4: C, 24.96; H, 3.29; N, 8.32. Found: C, 24.54; H, 
3.45; N, 8.00%. MS (ESI): m/z = 250 [M-2BF4]2+.  
 
4,4’-Diiodo-2,2’,3,3’,5,5’-hexamethyl-1,1’-(1,3-propylene)dipyrazolium bis(tetra- 
fluoroborate) (37c)  
37c was prepared in analogy to 37a 
from 1,3-bis(4-iodo-3,5-dimethylpyrazol-1-yl)propane 
(209 mg, 0.43 mmol) and trimethyloxonium 
tetrafluoroborate (141 mg, 0.95 mmol). Yield: 183 mg, 0.27 mmol, 62%. 1H NMR 
(300 MHz, CD3CN):  4.51 (t, 3J(H,H) = 8.2 Hz, 4 H, NCH2), 3.94 (s, 6 H, NCH3), 2.49 
(s, 6 H, CH3), 2.44 (s, 6 H, CH3), 2.12 (m, 3J(H,H) = 8.2 Hz, 2 H, CH2). 13C{1H} NMR 
(75.48 MHz, CD3CN): 150.4, 149.3 (s, CCH3), 67.7 (s, CI), 45.3 (s, NCH2), 36.2 (s, 
NCH3), 28.2 (s, CH2), 14.1, 14.0 (s, CCH3). 19F{1H} NMR (282 MHz, CD3CN): -75.3, 
-75.4 (s, BF4-). Anal. Calc. for C15H24B2F8I2N4: C, 26.19; H, 3.52; N, 8.15. Found: C, 














-tetrakis(triphenylphosphine)tetrapalladium(II) tetrakis(tetrafluoroborate) (38) 
Tris(dibenzylideneacetone)dipalladium(0) (183 
mg, 0.20 mmol) and triphenylphosphine (210 mg, 
0.80 mmol) were dissolved in dry CH2Cl2 (15 ml) 
and stirred at ambient temperature for 10 min 
under nitrogen. The resulting dark red solution 
was transferred to a suspension of 37a (132 mg, 0.20 mmol) in dry CH2Cl2 (30 ml) via 
cannula. The reaction mixture was heated under reflux for 18 h in an inert nitrogen 
atmosphere. After cooling to ambient temperature, the reddish brown suspension was 
filtered and the solvent of the filtrate was reduced in vacuo to 1 ml. Adding diethyl ether 
to the concentrated solution resulted in a reddish brown precipitate, which was collected 
and washed with diethyl ether again (4  30 ml). Recrystallization of the residue by slow 
evaporation of a concentrated CH2Cl2/hexane solution twice yielded yellowish crystals. 
The crystals were collected by filtration and washed with small portions of CH2Cl2. 
Dissolving the remaining crystals in acetonitrile and filtering off the palladium black 
followed by removal of the solvent in vacuo afforded the product as a yellow solid. Yield: 
38.0 mg, 0.014 mmol, 14% (assuming all bridging halides are iodides). 1H NMR (500 
MHz, CD3CN):  7.61-7.46 (m, 30 H, Ar-H), 6.12, (d, 2J(H,H) = 24 Hz, 2 H, CH2), 3.33 
(s, 3 H, NCH3), 3.24 (s, 3 H, NCH3), 2.08, 1.88 (s, 12 H, CH3). 13C{1H} NMR (125.77 
MHz, CD3 CN): 152.5, 148.7, 148.3 (s, CCH3), 135.1 (s, Ar-C), 132.8 (s, Ar-C), 120.0 (d, 
2J(P,C) = 11.0 Hz, Ar-C), 129.2 (d, 1J(P,C) = 49.5 Hz, Ar-C) 55.3 (s, CH2), 35.8 (s, 





















PPh3). 19F{1H} NMR (282.40 MHz, CD3CN): -75.1, -75.2 (s, BF4). Anal. Calc. for 
C98H100B4F16I4N8P4Pd4: C, 42.12; H, 3.61; N, 4.01. Found: C, 42.24; H, 4.16; N, 4.09% 
(the results do not match very well with the calculated values propably due to the 
iodo-chloro scrambling). MS (ESI): m/z = 1264.4 [F1+2BF4]2+, 1218.4 [F2+2BF4]2+, 
814.2 [F1+BF4]3+, 783.6 [F2+BF4]3+ (see Figure 4.10). 
 
trans-Diiodo-(2,2’,3,3’,5,5’-Hexamethyl-1,1’-(1,3-propylene)dipyrazolin-4,4’-diyli- 
dene)-tetrakis(triphenylphosphine)dipalladium(II) bis(tetrafluoroborate) (39) 
Tris(dibenzylideneacetone)dipalladium(0) 
(183 mg, 0.20 mmol) and 
triphenylphosphine (210 mg, 0.80 mmol) 
were dissolved in dry CH2Cl2 (15 ml) and stirred at ambient temperature for 10 min 
under nitrogen. The resulting dark red solution was transferred to a suspension of 37c 
(138 mg, 0.20 mmol) in dry CH2Cl2 (30 ml) via cannula. The reaction mixture was heated 
under reflux overnight in an inert nitrogen atmosphere. After cooling to ambient 
temperature, the reddish brown suspension was filtered and the solvent of the filtrate was 
reduced in vacuo to 1 ml. Adding diethyl ether to the concentrated solution resulted in a 
reddish brown precipitate, which was collected and washed with diethyl ether (4  30 ml) 
followed by with Me2CO (3  5 mL) to give a grayish white residue. Slow evaporation of 
a concentrated CH2Cl2/hexane solution of the crude product afforded the pure product as 
colorless crystals. Yield: 140 mg, 0.072 mmol, 36%. 1H NMR (500 MHz, CD2Cl2):  
7.53-7.36 (m, 60 H, Ar-H), 3.76 (t, 3J(H,H) = 8.2 Hz, 4 H, NCH2), 3.32 (s, 6 H, NCH3), 













NMR (125.77 MHz, CD2Cl2): 145.9 (t, 3J(P,C) = 3.7 Hz, CCH3), 145.8 (t, 3J(P,C) = 
3.7 Hz, CCH3), 135.0 (t, 2/3J(P,C) = 6.0 Hz, Ar-C), 131.4 (t, 1J(P,C) = 24.7 Hz, Ar-C), 
131.3 (s, Ar-C), 128.7 (t, 2J(P,C) = 7.3 Hz, Ccarbene), 128.5 (t, 2/3J(P,C) = 5.0 Hz, Ar-C), 
43.1 (s, NCH2), 34.3 (s, NCH3), 28.3 (s, CH2), 14.5, 14.4 (s, CH3). 31P{1H} NMR 
(202.46 MHz, CD2Cl2): 22.7 (s, 4 P, PPh3). 19F{1H} NMR (282 MHz, CD2Cl2): -75.1, 
-75.2 (s, BF4). Anal. Calc. for C87H84B2F8I2N4P4Pd2: C, 53.59; H, 4.34; N, 2.87%. Found: 
C, 53.51; H, 4.65; N, 3.02%. MS (ESI): m/z = 888 [M-2BF4]2+.  
 
General procedure for the Suzuki-Miyaura cross-coupling reaction 
In a typical run, a Schlenk-tube was charged with a mixture of aryl halide (1.0 mmol), 
phenylboronic acid (1.2 mmol), potassium carbonate (1.5 mmol), catalyst (1 mmol% [Pd] 
loading) and [N(n-Bu)4]Br (1.5 mmol) if necessary. If required, the reaction vessel was 
degassed under vacuum and filled with nitrogen. Appropriate solvent (3 mL) (degassed 
solvent was used in cases of air-free reactions) was then added to the mixture using a 
syringe. The reaction mixture was vigorously stirred at the appropriate temperature. After 
the desired reaction time, the solution was allowed to cool. 10 ml of dichloromethane was 
added to the reaction mixture and the organic phase was extracted with water (6×5 mL) 
and dried over MgSO4. The solvent was removed by evaporation to give a crude product, 
which was analyzed by 1H NMR spectroscopy. 
 
General procedure for the Mizoroki-Heck coupling reaction 
In a typical run, a reaction vessel was charged with a mixture of aryl halide (1.0 mmol), 
tert-butyl acrylate (1.5 mmol), anhydrous sodium acetate (1.5 mmol), catalyst 
(0.01 mmol) and [N(n-Bu)4]Br (1.5 mmol) if necessary. To the mixture was then added 
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DMF (3 mL). The reaction mixture was vigorously stirred at the appropriate temperature. 
After the desired reaction time, the solution was allowed to cool. 10 ml of 
dichloromethane was added to the reaction mixture and the organic phase was extracted 
with water (6 × 5 ml) and dried over MgSO4. The solvent was removed by evaporation to 
give a crude product, which was analyzed by 1H NMR spectroscopy. 
 
X-ray Diffraction Studies  
X-ray data were collected with a Bruker AXS SMART APEX diffractometer, using Mo 
K radiation with the SMART suite of Programs.88 Data were processed and corrected 
for Lorentz and polarization effects with SAINT,89 and for absorption effect with 
SADABS.90 Structural solution and refinement were carried out with the SHELXTL 
suite of programs.91 The structure was solved by direct methods to locate the heavy 
atoms, followed by difference maps for the light, non-hydrogen atoms. All hydrogen 
atoms were put at calculated positions. All non-hydrogen atoms were generally given 
anisotropic displacement parameters in the final model. A summary of the most important 









Figure A.1. Molecular structures of complexes 5c (top) and 5d·4CH2Cl2 (bottom) 
showing 50% probability ellipsoids; hydrogen atoms and solvent molecules are omitted 
for clarity. Selected bond lengths [Å] and angles [°]: 5c: Pd1-C1 1.956(3), Pd1-Br1 
2.4250(4), Pd1-Br2 2.4254(4), Pd1-N3 2.094(2), C1-N1 1.344(3), C1-N2 1.349(3), 
C19-C19A 1.520(6); C1-Pd1-Br1 91.59(8), C1-Pd1-Br2 85.85(8), N3-Pd1-Br1 92.05(7), 
N3-Pd1-Br2 90.36(7), N1-C1-N2 107.5(2). 5d·4CH2Cl2: Pd1-C1 1.943(10), Pd1-Br1 
2.4167(14), Pd1-Br2 2.4234(14), Pd1-N3 2.112(8), C1-N1 1.363(11), C1-N2 1.354(12), 
C19-C19A 1.357(18); C1-Pd1-Br1 88.7(3), C1-Pd1-Br2 86.7(3), N3-Pd1-Br1 92.7(2), 
















Figure A.2. Molecular structures of complexes 11f·0.8CH2Cl2·0.2CHCl3 (a), 11g·CH2Cl2 
(b), 11h·1/8THF (c) and 11i·0.88Me2CO (d) showing 50% probability ellipsoids; two 
molecules were found in the unit cell of 11h·1/8THF and 11i·0.88Me2CO but only one of 
them is shown here for each complex; hydrogen atoms and solvent molecules are omitted 
for clarity. Selected bond lengths [Å] and angles [°]: 11f·0.8CH2Cl2·0.2CHCl3: Pd1-C1 
2.001(3), Pd1-C14 2.052(3), Pd1-Br1 2.4568(4), Pd1-Br2 2.4273(3), N1-C1 1.357(3), 
N2-C1 1.351(3), N3-C14 1.357(3), N4-C14 1.352(3); C1-Pd1-Br1 87.70(7), C1-Pd1-Br2 
84.95(7), C14-Pd1-Br1 95.96(7), C14-Pd1-Br2 91.49(7), N1-C1-N2 107.0(2), 
N3-C14-N4 104.0(2). 11g·CH2Cl2: Pd1-C1 2.008(2), Pd1-C14 2.052(2), Pd1-Br1 
2.4538(3), Pd1-Br2 2.4238(3), N1-C1 1.349(3), N2-C1 1.347(3), N3-C14 1.333(3), 
N4-C14 1.333(3); C1-Pd1-Br1 87.13(7), C1-Pd1-Br2 84.97(6), C14-Pd1-Br1 96.65(6), 
C14-Pd1-Br2 91.38(6), N1-C1-N2 107.3(2), N3-C14-N4 108.5(2). 11h·1/8THF: Pd1-C1 
1.998(7), Pd1-C14 2.027(6), Pd1-Br1 2.4286(9), Pd1-Br2 2.4291(9), N1-C1 1.355(8), 
N2-C1 1.341(8), N3-C14 1.357(8), N4-C14 1.368(8); C1-Pd1-Br1 86.72(18), 
C1-Pd1-Br2 86.19(18), C14-Pd1-Br1 90.54(17), C14-Pd1-Br2 96.54(17), N1-C1-N2 
107.5(6), N3-C14-N4 104.4(5). 11i·0.88Me2CO: Pd1-C1 1.997(3), Pd1-C14 2.035(3), 
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Pd1-Br1 2.4353(4), Pd1-Br2 2.4359(4), N1-C1 1.348(4), N2-C1 1.347(4), N3-C14 
1.341(4), N4-C14 1.346(4); C1-Pd1-Br1 84.81(9), C1-Pd1-Br2 87.33(9), C14-Pd1-Br1 





Figure A.3. Molecular structures of complexes 34a (left) and 34b (right) showing 50% 
probability ellipsoids; hydrogen atoms are omitted for clarity. Selected bond lengths [Å] 
and angles [°]: 34a: Pd(1)-C(1) 1.981(7), Pd(1)-N(3) 2.121(6), Pd(1)-I(1) 2.6015(8), 
Pd(1)-I(2) 2.6033(8), C(1)-C(2) 1.395(10), C(1)-C(3) 1.393(11), N(1)-C(2) 1.362(10), 
N(2)-C(3) 1.380(9), N(1)-N(2) 1.361(9); C(1)-Pd(1)-I(2) 87.9(2), N(3)-Pd(1)-I(2) 
91.09(16), C(1)-Pd(1)-I(1) 89.8(2), N(3)-Pd(1)-I(1) 91.54(16), C(3)-C(1)-C(2) 106.3(6). 
34b: Pd(1)-C(1) 1.987(4), Pd(1)-N(3) 2.119(4), Pd(1)-I(1) 2.6168(5), Pd(1)-I(2) 
2.6033(5), C(1)-C(2) 1.403(6), C(1)-C(3) 1.396(6), N(1)-C(2) 1.354(6), N(2)-C(3) 
1.379(6), N(1)-N(2) 1.367(6); C(1)-Pd(1)-I(2) 91.04(13), N(3)-Pd(1)-I(2) 91.89(11), 
C(1)-Pd(1)-I(1) 87.24(13), N(3)-Pd(1)-I(1) 90.02(11), C(3)-C(1)-C(2) 105.2(4).
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Selected crystallographic data 
 
 AH2O 1C6H5CH3 2 34CHCl3 
Formula C13H21BrN2O C33H44Br4N4Pd2 C15H21Br2N3Pd C30H41Br3N4Cl3Pd 
Formula weight 301.23 1029.16 509.57 1229.20 
Crystal size [mm] 0.600.600.30 0.280.200.10 0.400.400.38 0.360.200.18 
Temperature [K] 223(2) 223(2) 223(2) 223(2) 
Crystal system Triclinic Triclinic Triclinic Monoclinic 
Space group P1 P1 P1 P21/c 
a [Å] 8.9656(5) 8.6931(6) 8.6495(4) 15.7290(7) 
b [Å] 9.1636(5) 9.2111(6) 9.7830(4) 8.9604(4) 
c [Å] 9.7359(5) 12.6637(8) 12.3440(5) 33.5536(16) 
α [°] 77.3460(10) 102.5090(10) 103.1770(10) 90 
β [°] 66.4200(10) 96.3810(10) 99.5350(10) 93.0060(10) 
γ [°] 83.5500(10) 110.5480(10) 109.9120(10) 90 
V [Å3] 715.01(7) 907.33(10) 921.84(7) 4722.5(4) 
Z 2 1 2 4 
Dc [gcm-3] 1.399 1.884 1.836 1.729 
μ [mm-1] 2.863 5.423 5.338 3.637 
θ range [°] 2.28-27.50 1.68-27.50 2.33-27.49 1.22-27.50 
Reflection collected    9106 11885 12169 32676 
Independent reflections 3287  
(Rint = 0.0191) 
4150 
(Rint = 0.0298) 
4220  
(Rint = 0.0242) 
10858  
(Rint = 0.0652) 
Max., min. transmission 0.4805, 0.2785 0.6131, 0.3120 0.2362, 0.2240 0.5605, 0.3543 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0258, 
wR2 = 0.0668 
R1 = 0.0312, 
wR2 = 0.0682 
R1 = 0.0215, 
wR2 = 0.0556 
R1 = 0.0591, 
wR2 = 0.1297 
R indices (all data) R1 = 0.0285, 
wR2 = 0.0682 
R1 = 0.0446, 
wR2 = 0.0733 
R1 = 0.0243, 
wR2 = 0.0566 
R1 = 0.1116, 
wR2 = 0.1483 
Goodness-of-fit on F2 1.060 1.010 1.059 0.996 





 cis-4 5a 5b·2THF 5c 
Formula C31H33Br2N2PPd C18H23Br2N3Pd C44H60Br4N6O2Pd2 C38H48Br4N6Pd2 
Formula weight 730.78 547.61 1237.42 1121.26 
Crystal size [mm] 0.460.300.20 0.400.360.08 0.560.540.14  0.360.300.10 
Temperature [K] 223(2) 223(2) 223(2)  223(2) 
Crystal system Monoclinic Orthorhombic Monoclinic Monoclinic 
Space group P21/n Iba2 C2/c P21/c 
a [Å] 10.5155(5) 16.990(4) 14.9471(7) 14.9211(8) 
b [Å] 17.5035(7) 24.792(6) 10.1197(4) 9.9826(6) 
c [Å] 16.4655(7) 9.693(2) 64.853(3) 16.1261(9) 
α [°] 90 90 90 90 
β [°] 94.7220(10) 90 90.1380(10) 116.7250(10) 
γ [°] 90 90 90 90 
V [Å3] 3020.3(2) 4083.0(16) 9809.6(7) 2145.4(2) 
Z 4 8 8 2 
Dc [gcm-3] 1.607 1.782 1.676 1.736 
μ [mm-1] 3.336 4.828 4.032 4.596 
θ range [°] 1.70-27.50 1.45-27.49 1.88-27.50 1.53-27.48 
Reflection collected    23338 25995 32683 14640 
Independent reflections 4831  
(Rint = 0.0414) 
4694  
(Rint = 0.0329) 
11233  
(Rint = 0.0396) 
4901  
(Rint = 0.0353) 
Max., min. transmission 0.5551, 0.3091 0.6987, 0.2483 0.6021, 0.2111 0.6564, 0.2884 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0283, 
wR2 = 0.0552 
R1 = 0.0298,   
wR2 = 0.0730 
R1 = 0.0788,    
wR2 = 0.1699 
R1 = 0.0312,  
wR2 = 0.0688 
R indices (all data) R1 = 0.0407, 
wR2 = 0.0565 
R1 = 0.0346,   
wR2 = 0.0756 
R1 = 0.0960,   
wR2 = 0.1762 
R1 = 0.0432,  
wR2 = 0.0731 
Goodness-of-fit on F2 0.845 1.033 1.184 1.018 





 5d·4CH2Cl2 cis-6a trans-6a cis-6b 
Formula C42H54Br4Cl8N6Pd2 C20H29Br2N3Pd C20H29Br2N3Pd C18H27Br2N3Pd 
Formula weight 1458.95 577.68 577.68 551.65 
Crystal size [mm] 0.560.090.08 0.300.260.12 0.560.400.16 0.400.300.14 
Temperature [K] 223(2) 223(2) 223(2) 293(2) 
Crystal system Monoclinic Orthorhombic Monoclinic Orthorhombic 
Space group P21/n P212121 P21/c P212121 
a [Å] 13.348(6) 10.1903(7) 15.2666(17) 10.1986(5) 
b [Å] 9.175(4) 13.3919(9) 10.6396(12) 13.0958(6) 
c [Å] 22.350(10) 17.0572(11) 14.0629(16) 16.2190(7) 
α [°] 90 90 90 90 
β [°] 102.540(10) 90 96.277(3) 90 
γ [°] 90 90 90 90 
V [Å3] 2672(2) 2327.8(3) 2270.5(4) 2166.19(17) 
Z 2 4 4 4 
Dc [gcm-3] 1.813 1.648 1.690 1.692 
μ [mm-1] 4.100 4.239 4.346 4.550 
θ range [°] 1.64-25.00 1.93-27.50 2.34-27.50 2.00-27.49 
Reflection collected    15058 30682 15491 15395 
Independent reflections 4696  
(Rint = 0.0811) 
5350 
(Rint = 0.0455) 
5208 
(Rint = 0.0750) 
4938 
(Rint = 0.0270) 
Max., min. transmission 0.7350, 0.2073 0.6302, 0.3628 0.5431, 0.1946 0.5683, 0.2633 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0643,    
wR2 = 0.1593 
R1 = 0.0313, 
wR2 = 0.0725 
R1 = 0.0794, 
wR2 = 0.1891 
R1 = 0.0227, 
wR2 = 0.0487 
R indices (all data) R1 = 0.1155,    
wR2 = 0.1805 
R1 = 0.0365, 
wR2 = 0.0745 
R1 = 0.1143, 
wR2 = 0.2014 
R1 = 0.0256, 
wR2 = 0.0493 
Goodness-of-fit on F2 1.022 1.052 1.136 0.989 





 trans-6c 7 8 92CHCl3 
Formula C22H27Br2N3Pd C30H38Br2N4Pd C25H29N3 C28H42Br4Cl6N6Pd2 
Formula weight 599.69 720.86 371.51 1207.82 
Crystal size [mm] 0.400.300.14 0.300.060.04 0.260.140.10 0.460.080.06 
Temperature [K] 223(2) 243(2) 243(2) 223(2) 
Crystal system Triclinic Orthorhombic Monoclinic Orthorhombic 
Space group P1 Pbcn C2/c Pccn 
a [Å] 8.8532(4) 27.983(3) 23.2291(15) 18.1241(9) 
b [Å] 10.2693(4) 16.8551(17) 13.0532(9) 26.0307(12) 
c [Å] 14.0845(6) 13.0760(13) 17.1124(12) 9.1762(4) 
α [°] 79.1370(10) 90 90 90 
β [°] 77.3210(10) 90 122.6700(10) 90 
γ [°] 70.0450(10) 90 90 90 
V [Å3] 1165.24(9) 6167.3(11) 4367.8(5) 4329.2(3) 
Z 2 8 8 4 
Dc [gcm-3] 1.709 1.553 1.130 1.853 
μ [mm-1] 4.238 3.218 0.067 4.920 
θ range [°] 1.49-27.50 1.41-27.50 1.88-25.00 1.56-25.00 
Reflection collected    15312 41611 12607 23435 
Independent reflections 5358 
(Rint = 0.0198) 
7085 
(Rint = 0.0868) 
3844 
(Rint = 0.0464) 
3814 
(Rint = 0.0471) 
Max., min. transmission 0.5884, 0.2820 0.8821, 0.4452 0.9934, 0.9829 0.7567, 0.2105 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0257, 
wR2 = 0.0659 
R1 = 0.0581, 
wR2 = 0.1251 
R1 = 0.0652, 
wR2 = 0.1282 
R1 = 0.0679, 
wR2 = 0.1614 
R indices (all data) R1 = 0.0320, 
wR2 = 0.0681 
R1 = 0.1063, 
wR2 = 0.1414 
R1 = 0.1228, 
wR2 = 0.1486 
R1 = 0.0792, 
wR2 = 0.1682 
Goodness-of-fit on F2 1.069 1.029 1.032 1.066 





 cis-10CH2Cl2 11e  11f·0.8CH2Cl2·0.2CHCl3 11g·CH2Cl2 
Formula C27H29Cl2F6N3O4Pd C32H38Br2N4Pd C35H44Br2Cl2.2N4Pd C35H46Br2Cl2N4Pd 
Formula weight 750.83 744.88 866.72 859.88 
Crystal size [mm] 0.600.400.34 0.340.120.10 0.500.360.20 0.460.300.20 
Temperature [K] 295(2) 223(2) 100(2) 150(2) 
Crystal system Triclinic Triclinic Orthorhombic Orthorhombic 
Space group P1 P1 Pbca Pbca 
a [Å] 8.5994(10) 8.6783(6) 16.6724(9) 16.8072(8) 
b [Å] 10.3393(12) 9.6517(7) 16.7849(9) 16.9378(8) 
c [Å] 19.243(2) 19.2247(13) 26.3598(3) 26.0670(12) 
α [°] 88.083(2) 100.588(2) 90 90 
β [°] 85.830(2) 98.313(2) 90 90 
γ [°] 73.500(2) 99.149(2) 90 90 
V [Å3] 1635.9(3) 1537.5(2) 7376.6(7) 7420.7(6) 
Z 2 2 8 8 
Dc [gcm-3] 1.524 1.609 1.561 1.539 
μ [mm-1] 0.800 3.230 2.862 2.827 
θ range [°] 2.05-27.50 1.10-27.50 1.55-27.50 1.56-27.50 
Reflection collected    21260 20375 49872 50565 
Independent reflections 7488 
(Rint = 0.0246) 
7060  
(Rint = 0.0572) 
8472  
(Rint = 0.0427) 
8509  
(Rint = 0.0369) 
Max., min. transmission 0.7727, 0.6454 0.7383, 0.4064 0.5983, 0.3287 0.6017, 0.3563 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0389, 
wR2 = 0.1015 
R1 = 0.0500, 
wR2 = 0.1152 
R1 = 0.0330,  
wR2 = 0.0840 
R1 = 0.0308,  
wR2 = 0.0753 
R indices (all data) R1 = 0.0437, 
wR2 = 0.1049 
R1 = 0.0715, 
wR2 = 0.1257 
R1 = 0.0454,  
wR2 = 0.0894 
R1 = 0.0425,  
wR2 = 0.0796 
Goodness-of-fit on F2 1.051 0.984 1.063 1.055 





 11h·1/8THF 11i·0.88Me2CO trans-12 trans-13 
Formula C40.50H55Br2O0.13N4Pd C42.63H61.25Br2N4O0.88Pd C26H36Br2N4Pd C26H36I2N4Pd 
Formula weight 866.10 909.93 670.81 764.79 
Crystal size [mm] 0.460.360.20 0.470.260.20 0.500.400.34  0.340.300.16 
Temperature [K] 223(2) 100(2) 295(2)  223(2) 
Crystal system Tetragonal Tetragonal Orthorhombic Orthorhombic 
Space group P4/n P4/n Pbca Pbca 
a [Å] 33.6029(15) 33.4261(12) 17.2150(9)  17.774(2) 
b [Å] 33.6029(15) 33.4261(12) 9.4878(5) 9.402(1) 
c [Å] 16.6252(15) 16.5750(11) 17.8106(9) 18.014(2) 
α [°] 90 90 90 90 
β [°] 90 90 90 90 
γ [°] 90 90 90 90 
V [Å3] 18772(2) 18519.3(15) 2909.0(3) 3010.3(6) 
Z 16 16 4 4 
Dc [gcm-3] 1.226 1.305 1.532 1.687 
μ [mm-1] 2.126 2.159 3.405 2.687 
θ range [°] 1.37-27.50 1.22-27.50 2.29-27.50 2.26-27.50 
Reflection collected    130607 130217 33420 19972 
Independent reflections 21589  
(Rint = 0.1331) 
21291  
(Rint = 0.0665) 
3346  
(Rint = 0.0249) 
3451  
(Rint = 0.0328) 
Max., min. transmission 0.6758, 0.4413 0.6720 and 0.4320 0.3907, 0.2809 0.6731, 0.4619 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0748,  
wR2 = 0.2034 
R1 = 0.0641, 
wR2 = 0.1441 
R1 = 0.0272,  
wR2 = 0.0691 
R1 = 0.0297,  
wR2 = 0.0719 
R indices (all data) R1 = 0.1406,  
wR2 = 0.2345 
R1 = 0.0919, 
wR2 = 0.1528 
R1 = 0.0344,  
wR2 = 0.0729 
R1 = 0.0367,  
wR2 = 0.0754 
Goodness-of-fit on F2 1.011 1.213 1.060 1.053 





 cis-14 cis-152CHCl3 trans-16 cis-17 
Formula C30H36F6N4O4Pd C17H26Br2Cl6N2OPtS C26H36Br2N4Pt C31H33Br2N2PPt 
Formula weight 737.03 874.07 759.50 819.47 
Crystal size [mm] 0.200.060.06 0.600.460.14 0.280.240.16 0.400.240.20 
Temperature [K] 223(2) 243(2) 295(2) 223(2) 
Crystal system Monoclinic Monoclinic Orthorhombic Monoclinic 
Space group C2/c P21/m Pbca P21/n 
a [Å] 21.057(3) 9.547(3) 17.2381(9) 10.5275(5) 
b [Å] 10.773(2) 10.589(3) 9.5180(5) 17.5069(8) 
c [Å] 14.149(2) 14.693(4) 17.8717(9) 16.5319(7) 
α [°] 90 90 90 90 
β [°] 101.415 104.055(6) 90 94.7690(10) 
γ [°] 90 90 90 90 
V [Å3] 3146.2(8) 1440.9(7) 2932.2(3) 3036.3(2) 
Z 4 2 4 4 
Dc [gcm-3] 1.556 2.015 1.720 1.793 
μ [mm-1] 0.667 8.284 7.530 7.328 
θ range [°] 1.97-27.49 2.20-27.47 2.28-27.49 1.70-27.50 
Reflection collected    11028 9829 19674 21495 
Independent reflections 3611  
(Rint = 0.0506) 
3484  
(Rint = 0.0531) 
3372  
(Rint = 0.0419) 
6985  
(Rint = 0.0391) 
Max., min. transmission 0.9611, 0.8782 0.3901, 0.0827 0.3788, 0.2269 0.3219, 0.1576 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0571,  
wR2 = 0.1268 
R1 = 0.0352,         
wR2 = 0.0926 
R1 = 0.0269,   
wR2 = 0.0610 
R1 = 0.0319,      
wR2 = 0.0753 
R indices (all data) R1 = 0.0625,  
wR2 = 0.1293 
R1 = 0.0405,         
wR2 = 0.0947 
R1 = 0.0538,  
wR2 = 0.0692 
R1 = 0.0412, 
wR2 = 0.0783 
Goodness-of-fit on F2 1.257 1.089 0.992 1.053 





 trans-18THF 192Me2CO 20 21 
Formula C22H31Br2N3OPt C72H62Br2N4O3Pd C33H26AgBrN2 C35H29Br2N3Pd 
Formula weight 708.41 1297.48 638.34 757.83 
Crystal size [mm] 0.300.200.08 0.380.200.20 0.240.100.08 0.540.320.10 
Temperature [K] 223(2) 223(2) 223(2) 223(2) 
Crystal system Orthorhombic Triclinic Monoclinic Monoclinic 
Space group Pbca P1 P21/n P21/n 
a [Å] 17.1196(7) 11.581(2) 17.5789(11) 16.6225(12) 
b [Å] 9.7318(4) 15.459(4) 9.1363(6) 10.6140(8) 
c [Å] 29.7136(11) 18.044(4) 18.2095(12) 18.0485(14) 
α [°] 90 69.890(13) 90 90 
β [°] 90 89.00(2) 114.853(2) 101.962(2) 
γ [°] 90 82.013(14) 90 90 
V [Å3] 4950.4(3) 3002.4(12) 2653.7(3) 3115.2(4) 
Z 8 2 4 4 
Dc [gcm-3] 1.901 1.435 1.598 1.616 
μ [mm-1] 8.915 1.692 2.290 3.189 
θ range [°] 1.81-27.50 1.20-27.50 1.35-27.48 1.52-27.50 
Reflection collected    33569 39475 18198 21635 
Independent reflections 5690  
(Rint = 0.0537) 
13748  
(Rint = 0.0247) 
6065  
(Rint = 0.0560) 
7164  
(Rint = 0.0561) 
Max., min. transmission 0.5357, 0.1751 0.7284, 0.5657 0.8380, 0.6094 0.7410, 0.2777 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0305, 
wR2 = 0.0636 
R1 = 0.0311, 
wR2 = 0.0813 
R1 = 0.0574, 
wR2 = 0.1362 
R1 = 0.0454, 
wR2 = 0.0934 
R indices (all data) R1 = 0.0444, 
wR2 = 0.0675 
R1 = 0.0394, 
wR2 = 0.0873 
R1 = 0.0889, 
wR2 = 0.1490 
R1 = 0.0769, 
wR2 = 0.1041 
Goodness-of-fit on F2 1.022 1.067 1.020 0.973 





 222CHCl3 26a0.5C6H5CH3 26b0.5CH2Cl2 29aCH2Cl2H2O 
Formula C68H54Br4Cl6N4Pd2 C34.50H35I2N2PPd C26.50H30ClI2N2PPd C51H50Cl2F3IN2O4P2PdS 
Formula weight 1672.29 868.82 803.14 1210.13 
Crystal size [mm] 0.560.420.16 0.140.080.02 0.360.260.10 0.240.140.04 
Temperature [K] 223(2) 295(2) 295(2) 293(2) 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic 
Space group P21/c P21/c P21/c P21/c 
a [Å] 21.2354(10) 9.3123(4) 9.3019(5) 12.0615(5) 
b [Å] 17.7672(8) 16.8404(7) 16.8771(9) 39.2897(18) 
c [Å] 18.5717(9) 21.6379(9) 18.9728(9) 11.1728(5) 
α [°] 90 90 90 90 
β [°] 110.1270(10) 95.7190(10) 94.5300(10) 100.8010(10) 
γ [°] 90 90 90 90 
V [Å3] 6579.1(5) 3376.4(2) 2969.2(3) 5200.9(4) 
Z 4 4 4 4 
Dc [gcm-3] 1.688 1.709 1.797 1.545 
μ [mm-1] 3.264 2.451 2.865 1.211 
θ range [°] 1.02-27.50 1.54-25.00 1.62-27.50 1.72-27.50 
Reflection collected    46299 19717 20857 37279 
Independent reflections 15108 
(Rint = 0.0382) 
5935 
(Rint = 0.0657) 
6797 
(Rint = 0.0357) 
11951  
(Rint = 0.0644) 
Max., min. transmission 0.6232, 0.2622 0.9526, 0.7254 0.7626, 0.4252 0.9532, 0.7599 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0415, 
wR2 = 0.0993 
R1 = 0.0789,  
wR2 = 0.1464 
R1 = 0.0638,  
wR2 = 0.1509 
R1 = 0.0607, 
wR2 = 0.1231 
R indices (all data) R1 = 0.0637, 
wR2 = 0.1093 
R1 = 0.1018,  
wR2 = 0.1548 
R1 = 0.0758,  
wR2 = 0.1573 
R1 = 0.0962, 
wR2 = 0.1356 
Goodness-of-fit on F2 1.029 1.253 1.168 1.038 





 29bCH2Cl2 33aMe2CO cis-33b·CH2Cl2 trans-33b·0.5CH3CN 
Formula C46H46Cl2F3IN2O3P2PdS C51H50BF4IN2PdOP2 C59H50BF4Cl2IN2PdP2 C59H49.5BF4IN2.5PdP2 
Formula weight 1130.05 1088.98 1239.96 1175.56 
Crystal size [mm] 0.260.100.06 0.160.140.06 0.300.080.02 0.400.300.14 
Temperature [K] 223(2) 295(2) 223(2) 223(2) 
Crystal system Orthorhombic Monoclinic Monoclinic Monoclinic 
Space group Pnma P21/c P21/n P21/c 
a [Å] 10.0914(5) 19.396(8) 18.9177(11) 18.2230(14) 
b [Å] 22.4737(11) 11.130(5) 14.4464(9) 16.6331(14) 
c [Å] 20.9892(11) 24.415(9) 21.7262(12) 17.5608(14) 
α [°] 90 90 90 90 
β [°] 90 109.236(11) 115.2320(10) 104.543(2) 
γ [°] 90 90 90 90 
V [Å3] 4760.2(4) 4976(3) 5371.1(5) 5152.2(7) 
Z 4 4 4 4 
Dc [gcm-3] 1.577 1.454 1.533 1.516 
μ [mm-1] 1.315 1.110 1.134 1.078 
θ range [°] 1.81-27.50 1.11-25.00 1.20-27.50 1.68-25.00 
Reflection collected    32206 28274 37433 29651 
Independent reflections 5584  
(Rint = 0.0761) 
8753 
(Rint = 0.1337) 
12321 
(Rint = 0.0630) 
9073 
(Rint = 0.0844) 
Max., min. transmission 0.9253, 0.7262 0.9364, 0.8424 0.9777, 0.7272 0.9582, 0.4869 
Final R indices 
[I > 2σ(I)] 
R1 = 0.0705,  
wR2 = 0.1551 
R1 = 0.0786, 
wR2 = 0.1615 
R1 = 0.0528, 
wR2 = 0.1248 
R1 = 0.0752, 
wR2 = 0.1475 
R indices (all data) R1 = 0.1000,  
wR2 = 0.1674 
R1 = 0.1600, 
wR2 = 0.1991 
R1 = 0.0829, 
wR2 = 0.1408 
R1 = 0.1064, 
wR2 = 0.1595 
Goodness-of-fit on F2 1.079 0.989 1.016 1.119 





 33c 34a 34b 34c·0.5H2O 
Formula C68H74B2F8I2N4Pd2P2 C17H19I2N3Pd C27H23I2N3Pd C21H28I2N3PdO0.5 
Formula weight 1649.47 625.55 749.68 690.66 
Crystal size [mm] 0.120.100.02 0.260.080.02 0.200.160.12 0.560.340.20 
Temperature [K] 223(2) 223(2) 223(2) 223(2) 
Crystal system Monoclinic Monoclinic Monoclinic Monoclinic 
Space group P21/n P21/n P21/n P21/n 
a [Å] 10.8110(16) 11.3735(14) 9.5081(5) 18.577(2) 
b [Å] 45.221(7) 8.5316(11) 13.5672(7) 9.4289(11) 
c [Å] 15.263(2) 20.507(3) 20.1031(11) 28.349(3) 
α [°] 90 90 90 90 
β [°] 96.852(3) 97.151(3) 93.2980(10) 99.156(2) 
γ [°] 90 90 90 90 
V [Å3] 7408.4(19) 1974.4(4) 2589.0(2) 4902.5(10) 
Z 4 4 4 8 
Dc [gcm-3] 1.479 2.104 1.923 1.871 
μ [mm-1] 1.422 4.069 3.121 3.289 
θ range [°] 1.42-25.00 1.95-27.50 1.81-27.50 1.46-27.47 
Reflection collected    42614 13400 18097 26478 
Independent reflections 13042 
(Rint = 0.1841) 
4522 
(Rint = 0.0630) 
5940 
(Rint = 0.0322) 
11178 
(Rint = 0.0305) 
Max., min. transmission 0.9721, 0.8479 0.9230, 0.4176 0.7058, 0.5741 0.5592, 0.2603 
Final R indices 
[I > 2σ(I)] 
R1 = 0.1052, 
wR2 = 0.2488 
R1 = 0.0562, 
wR2 = 0.1093 
R1 = 0.0406, 
wR2 = 0.0977 
R1 = 0.0455, 
wR2 = 0.1035 
R indices (all data) R1 = 0.2092, 
wR2 = 0.2907 
R1 = 0.0820, 
wR2 = 0.1175 
R1 = 0.0461, 
wR2 = 0.1000 
R1 = 0.0595, 
wR2 = 0.1091 
Goodness-of-fit on F2 1.034 1.069 1.132 1.075 





 35b·4CH2Cl2 38·2C6H5CH3 39·2CH2Cl2  
Formula C20H36Cl8I4N4Pd2 C112H116B4ClF1I3N8P4Pd4 C89H88B2Cl4F8I2N4P4Pd2  
Formula weight 1336.53 2887.00 2119.53  
Crystal size [mm] 0.700.140.10 0.100.080.04 0.220.220.14  
Temperature [K] 223(2) 293(2) 223(2)  
Crystal system Triclinic Triclinic Monoclinic  
Space group P1 P1 P21/c  
a [Å] 9.306(8) 10.8997(5) 18.0676(9)  
b [Å] 10.916(8) 15.5584(7) 24.2063(11)  
c [Å] 10.961(9) 18.2820(8) 20.8600(10)  
α [°] 66.564(17) 108.7450(10) 90  
β [°] 75.026(16) 94.0810(10) 94.5720(10)  
γ [°] 80.789(16) 100.3340(10) 90  
V [Å3] 984.9(13) 2860.5(2) 9094.1(8)  
Z 1 1 4  
Dc [gcm-3] 2.253 1.676 1.548  
μ [mm-1] 4.609 1.584 1.325  
θ range [°] 2.04-27.50 1.51-25.00 1.41-25.00  
Reflection collected    6632 30914 53179  
Independent reflections 4446 
(Rint = 0.0239) 
10065  
(Rint = 0.0547) 
16003  
(Rint = 0.1323) 
 
Max., min. transmission 0.6557, 0.1407 0.9393, 0.8577 0.8363, 0.7593  
Final R indices 
[I > 2σ(I)] 
R1 = 0.0467,  
wR2 = 0.1265 
R1 = 0.0818,  
wR2 = 0.1604 
R1 = 0.0783,  
wR2 = 0.1641 
 
R indices (all data) R1 = 0.0610,  
wR2 = 0.1362 
R1 = 0.0955,  
wR2 = 0.1659 
R1 = 0.1415,  
wR2 = 0.1892 
 
Goodness-of-fit on F2 1.038 1.281 1.005  
Peak/hole [eÅ-3] 1.335 / -0.951 1.309 / -2.019 0.718 / -0.958  
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